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Advances in medical treatment are leading away from generalized care towards 
intelligent systems or devices which can sense and respond to their environment.  With 
these devices, the burden of monitoring and dosing for treatment can be removed from 
the doctor (or the patient) and be placed on the device itself.  Implicit closed-loop 
control systems will allow the device to respond to its environment and release a 
therapeutic agent in response to a specific stimulus.  Environmentally responsive 
hydrogels show great promise in being incorporated in such an intelligent device, such 
as pH-responsive hydrogels which can swell and deswell in response to changes in the 
pH of the media.  Thus, pH changes can be exploited for controlled and intelligent drug 
delivery when used in combination with these pH-responsive hydrogels. 
In this work, heterogeneous, thermal-redox initiated free-radical polymerizations 
were developed to synthesize novel pH-responsive hydrogels, microparticles, and 
nanogels.  The specific disease of interest was type I diabetes, which requires daily 
doses of insulin both at a basal amount and either a postprandial or preprandial bolus in 
order to maintain blood glucose levels within safe limits.  To allow pH-responsive 
 vii 
hydrogels to be sensitive to glucose, glucose oxidase was incorporated which oxidizes 
glucose to gluconic acid. 
A novel inverse-emulsion polymerization method was developed for the 
synthesis of poly[2-(diethylaminoethyl methacrylate)-grafted-polyethylene glycol 
monoethyl ether monomethacrylate] (P(DEAEM-g-PEGMMA)) nanogels (100-400 nm) 
for intelligent insulin delivery.  The new polymerization method allowed the 
incorporation of hydrophilic components, such as glucose oxidase and catalase, as well 
as PEG surface tethers of lengths 400 Da up to 2000 Da.  Surface tethers successfully 
decreased the surface charge of the nanogels.  Insulin loading and release was 
determined for microparticles which were able to imbibe substantial amounts of insulin 
from solution when swollen, entrap the insulin when collapsed, and then release the 
insulin in response to either a pH or glucose stimulus. 
 viii 
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There is a growing need in the medical field for devices that can provide patients 
with custom doses of a therapeutic agent [1] in response to high concentrations of 
selected biomarkers.  More importantly, these devices need to be “intelligent;” they 
need to only release the drug when the patient is in need of its therapeutic effects.  To 
provide this automatic and customized dosing, these devices must be able to first sense 
a specific biomarker associated with the diseased state and then release the drug at a 
predetermined biomarker level.  Once the biomarker concentration drops and signals 
the end of the dosing period, the device must then limit its release of the therapeutic 
agent.  Thus, a closed-loop system involving sensors, transducers, and actuators must be 
synthesized to provide this desired response. 
The detection of a biomarker can be implemented in numerous ways.  
Molecularly imprinted polymers (MIPs) have shown great promise as “artificial 
antibodies” that can recognize specific substrates [2-6].  The polymer is formed around 
the desired substrate, which allows monomer moieties to form interactions, generally 
noncovalent, with the substrate.  Cavities are left behind once the template molecules 
are rinsed out of the polymer; thus, the polymer is able to preferentially absorb 
molecules that fit these cavities.  A major drawback to MIPs is the high crosslinking ratio 
necessary to prevent the cavities from “forgetting” their imprint [7, 8] a crosslinking 
ratio that decreases the magnitude of swelling and thus decreases the possible increase 
of release of a drug molecule.  
A second possible sensing mechanism incorporates competitive binding of a 
ligand [9-11].  One such instance is the use of concanavalin A (ConA), which is a lectin 
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that binds sugar molecules.  It has a very high affinity for glucose, which leads to 
numerous methods of delivering insulin.  Hydrogels can be synthesized containing 
crosslinks of ConA complexed with either glucosyloxyethyl methacrylate [10] or some 
other glycosylated monomer unit [12].  In the presence of glucose, the glucosyloxyethyl 
methacrylate-ConA complex dissociates, and ConA reassociates with glucose in solution.  
This process leads to the dissolution of the polymer complex, which can be combined 
with the release of imbibed insulin.  ConA can also be used to bind a bioactive 
glycosylated insulin conjugate which, in the presence of glucose, is released from the 
system [13, 14].  However, over time, most systems slowly lose ConA to the surrounding 
fluid, thus decreasing sensitivity. 
The toxicity of such devices has been questioned, though a recent review [15] 
has concluded that, provided the devices are not injected intravenously, a functional 
amount of ConA could safely be incorporated.  Another method incorporates 
phenylboronic acid moieties, which can also reversibly bind to diols, forming repulsive 
charges on the polymeric backbone [16, 17].  One other complication with these ligand-
binding based sensors is their affinity for other saccharides such as mannose.  It has 
been shown that oral ingestion of mannose increases blood mannose levels [18], which 
could undermine the glucose sensitivity of a ConA based device and possibly prove 
dangerous. 
There are numerous methods proposed and used for sensing glucose.  However, 
enzymes have evolved to have a highly specific affinity for certain biomolecules, and 
exploiting this specificity could prove to be an ideal method of detection in 
pharmaceutical devices.  Of the sensors currently being researched, enzyme-based 
sensors appear to be the most promising; their specificity does not allow “forgetting” of 
the biomarker, and they also tend to have orders of magnitude more specificity for one 
molecule compared to similar molecules.  For this thesis, type I diabetes will be used as a 
 3
model disease, using glucose as the biomarker and glucose oxidase as the sensor 
enzyme.   
Type I diabetes mellitus is a disease in which the patient’s pancreas is no longer 
able to produce the required insulin for glucose cellular uptake, and thus the patient 
requires supplemental insulin for survival.  Typically, this is due to an autoimmune 
response to the patient’s own β-islet cells. 
The current standard method of insulin delivery is subcutaneous injection of an 
insulin solution multiple times per day, primarily before consuming a meal.  The insulin 
pump is a second method, in which the patient has a catheter implanted for prolonged 
periods of time that is connected to an external insulin delivery device.  The patient can 
easily control the dosing of insulin to account for his current activities.  In both of these 
treatments, for optimal glucose control, the patient must know precisely how much 
insulin is needed at any given time.  The extraction of a small amount of blood, most 
commonly via needle prick, is necessary for glucose measurements. 
To provide patients with optimal blood glucose control, a closed loop delivery 
device is ideal.  The device itself can continuously monitor the patient’s glucose levels, 
and then deliver insulin when necessary.  The inconvenience of forcing the patient to 
monitor his or her glucose levels can thus be eliminated, along with the requirement 
that the patient knows how much insulin to dose himself or herself in any given 
situation.  The patient’s blood glucose levels can remain within healthy physiological 
limits, which significantly decrease secondary complications such as blindness, renal 
failure, microvascular problems, nerve damage, and more [19-25].  The cost of treating 
these complications has been shown to be significantly more than the cost of treating 
diabetes itself [26]. 
This thesis focuses on determining whether enzyme-based hydrogel carriers can 
be used for intelligent closed-loop drug delivery.  The hypothesis of the research was 
that polymeric carriers using enzymes to sense specific biomarkers will provide 
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intelligent, feedback-controlled closed-loop release of a pharmaceutical agent, 
ultimately resulting in better control of the diseased state.  Type I diabetes mellitus was 
used as a model disease, and tighter glycemic control that will thus improve the living 
standards of type I diabetics was be the final goal.  It was important to determine 
whether the specificity of an enzyme can be coupled to a polymeric device to provide 
the desired sensing and release properties necessary for a pharmaceutical device. 
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2.1 DIABETES MELLITUS 
2.1.1 Pathology 
Diabetes mellitus is a disorder in which the patient has elevated blood glucose 
levels, either due to the inability to produce enough insulin or the inability to efficiently 
use the insulin produced [1].  The body uses glucose as the main metabolite for 
generating adenosine triphosphate (ATP), the energy source for most cellular activity.  
The typical level of blood glucose in healthy individuals is around 80-90 mg/dL.  Even 
after consuming a meal, a healthy individual will rarely have glucose levels above about 
120-140 mg/dL.  Excess glucose is removed from the plasma and either used or stored 
as glycogen.  During fasting conditions, the body will regenerate this glucose, either 
from the breakdown of glycogen, amino acids, or fatty acids.  In order to help cells 
uptake and use glucose, the pancreas secretes the regulating hormone insulin from the 
β-cells in the Islets of Langerhans. 
At the onset of a blood glucose level spike, the β-islet cells release insulin to 
accelerate glucose usage and prevent hyperglycemia (Figure 2.1).  The response of these 
cells to elevated blood glucose levels is not zero order.  There is an initial spike in insulin 
release, which is then followed by a large decrease in the insulin concentration.  As the 
islet cells synthesize more insulin, it is released to the surroundings, eventually reaching 
the maximum amount to be delivered.  This response has been characterized as having 
both a proportional and a derivative response to the glucose input [2].  While increased 
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blood glucose levels are a strong factor in determining how much insulin is released, 
other metabolites are important as well.  Amino acids, free fatty acids, as well as 
numerous proteins and hormones all contribute to the islet cells’ insulin production.  
Diabetes sets in when the pancreatic cells are no longer able to operate as normal, and 
thus blood glucose levels rise above normal. 
There are two main types of diabetes mellitus.  Type 1 diabetes is characterized 
by either a severe or total lack of insulin production.  This disease is usually caused by an 
autoimmune attack of the patient’s β-islet cells where insulin is produced.  The cells are 
destroyed, leaving the individual unable to produce insulin.  Thus, the patient must take 
insulin supplements to survive.  Type 2 diabetes is caused by a resistance to the effects 
of normal insulin levels.  Patients can have a genetic predisposition for this disease, and 
it is more common in obese patients.  While diet and exercise were the normal 
treatments for type 2 diabetes, insulin supplements have recently become more 
commonly prescribed.  Diabetes is a serious disease afflicting over 180 million people 
worldwide with estimates that this number will double by 2030, according to the World 
Health Organization.  This diabetes epidemic has therefore influenced numerous 
researchers to try to improve upon current treatment options.  Because type 1 diabetes 
is always insulin dependent, it will be the focus of this research. 
2.1.2 Current Treatments 
Current treatments for type 1 diabetes consist of dosing the patient with 
exogenous insulin.  The most common method of delivering the insulin is 
subcutaneously via syringe.  The patient must first test his or her blood glucose level 
with a sample of blood, usually obtained by a needle stick to the finger or some other 
body part.  Once the current glucose level is known, the patient must decide whether an 
insulin dose is necessary.  If a dose is necessary, the patient must calculate how much 
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insulin is needed depending on what activities are planned in the near future.  
Consuming a meal, exercising, and many other activities affect how much insulin the 
patient will need.  If instead it is determined that hypoglycemia has set in, a small 
amount of sugar is necessary to prevent the condition from becoming dangerous, which 
could lead to fainting or even a coma.  This treatment regime is an open-loop control of 
blood glucose levels, since the patient must both measure his or her glucose levels and 
then use that measurement to decide what action must be taken. 
There are other methods available for diabetic patients to combat insulin 
deficiency, though nearly every one is also an open loop control.  Insulin pumps have 
become more common over the years.  Instead of having to repeatedly inject oneself 
with insulin, a cannula is implanted subcutaneously for a number of days and a 
continuous supply of insulin is provided.  When the patient needs to adjust the infusion 
rate, the pump can be reprogrammed and the patient can receive insulin without using 
a new syringe accompanied by an injection.  However, blood glucose levels need to still 
be monitored by the patient to know when the insulin dosage needs to be altered.  
Higher risks of ketoacidosis have been reported, especially when the pump 
malfunctions.  The device usually must be removed during certain physical activities 
such as strenuous exercise or bathing.  Recently, implantable insulin pumps (IIP) have 
been released in Europe and America.  These devices solve many of the problems of 
external pumps, yet still require user intervention to change insulin infusion rates.  Also, 
new problems have arisen, such as scarring or fibrotic tissue formation near the implant 
site [3]. 
These insulin delivery routes both pose numerous problems.  Needles are 
involved with both methods, which decrease patient compliance and comfort due to 
pain and/or needle phobia [4].  Needles also pose a biohazard risk.  Exubera®, an 
inhalable form of insulin, was recently released, but it had problems with product 
bulkiness and a limited number of patients that could actually use the device.  Smaller 
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than average lung capacity, such as a child’s, or even damaged lungs from being a 
smoker or having uncontrolled asthma, rendered the patient unable to use inhalable 
insulin.  Even for those patients lucky enough to qualify for inhalable insulin, the dosing 
was a fixed amount, and the patient had to take the inhalation ten minutes before every 
meal.  These problems, among others, forced Pfizer to halt production and sales of 
Exubera.  Oral delivery of insulin has been labeled as the holy grail for insulin delivery, 
since the patient would no longer need to inject insulin.  The problem of protein 
degradation in the stomach has been solved using methacrylic acid based complexation 
hydrogels, but low bioavailability still remains an issue [5].  Also, all of these treatments 
are part of an open loop control of the patient’s blood glucose levels, where the patient 
must first check his glucose levels and then dose himself accordingly. 
2.1.3 Closed-Loop Diabetes Control 
Patient inconvenience is not the only problem associated with the open-loop 
control of a diabetic’s blood glucose levels.  Severe complications have been associated 
with chronically poor blood glucose control.  Tissue damage occurs after years of high 
glucose levels.  Blood vessels can be damaged on both the microvasculature and 
macrovasculature levels, leading to numerous other problems such as loss of sight, 
kidney failure, and nerve damage.  The Centers for Disease Control and Prevention have 
stated that diabetes-caused nerve damage is the leading reason for the non-traumatic 
amputation of lower limbs in the United States.  Preventing these complications not 
only helps improve the quality of life of diabetics, but it also helps decrease healthcare 
needs.  Thus, diabetic patients need to have their blood glucose levels monitored and 
controlled on a continuous basis, bringing treatment closer to the response of an actual 
pancreas. 
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In order to provide the ideal control of blood glucose levels, the device must 
continuously monitor glucose and release insulin.  This concept is the basis for closed-
loop control devices for the treatment of diabetes.  A logical option would be to 
transplant a healthy pancreas into the patient; however, due to shortages of healthy 
pancreases as well as severe problems with immune responses, a pancreas transplant is 
not typically a feasible route.  Encapsulating the β-cells in a semipermeable membrane 
has been heavily researched [6], which could possible act as an artificial pancreas.  The 
membrane prevents cells or antibodies from destroying the encapsulated cells, yet 
allows glucose into the device and insulin out of the device.  However, cell viability and 
immune responses are still major problems.  Different geometries are being researched 
to maximize the response of these cells to the blood glucose levels while still protecting 
them from the immune response. 
Entirely synthetic devices have also been researched and manufactured.  The 
Biostator® is one such device, with both a glucose sensor and an insulin infusion pump, 
acting as an artificial pancreas.  A computer algorithm controls the insulin infusion, 
depending on the needs of the patient.  However, the device is too large to be 
implanted and is thus extracorporeal.  More problems with this device included catheter 
fouling, maintaining insulin activity in the reservoir, and needing to tune the algorithm 
for the specific patient, among others.  While it is impractical for daily use, it is a 
significant contribution to the medical field and academic community.  More work is 
being conducted, attempting to combat these issues while miniaturizing the whole 
device by linking an IIP with a continuous glucose monitoring device. 
Another alternative to these devices is an implicit closed-loop insulin delivery 
device based on a chemical system that can perform all three functions of the artificial 
pancreas in one unit.  The device can detect the surrounding glucose levels, and then 
alter the infusion rate of insulin based on this concentration.  It acts as a sensor for 
glucose, a control algorithm by mechanically changing in response to the glucose levels, 
 14 
and an infusion system by passively allowing the diffusion of insulin out of the device.  
Since the device itself must respond appropriately to its surroundings, the design and 
fabrication of the device, both chemically and physically, is integral to providing the 
necessary therapeutic effects. 
The field of novel diabetes treatment research is continually evolving and resides 
at an exciting forefront of medicinal research.  Diabetes was initially diagnosed by a 
patient having sweet-tasting urine, from ancient times up until about the 20th century.  
Initial treatments were also just as crude and thus life expectancy was quite short.  
Around the 1920s several milliliters of crudely purified insulin was discovered to 
effectively treat patients.  Significant advancements have occurred over the last century, 
though there is still plenty of room for improvement.  Improving the lives of diabetic 
patients will continually be sought until a cure for the disease itself is discovered. 
2.2 HYDROGELS IN DRUG DELIVERY 
2.2.1 Hydrogels 
Hydrogels are hydrophilic polymers that have been crosslinked to form a three- 
dimensional polymer matrix.  Under the correct environmental conditions, these 
materials can imbibe significant amounts of water, often over two orders of magnitude 
more water than polymer by weight.  Due to the large water content, hydrogels are 
currently the synthetic material most resembling living tissue [7].  These properties help 
make hydrogels ideal for use in tissue engineering, as well as numerous other 
applications such as drug delivery, surface coatings, contact lenses, wound dressings, 
and even polluted water treatment [8-11]. 
There are several important physical parameters of hydrogels that alter the 
properties and ultimately can determine the potential uses of a polymer system.  One of 
 15 
the most important parameters is the average molecular weight between crosslinks, 
cM , which indicates how frequently crosslinks have formed along the polymer 
backbone.  However, for diffusion studies, it is more important to know the physical size 
between the polymer chains.  By using Equation (2.1), cM can be manipulated to find 
the mesh size, ξ , which essentially indicates what sized particle could theoretically 















lCQξ         (2.1) 
In this equation, Q  is the volume swelling ratio, nC  is the Flory characteristic ratio, l  is 
the length of a bond on the polymer backbone, and rM is the molecular weight of the 
repeat unit.  As a hydrogel swells, its mesh size increases allowing larger solutes to 
diffuse through its macromolecular chain network.  This swelling is characterized by the 
polymer volume fraction in the swollen state, sv ,2 , which is the inverse of the volume 
swelling ratio. 
The study of hydrogel use in drug delivery applications has been in place for 
decades [12-15].  It was realized early on that reservoir devices yielded zero-order 
release kinetics, that is, a release rate that was not a function of time.  Transport 
through the membrane shell is the diffusion-limiting step, and so the rate of release can 
be controlled by changing the thickness or type of membrane.  These devices tend to 
have either a burst-effect or lag-effect, depending on whether or not the drug had time 
to dissolve in the membrane during storage.  Since many diseased states can be treated 
with a constant, therapeutic level of drug, reservoir devices seemed ideal.  However, 
difficulties in manufacturing as well as problems with membrane rupture were 
significant hindrances.  Also, large molecular weight drugs such as proteins are not able 
to diffuse at an appreciable rate through the biocompatible polymers used in reservoir 
devices. 
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Non-degrading matrix type systems, on the other hand, typically yield first-order 
release kinetics.  A matrix system has the drug homogeneously dispersed or dissolved 
throughout the polymer.  For these devices, the release profile is a function of the 
square root of time.  Thus, the drug is released faster at earlier time points compared to 
later ones.  This is because the drug has to diffuse through the whole polymer system in 
order to be released, and so the diffusional path length increases with time as the drug 
concentration decreases.  The burst and lag effects tend to not be present, and the 
manufacturing of these devices can be less intricate than reservoir systems.  There is 
also no need to worry about the polymer rupturing, since the drug is dispersed 
throughout the whole polymer system and it is less likely to cause a significant 
overdose.  These devices permit site-specific drug delivery and others can even permit 
tissue targeting [16]. 
2.2.1.1 Neutral Hydrogels 
Depending on their charges, hydrogels can be divided into two types: neutral 
and ionic.  Neutral hydrogels are a class of polymer gels that do not have any ionizable 
moieties on their side chains, such as poly(vinyl alcohol) (PVA).  These polymers swell 
due to a balance between the elastic retractive forces of the polymer chains and the 
thermodynamic mixing of the polymer chains with the solvent molecules.  These 
polymers can be used as bioadhesives or in both reservoir and matrix drug delivery 
systems, among other applications. 
Certain hydrogels exhibit environmental sensitivity due to these forces being 
functions of temperature [17, 18] or some other variable.  One such polymer, poly(N-
isopropyl acrylamide), exhibits a lower critical solution temperature (LCST); at 
temperatures above this LCST, the polymer is hydrophobic and remains in a collapsed 
state.  Below the LCST, the hydrogel is hydrophilic and imbibes large amounts of water.  
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Thus, if a drug is dissolved or suspended in the polymer, it is more easily able to diffuse 
out when the polymer is swollen.  A similar swelling behavior is observed with polymers 
that exhibit an upper critical solution temperature (UCST), though these systems swell 
above the threshold temperature and collapse below it (Figure 2.2). 
Poly(ethylene glycol) (PEG) is a neutral polymer that does not exhibit pH 
sensitivity but is still quite important to mention.   It is a highly biocompatible polymer 
of repeating ethylene glycol units.  In an aqueous environment, each ethylene glycol 
repeat unit is able to bind multiple molecules of water.  This phenomenon allows the 
PEG chains to repel each other and form a “brush-like” conformation when the 
appropriate PEG density is achieved [19].  It is believed that the chains form a 
mushroom morphology when the surface density of PEG is much lower.  Thus, a high 
surface density of PEG grafts is usually desired. 
PEG has long been known for its resistance to protein adsorption [20-22] which 
can be attributed to its steric repulsion, hydrophilicity, and chain mobility [23].  Two 
surfaces coated with PEG will develop repulsive forces when brought close enough, due 
to the steric stabilization of each PEG chain.  The interaction between infinitely sized 
[21] to small sized [20] proteins has been modeled, showing that van der Waals 
interactions between the PEG and protein are negligible.  Materials coated with PEG 
tethers have been shown to decrease opsonization and often complement system 
activation [24].  These properties can allow the prolonged use of medical devices in vivo 
while preventing coagulation, protein binding, or severe immune response.  Thus, these 
properties have made PEG the most widely used polymer to impart biocompatibility and 
stealth properties to materials.  For a more in-depth review of PEG, see Appendix A. 
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2.2.1.2 Ionic Hydrogels 
One of the interesting types of environmentally-sensitive hydrogels is the ionic 
hydrogel [25].  These polymers exhibit extensive swelling when in certain media, in part 
due to electrostatic forces.  Changes in environmental conditions such as pH [26, 27], 
ionic strength [28], buffer species [29, 30], temperature [31, 32], or other conditions 
cause swelling of these systems.  Anionic pH-sensitive hydrogels are neutral at a pH 
below their pKa, where the backbone and/or pendant groups are uncharged.  When in 
this state, hydrogen bonding between moieties is possible, especially when acidic and 
ethereal groups are present such as methacrylic acid and PEG.  It is interesting to note 
that the pKa can be a slight function of temperature, thus adding some temperature 
dependence to pH-sensitive polymers. 
Once the pH rises above the pKa of the pendant groups they become charged.  
Usually, a carboxylic acid becomes deprotonated which imparts a negative charge on 
the system.  Often, hydrogen bonds are broken and electrostatic repulsion ensues.  The 
polymer also tends to become more hydrophilic, thus imbibing more water as it swells.  
Osmotic forces also play a role in the extent of swelling.  Thus, the pH, buffer species, 
and ionic strength are all important parameters in determining the extent of swelling of 
a given polymer system.  Common anionic polymers consist of methacrylic acid (MAA) 
or acrylic acid (AA), which have carboxylic acid functional groups that can deprotonate 
to form carboxylate anions (Figure 2.3).  It has also been shown that copolymers of 
acrylic acid and acrylamide exhibit both a pH and very significant temperature swelling 
response [33]. 
Cationic hydrogels function in the opposite manner as anionic hydrogels.  When 
the pH of the medium is above the pKa of the polymer, the polymer is in its uncharged, 
deprotonated state.  Many polymers are also fairly hydrophobic in this state.  The 
polymer is collapsed, excluding a significant amount of water from the interior of the 
 19 
system.  Once the pH is dropped below the pKa, significant portions of the polymer 
become protonated, thus taking on a positive charge.  This positive charge can then 
induce swelling due to charge repulsion and an increase in hydrophilicity of the system, 
imbibing significant amounts of water.  These hydrogels can then be collapsed again by 
raising the pH.  Many cationic hydrogels are based on amines since the lone electron 
pair on the nitrogen is able to capture a hydrogen ion, imparting a positive charge to the 
nitrogen atom (Figure 2.3). 
Significant research has been conducted on cationic systems based on either 
polymers or copolymers of N,N-diethylaminoethyl methacrylate (DEAEM) or N,N-
dimethylaminoethyl methacrylate (DMAEMA) [30, 34-40].  The pKa of PDEAEM at 
physiological temperature is very close to physiological pH, between about 7.0 and 7.3; 
therefore, a slight drop in local pH from physiological will cause significant swelling of 
the hydrogel system.  This swelling is coupled to an increase in the mesh size of the 
system, allowing imbibed solutes to more easily diffuse out.  One important limitation 
that Siegel et al. observed is that Donnan equilibrium excludes hydrogen ions from the 
hydrogels, which can be partly overcome by using buffered media.  In high ionic 
strength media, Donnan equilibrium also limits the extent of swelling, due to the 
partitioning of the dissolved salts.  Mallapragada and Anderson have synthesized 
copolymers of DEAEM and PEG via anionic polymerizations [41].  The initiator potassium 
t-butoxide was used to produce very monodisperse linear pH responsive polymers.  
Cytocompatibility tests were also conducted.  While polymers of pure DEAEM were 
cytotoxic, polymers containing PEG tethers were shown to be cytocompatible at 
concentrations as high as 3 mg/L.  Thus, the PEG tethers act as expected and can help 
decrease cell toxicity. 
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2.2.2 Hydrogels in Insulin Delivery 
Insulin delivering hydrogels have been heavily researched, though the success of 
these systems is variable.  Ishihara et al. characterized the permeation of insulin through 
membranes made of 2-hydroxyethyl methacrylate (HEMA) with methyl methacrylate 
(MMA) as a comonomer [42].  These devices exhibited zero order release profiles of 
insulin, and permeability increased with increasing HEMA content.  However, the insulin 
needs of a patient that has just consumed a meal are not met with a zero order release.  
They also showed the responsiveness of a poly(amine) membrane to glucose using 
immobilized glucose oxidase [43, 44].  The diffusion of insulin through the membrane 
was shown to increase as the glucose concentrations increased.  This concept was later 
used to form polymer capsules of 1.5 mm diameter synthesized out of complexed 
random copolymers of DEAEM, 2-hydroxyethyl acrylate (HEA), and 4-
trimethylsilylstyrene (TMS) with entrapped glucose oxidase [45].  These capsules were 
loaded with insulin when synthesized, and release rates were determined.  A cyclic 
response was observed when the capsules were repeatedly exposed to glucose 
solutions. 
Most hydrogel based insulin delivery systems rely on glucose oxidase coupled 
with environmentally sensitive hydrogels to detect glucose.  Glucose oxidase (GOx) is 
approximately a 160 kDa dimeric enzyme for oxidizing glucose into gluconic acid (Figure 
2.4).  Dissolved oxygen is reduced to hydrogen peroxide in the process of glucose 
oxidation (Figure 2.5).  Since an acid is produced from glucose, it is possible to use the 
decrease in pH as a signal for increased glucose levels.  Glucose oxidase has been used 
for decades in the determination of blood glucose levels for diabetic patients.  It has 
also been demonstrated that molecules other than oxygen can be reduced, thus 
allowing the transfer of charge along a conductive material to directly operate as a 
sensor.  Due to the toxicity of hydrogen peroxide, catalase (CAT), a 250 kDa tetrameric 
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enzyme, has been incorporated in some devices to prevent a toxic buildup (Figure 2.5).  
Catalase also regenerates the consumed dissolved oxygen, thus helping to eliminate one 
limitation of the glucose oxidase/glucose sensor.  Both enzymes occur naturally in many 
organisms, though the mold Aspergillus niger is a common source for industrial and 
medical uses.   
A graphical representation of how a pH responsive cationic polymer with 
immobilized glucose oxidase and catalase responds to glucose levels is shown in Figure 
2.6.  An appropriate hydrogel needs to be selected such that the system is collapsed at 
normal physiological pH, with a relatively small mesh size.  Thus, the pKa of the hydrogel 
needs to be at or below about 7.4.  As the glucose levels rise, the glucose oxidase 
catalyzes more oxidations of glucose and therefore the concentration of gluconic acid 
increases.  Locally, this gluconic acid buildup drops the pH.  The hydrogel absorbs these 
excess hydrogen ions, imparting a positive charge along the polymer backbone.  The 
governing thermodynamics force the polymer to swell.  Larger quantities of gluconic 
acid cause larger amounts of swelling.  As the hydrogel swells, the mesh size increases, 
thus allowing imbibed insulin to diffuse out of the system.  Once the released insulin 
starts to cause a drop in glucose levels, the concentration of gluconic acid inside the 
system decreases and the insulin release slows or stops. 
Horbett et al. designed systems based on crosslinked DMAEMA with HEMA and 
glucose oxidase [46].  These films were synthesized by first freezing the monomer 
mixture and then exposing it to radiation from a 60Co source to initiate the 
polymerization.  Glucose oxidase was entrapped in the hydrogel structure, thus 
imparting glucose sensitivity to the pH sensitive hydrogel.  Storage of the systems for 
300 days in buffer still retained more than a third of the enzymatic activity, whereas 
storage in blood for 60 days retained almost half of the enzymatic activity.  Thus, long 
term usage of such devices may be possible, since the enzyme remains stable over long 
periods of time.   125I labeled insulin was used for release studies, which were performed 
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in vitro as well as in vivo.  They concluded that insufficient amounts of insulin were 
being released, however, and that macroporous structures may be necessary.  Further 
work showed that these macroporous structures were able to regulate insulin release at 
more relevant levels [47]. 
Siegel and Firestone [40] also used polybasic gels based on DMAEMA.  
Oscillatory swelling and deswelling was demonstrated, yielding an ultimate collapsed 
state.  These systems were then used to selectively release caffeine as a model drug 
[38].  At a very low pH, release continued for almost two hours.  At slightly acidic and 
neutral pH, the gels took nearly twice as long to fully release the caffeine.  Thus, the 
collapsed hydrogels were able to trap the small molecular weight drug significantly 
more than the swollen hydrogels.  When they copolymerized DMAEMA with methyl 
methacrylate [35], they showed that temperature and ionic strength also affected 
swelling and deswelling.  Significant amounts of water were able to be imbibed in these 
systems.  As the amount of MAA or the alkyl chain length of n-alkyl methacrylate esters 
increased, swelling volume decreased [28].  This effect was attributed to an increase in 
the overall hydrophobicity of the system, which decreased the total amount of water 
able to be imbibed. 
Siegel and Firestone also studied the effects of the ionic strength and buffer 
composition of the swelling media [30, 34, 36].  They tested how different ions affected 
swelling extent and rates using a 70/30 gel of MMA/DMAEMA.  These systems exhibited 
significant sensitivities to the different ions tested, especially the multivalent ions.  
Increased ion concentrations decreased overall swelling.  Weak electrolytes allowed 
faster swelling than strong electrolytes.  A rigorous application of the ideal Donnan 
equilibrium theory was unsuccessfully able to fit all the data, and so a heuristic 
approach was taken to qualitatively describe the responses of the systems to different 
ionic species [30]. 
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Kinetic experiments were performed using DMAEMA and n-alkyl methacrylate 
esters [35].  The alkyl chain length was altered to vary the overall hydrophobicity of the 
systems.  A biphasic means of swelling was observed in glassy disks, having an initial 
slow uptake of water followed by a rapid volume expansion.  This initial swelling rate 
was observed to increase with four factors: increased temperature, decreased pH, 
decreased n-alkyl methacrylate content, and decreased alkyl chain length.  When the 
opposite conditions are met, a non-Fickian zero-order behavior is observed.  Weak 
electrolytes were observed to increase swelling kinetics substantially compared to 
strong electrolytes, which was attributed to the ease of ion transport through the 
membranes.  Initially rubbery disks, on the other hand, did not exhibit these biphasic 
swelling fronts.  Instead, they had monophasic but still non-Fickian sorption of the 
solvent. 
More recently, Siegel has moved away from a hydrogel for releasing insulin 
towards one that acts as an actuator for a glucose sensing device based on 
phenylboronic moieties [48].  The glucose reversibly bound to the phenylboronic 
groups, imparting a charge to the boron atom.  This charge induced swelling in the 
system similarly to the cationic hydrogels.  As the gel swelled in the presence of glucose, 
it pressed against a plate attached to a variable capacitor, thus altering the resonant 
frequency of an LC resonator.  This device had a response time of 90 min, though this 
should be improved by decreasing the thickness of the responsive hydrogel layer.  They 
have also been working on a P(NIPAAm-co-MAA) membrane that could temporarily shut 
off glucose transport at low pH [49].  Glucose flux resumed after equilibration at this low 
pH, albeit at much lower rates.  These results were attributed to a collapsed “skin” that 
formed on the acidic side of the membrane. 
Goldraich and Kost [50] studied systems based on DEAEM and HEMA, crosslinked 
with tetraethylene glycol dimethacrylate (TEGDMA).  Glucose oxidase, either 
immobilized or entrapped, was included in these systems.  Swelling as a function of the 
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comonomer and crosslinking ratios was determined, and insulin release was tested.  In 
high pH media, little insulin was released.  Unfortunately, the collapse of a gel was much 
slower than the swelling, and thus the cutoff of insulin release was much slower than 
the initiation of insulin release.  This slowed collapse may be due to Donnan equilibrium 
effects, which make it more difficult to remove the hydrogen ion from the swollen gel.  
Other problems noticed were low physiological oxygen concentrations and possible 
encapsulation after implantation.  Since glucose oxidase is dependent on dissolved 
oxygen as a reactant, low physiological levels significantly hinders the kinetic rate of the 
glucose oxidation. 
Imanishi and associates took a different approach to releasing insulin.  Porous 
cellulose films were grafted with poly(acrylic acid) and glucose oxidase [51].  At neutral 
pH, the chains were charged and extended due to charge repulsion, thus blocking the 
pores of the cellulose membrane.  Once the glucose levels increased, glucose oxidase 
catalyzed the formation of gluconic acid.  The pH dropped, and the acrylic acid groups 
became protonated and lost their charge.  This decrease in electrostatic repulsion 
between polymer chains allowed the opening of the pores, releasing insulin.  A second 
method of insulin release consisted of insulin immobilized to a polymer membrane 
using a disulfide bond [52].  Glucose dehydrogenase (GDH) was used to ultimately 
reduce the disulfide bond in the presence of glucose, thus releasing insulin.  NAD was 
also incorporated to help with the charge transfer from the GDH to the insulin disulfide 
bond.  Released insulin activity was reported to be the same as untreated insulin. 
Heller et al. also took a different route to release insulin [53].  A bioerodible 
poly(ortho ester) was used, which should have degraded in response to very slight pH 
decreases.  Thus, with the incorporation of glucose oxidase would render the system 
glucose erodible, since it would degrade much faster in the presence of glucose.  This 
degradation could be coupled to the release of infused insulin.  However, it was noticed 
that the poly(ortho ester) was not terribly specific for its degradation.  The inclusion of 
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tertiary amine components solved this problem by increasing the hydrophilicity of the 
system when in an acidic pH.  The increased hydrophilicity allowed higher water 
penetration, which in turn led to a faster erosion rate.  This erosion was coupled to a 
release of the impregnated insulin.  They demonstrated cyclic responses as well, and 
these data suggest the possibility of a long-term device that could release insulin in 
bursts, in response to high glucose concentrations. 
Peppas et al. have been studying both anionic and cationic hydrogels for the 
delivery of insulin and other drugs for decades.  Hariharan and collaborators [54-56] 
studied copolymers of DEAEM and HEMA, N,N-diethylaminoethyl acrylate (DEAEA) and 
HEMA, methacrylaminopropyl ammonium chloride and HEMA, and acrylic acid (AA) and 
HEMA.  Model drugs such as insulin, oxprenolol, lysozyme, and bovine serum albumin 
(BSA) were used in the studies.  As the crosslinking amount increased, the mesh size 
decreased and solute release was either decreased or slowed.  For the cationic gels, 
solute release increased with a decrease in pH.  Anionic gels exhibited the opposite 
behavior, where solute release increased with an increase in pH.  Release of solutes was 
by a diffusion-controlled process. 
Dorski et al. took another approach to insulin release [57-59].  Instead of 
coupling glucose oxidase to a cationic hydrogel for insulin release in the presence of 
glucose, an anionic gel was studied.  Since the decrease in pH still needed to illicit the 
release of insulin, a tighter network was used.  Thus, upon constriction of the hydrogel, 
insulin was “squeezed” out of the system.  Copolymers of methacrylic acid (MAA) and 
ethylene glycol (EG) were synthesized, containing immobilized glucose oxidase and 
catalase.  The system exhibited strong complexation at acidic pH, thus providing a 
means of insulin release in the presence of glucose. 
There is great promise in DEAEM based devices, as shown by Podual et al. [60-
66].  Hydrogels were synthesized with DEAEM and PEG grafts, and crosslinked with 
TEGDMA.  Glucose oxidase and catalase were chemically immobilized in the systems 
 26 
using acryloyl chloride.  Both films and microparticles were synthesized, both of which 
showed pH and glucose sensitivity.  The films were made via UV initiated polymerization 
between two glass plates.  The particles were synthesized via suspension polymerization 
in silicone oil with redox initiators, and different sized particles were formed depending 
on the speed of mixing and the amount of surfactant used.  Smaller particles swelled 
faster, whereas larger particles and disks swelled slower.  The films were determined to 
have too slow a response time for physiological need; however, the microparticles did 
have a fast enough response time.   
Other parameters were also changed, such as crosslinking ratio and PEG graft 
length.  Varying the crosslinking ratio was shown to alter the swelling rates and maxima.  
It was found that a crosslinking ratio of 3 mol % gave the highest ratio of diffusion of 
insulin out of the swollen hydrogel to the collapsed hydrogel.  Systems with longer PEG 
grafts were determined to have swelling responses dominated by relaxation of chains, 
whereas shorter PEG grafted systems had diffusion-controlled swelling rates.  Modeling 
of these systems was performed, which provided a means of estimating insulin release 
profiles.  It was determined that a reasonable amount of polymer particles could be 
loaded and delivered to a patient. 
Hydrogels have also been used in the oral delivery of proteins.  Lowman et al. 
showed that copolymers of MAA and PEG form significant complexation in their 
collapsed states [67, 68].  Hydrogen bonding at low pH between the hydrogen on the 
MAA group to an etheric oxygen on the PEG unit was observed.  This complexation was 
broken once the pH rose above the pKa of the material and the acid moiety became 
deprotonated and negatively charged.  These systems were also very efficient at loading 
insulin.  Since these hydrogels were collapsed at a low pH and swollen at a neutral pH, 
they were ideal for oral insulin delivery to the small intestines.  The stomach has a low 
pH as well as peptidases that are designed to destroy proteins.  Thus, when insulin was 
encapsulated in the collapsed hydrogel at low pH values, it was protected from the 
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harsh environment of the stomach.  The environment in the upper small intestines is 
much more hospitable to insulin, with fewer peptidases and a much higher pH.  Thus, 
after being protected in the stomach, the insulin was released in the neutral 
environment of the small intestines when the complexation of the MAA and PEG broke 
down. 
One last example worth mentioning, though not for insulin delivery, is the 
detection of glucose levels using glucose oxidase imbedded in a conductive polymer 
[69].  Instead of coupling glucose oxidase with acid production to generate a signal, the 
reduction of redox hydrogels was used to capture electrons from the enzymatic reaction 
and pass them along the polymer to an electrode.  The polymer backbone itself was not 
conductive, contrary to standard conductive polymers such as polyaniline.  Rather, long 
flexible pendant chains off the polymer backbone had a functional group susceptible to 
redox reaction, which allowed the charge to diffuse by swinging from pendant chain to 
pendant chain towards the imbedded electrode, as shown in Figure 2.7.  This 
arrangement allowed the enzyme to be throughout the entire hydrogel contrary to 
monolayers coating an electrode. 
2.3 CONCLUSIONS 
It is apparent from the above literature survey that designing a device to release 
insulin in a physiological manner is highly desirable.  Hydrogels seem a logical building 
block, since their parameters can be precisely tuned to provide specific key features, 
such as mesh size, response time, and release rates.  They also can easily be made 
biocompatible, either by choosing already biocompatible materials or by grafting chains 
such as PEG to the surface (see Appendix A).  The environmental sensitivity of the many 
hydrogels being studied also provides a means of incorporating a drug reservoir, a 
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sensor, and an actuator all into one device with minimal components.  Thus, designing 
















































Figure 2.1. Insulin Infusion of a Healthy Individual 
Increase in blood insulin levels in isolated rat pancreatic islets in response to different 
increases in blood glucose levels.  Glucose levels were initially 80 mg/dL and were 
ramped to a final constant value.  The initial high rate of infusion is due to the rapid 
dumping of previously synthesized insulin, while the secondary release is from currently 



























Figure 2.2. Swelling of Theoretical Temperature-Sensitive Polymers. 
The solid line represents a theoretical polymer exhibiting a lower critical solution 
temperature (UCST), the hashed line represents a theoretical polymer exhibiting an 
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Figure 2.3. Swelling of Theoretical pH-Sensitive Polymers. 
The solid line represents a theoretical anionic polymer; the hashed line represents a 








Figure 2.4. Molecular Computer Model of Glucose Oxidase from Aspergillus Niger. 
The red atoms represent the surface mapping of the enzyme glucose oxidase.  The 
green spheres are typical glycosylation molecules.  The blue in the center of the image is 






























Figure 2.5. Chemical Reaction Catalyzed by Glucose Oxidase 
(a)  β-D-glucose is first oxidized to β-D-glucono-1,5-lactone while dissolved oxygen is 
reduced to hydrogen peroxide by the enzyme glucose oxidase (GOx).  β-D-glucono-1,5-
lactone is then hydrolyzed to gluconic acid in the presence of water. 
(b)  Hydrogen peroxide is oxidized back into water by catalase (CAT), evolving molecular 






 Figure 2.6. Diagram of a Cationic Hydrogel System Response to a Glucose Stimulus 
As glucose concentrations rise, gluconic acid production increases.  The system swells 













































































































Figure 2.7. Electron Diffusion in Redox Hydrogels 
Electrons diffuse in the redox hydrogels by collisions between mobile redox centers 
tethered to the backbone of the cross-linked and hydrated polymer.  When the tethers 
are long enough, the reduced (black) and the oxidized (white) members of the couple 
can come within the Marcus theory-defined distance δ that the electron can cross 
(adapted from ref [69]). 
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The main objective of this Ph.D. thesis was to contribute to the medical field 
through the evaluation of enzyme-containing systems for intelligent, feedback-
controlled drug delivery.  This work had several goals: a) synthesize novel self-regulating 
polymeric systems consisting of pH-responsive moieties, as well as immobilized enzymes 
to impart sensitivity of a specific biomarker; and b) study the release kinetics from these 
systems. 
We proposed that a new intelligent polymeric system can have the ability to 
regulate its drug release and provide closed-loop control of the intended disease.  As a 
model case, type I diabetes was evaluated.  Closed-loop control should decrease 
complications typically associated with poor glucose control by preventing spells of 
severely high or low glucose levels [1]; the system will be able to respond to its 
environment and only release insulin when necessary.  The specific aims of this research 
project were to 
1. Identify systems where enzymes can be used to help detect biomarkers. 
2. Apply concepts to glucose oxidase containing systems for intelligent 
response to glucose, using type I diabetes as the model disease. 
3. Prepare and characterize the systems, including under physiologically 
relevant conditions. 
4. Provide guidance for the design and development of devices using these 
concepts. 
Each of these specific aims was covered in a chapter below.  The first two specific 
aims were covered in Chapter 4.  The third specific aim was broken down into several 
chapters; the macro- and microscopic polymer synthesis and characterization was 
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discussed in Chapter 5, the nanoparticle polymer synthesis and characterization was 
discussed in Chapter 6, Chapter 7 discusses the insulin loading and release behavior of 
all polymer systems, and monomer and crosslinker synthesis was discussed in Chapter 8.  
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CHAPTER 4 
Enzyme Selection for Biomarker Detection in Hydrogel Devices 
4.1 HYDROGELS FOR CONTROLLED DRUG DELIVERY 
There are two main methods of using enzymes paired with hydrogels to control 
drug delivery; one system swells in acidic media (cationic), the other swells in basic 
media (anionic).  The pKa of an ionic polymer indicates the critical swelling pH, where 
the hydrogel will transition between its fully collapsed to its fully swollen state.  Cationic 
hydrogels typically contain a basic moiety such as an amine which causes the swelling.  
In basic media, above the pKa, the amine is deprotonated and in its collapsed, 
hydrophobic states.  In an acidic medium, below the pKa of the polymer, the amine is 
protonated and carries a net positive charge.  This net charge causes an increase in 
hydrophilicity and net repulsive forces that increase the osmotic pressure inside the 
hydrogel.  A balance is struck between the elasticity, mixing, and ionic Gibbs free 
energies which results in a swollen hydrogel.  This swelling is reversible upon increasing 
the pH back to above the pKa, causing a collapse in the system. 
Anionic hydrogels typically contain an acidic moiety such as a carboxylic acid 
which causes the swelling.  In acidic media, below the pKa, the carboxylic acid is 
protonated and in its collapsed, possibly complexed state (hydrogen bonding between 
the acid hydrogen and electron pairs on nearby oxygen atoms).  In basic media, above 
the pKa of the polymer, the acid is deprotonated and carries a net negative charge.  This 
net charge causes a breakdown in hydrogen bonding and net repulsive forces that 
increase the osmotic pressure inside the hydrogel.  A balance is struck between the 
elasticity, mixing, and ionic Gibb’s free energies which results in a swollen hydrogel.  
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This swelling is reversible upon decreasing the pH back to below the pKa, causing a 
collapse in the system and reformation of hydrogen bonded complexes. 
Cationic monomers which could be used in controlled drug delivery devices 
include N,N-dimethylaminoethyl methacrylate, N,N-diethylaminoethyl methacrylate, 2-
(diisopropylamino)ethyl methacrylate, 2-(N-morpholino)ethyl methacrylate.  The 
associated pKa values of the polymers of these monomers are 8.0, 7.3, 6.0, and 4.9, 
respectively [1].  Reduction of the pKa of the hydrogel shifts the critical pH at which it 
will swell, and also dictates the sensitivity of the system to slight perturbations in local 
pH.  It is possible to slightly shift any of these pKa values to either higher or lower values 
by copolymerization with more hydrophilic or hydrophobic monomers, or by 
synthesizing similar molecules with differing structures.  These modifications allow one 
to tune the way the system responds to a given stimulus. 
Anionic hydrogels, on the other hand, are capable of swelling in elevated pH 
ranges.  These gels have also been investigated for “squeezing out” a drug at low pH 
values, since they collapse in acidic media.  Possible monomers for such delivery devices 
are acrylic acid (AA), methacrylic acid (MAA), ethacrylic acid (EAA), and so on.  The pKa 
values of these monomers are 4.8, 6.2, and 7.2, respectively [2-4].  Obviously, polymers 
containing EAA have a substantial biological potential due to physiological pH being 7.4. 
4.2 SPECIFIC ENZYMES FOR BIOMARKER DETECTION 
Typically, an enzyme is selected that is inherently specific to a certain biomarker 
of interest.  This process provides maximum selectivity and specificity for the desired 
biomarker, reducing the chance of unwanted  
Urease is an oxidoreductase that converts urea to carbon dioxide and ammonia 
(Figure 4.1).  High levels of urea, while not toxic, may indicate problems with a patient’s 
kidneys [5].  Increased urea production has also been shown to accompany moderate to 
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severe bleeding from gastric ulcers [6].  Thus, when one of these two conditions occurs, 
an increase in urea in the presence of urease would cause an increase in ammonia.  
Since ammonia is a base, it could be coupled to anionic hydrogels to induce swelling and 
then release a drug to combat the symptoms.  Since both conditions are chronic, the use 
of an enzyme system could prove quite promising as a long-term solution that would 
require little to no intervention from the patient.   
Cholesterol oxidase is another enzyme that may be promising to the controlled 
drug delivery field.  The enzyme oxidizes cholesterol to cholest-4-en-3-one (Figure 4.2), 
which has been shown to significantly reduce body weight gain and body fat 
accumulation [7].  Hydrogen peroxide is also produced as a byproduct of this reaction.  
While the conversion of cholesterol itself is of therapeutic importance, this process 
could possibly be coupled to the release of a drug for high cholesterol.  Due to the 
toxicity of hydrogen peroxide and the dependence on the reaction rate on dissolved 
oxygen, catalase is often used to consume excess hydrogen peroxide that is formed in 
such reactions.  However, it may be possible to use a second enzyme, such as 
horseradish peroxidase, to instead couple the hydrogen peroxide production with the 
swelling of the hydrogel.  Horseradish peroxidase is able to oxidize numerous 
substrates, and thus it may be possible to oxidize another molecule imbibed in the 
system or an aldehyde monomer unit to a carboxylic acid, which could in turn cause 
swelling of the hydrogel system.   This route could be coupled with either a cationic or 
an anionic hydrogel, depending on the compound to be oxidized. 
Finally, one of the most promising biomarker-enzyme combinations to date for 
intelligent drug delivery is the glucose-glucose oxidase pair.  Glucose oxidase will oxidize 
glucose, forming gluconic acid.  Since the presence of glucose causes a drop in pH, the 
combination of this enzyme with pH sensitive hydrogels has been studied for intelligent 
insulin delivery.  In this body of work, the main monomer of interest was N,N-
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diethylaminoethyl methacrylate, since the pKa is just below physiological pH of 7.4 and 
















Figure 4.1. Urease  Oxoreduction 
Chemical reaction catalyzed by the urease enzyme.  Urea is hydrolyzed into carbon 

























Figure 4.2. Cholesterol Oxidation via Cholesterol Oxidase 
Chemical reaction catalyzed by the cholesterol oxidase enzyme.  Cholesterol is oxidized 
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Preparation and Characterization of Poly(Diethyaminoethyl methacrylate) 
Based Hydrogels 
5.1 INTRODUCTION 
The monomer 2-(diethylamino)ethyl methacrylate (DEAEM) is a well studied 
methacrylate monomer that easily undergoes free-radical polymerizations [1-3].  
Several research groups have studied the macroscopic properties of hydrogels based on 
DEAEM, either as a homopolymer or copolymerized with such monomers as methyl 
methacrylate (MMA) [4], 2-hydroxyethyl methacrylate (HEMA) [5], and others [6, 7].  
These polymers have an increased hydrophilicity at pH values near and below the pKa of 
the polymer due to the protonation of the tertiary amine.  This process is reversible, and 
hydrophobicity increases with increased pH. 
Initial studies with DEAEM were performed by Shatkay and Michaeli [8], who 
identified the phase separation of PDEAEM at 7.48 and measured a pKa of 7.68 via 
titration.  Several factors can influence this pKa value such as polymer chain length, 
comonomer composition (and thus hydrophobicity), and crosslinking ratio, with other 
groups reporting values in the range of 7.0 to 7.4.  These polymers also have a Tg below 
ambient temperature, with values ranging from 16-24°C [4, 9]. 
In order to accomplish the second specific aim, free-radical initiated cationic 
hydrogel films and microparticles were synthesized.  One of the most promising 
polymeric systems for closed-loop insulin delivery is based on PDEAEM.  These polymers 
are cationic, with a pKa value very near physiological pH.  To impart glucose sensitivity, 
glucose oxidase (GOx) is typically entrapped in these hydrogels.  GOx oxidizes β-D-
glucose (which remains in equilibrium with α-D-glucose while in solution [10]) into 
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gluconic acid, reducing dissolved oxygen into hydrogen peroxide in the process, as 





  (5.1) 
With an increase in glucose concentration, glucose oxidase catalyzes the formation of 
gluconic acid.  Therefore, the local pH drops, protonating the tertiary amines and 
swelling the polymer due to charge repulsion and polymer hydration.  However, it has 
been shown that the depletion of dissolved oxygen will affect the reaction kinetics, and 
that saturating the reaction solution with oxygen can increase reaction rate by as much 
as 100%.  Also, hydrogen peroxide is toxic to biological systems and has a poisoning 
effect on this reaction.  Thus, the incorporation of Catalase (CAT) allowed the oxidation 
of hydrogen peroxide back into dissolved oxygen, removing the toxic byproduct and 




      (5.2) 
Optimization was performed to determine the optimal concentrations of glucose 
oxidase and catalase, as well as the ratio of functional monomers to PEG grafts and 
crosslinks.  The structures of the monomers used can be seen in Figure 2.5. 
Currently, most attempts at designing DEAEM-based closed-loop drug delivery 
devices have involved the physical entrapment of both glucose oxidase and catalase in 
the device.  This procedure may allow the slow release of these enzymes into the 
surrounding medium, thus decreasing the effectiveness of the device as time 
progresses.  The hydrogels reported here have chemically bound enzymes, which 
prevent the loss of enzyme over time.  It has also been shown that chemically bound 
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enzymes may have increased specific activities when compared to physically entrapped 
enzymes [11].  The N-terminus of each enzyme was functionalized with acryloyl 
chloride, essentially turning each enzyme into a very large monomer.   
5.2 MATERIALS AND METHODS 
5.2.1 Poly(Diethylaminoethyl methacrylate) Polymer Film Synthesis 
Hydrogels of N,N-diethylaminoethyl methacrylate and poly(ethylene glycol)-n 
monomethyl ether monomethacrylate, henceforth P(DEAEM-g-EGn) were synthesized 
using a free radical thermal polymerization in solution, where ‘n’ refers to the average 
molecular weight of the ethylene glycol repeat units.  To synthesize these hydrogels, a 
solution of DEAEM (Sigma-Aldrich, St. Louis. MO), PEGnMMA (Polysciences, Warrington, 
PA) and the crosslinking agent tetraethylene glycol dimethacrylate (TEGDMA) or 
polyethylene glycol 400 dimethacrylate (PEG400DMA) (Acros Organics, Morris Plains, 
NJ) was made.  The DEAEM was passed through a column of basic alumina (Fisher 
Scientific, Fair Lawn, NJ) prior to use to remove inhibitor.  All other reagents were used 
as received.  Phosphate buffered saline (PBS) (Fisher Scientific) was used as the solvent 
to prevent autoacceleration and was reconstituted from a 10X concentrate with 
deionized water (Milli-Q Plus system, Millipore, Bedford, MA), in a ratio of about 1:1 by 
weight of the monomers.  Hydrochloric acid (ca. 37 wt%, Fisher Scientific) was used to 
increase solubility.  Ammonium persulfate (APS) (Fisher Scientific) and sodium 
metabisulfite (NaMBS) (Fisher Scientific) were used to initiate the polymerization. 
Several different polymers were synthesized with varying compositions.  The 
ratio of DEAEM to PEG grafts was either 10:1, 25:1, or no PEG grafts.  Crosslinking ratios 
varied from 3 mol% up to 15 mol%.  Once all compounds had been well mixed in a test 
tube, the solution was transported to a glove box where it was purged with nitrogen for 
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20 min to remove dissolved oxygen, a free-radical scavenger.  The initiator solution was 
then added, mixed via aspiration, and then pipette between two glass slides, separated 
by a 760 μm Teflon spacer.  The glass slide assembly was then placed in an acrylic air-
tight polymerization box, sealed, and transported to an incubator at 37°C for 24 h.  This 
procedure resulted in polymer films which were either cut into small discs (ca. 11 mm 
diameter) or crushed into microparticles via a wet-sieving technique.  The discs were 
then washed in a jar of PBS for one week to remove unreacted monomers and small 
molecular weight polymers.  The microparticles were suspended in fresh ddH2O, spun 
on a rotary mixer for 45 min, and then centrifuged at 3200 rcf (relative centrifugal force) 
for 20 min.  The pellets were resuspended and this process was repeated 5 times total.  
The polymers were then either stored in buffer or dried in a vacuum oven (discs) or 
freeze dried (particles) and stored in a dessicator until use. 
The DEAEM is hydrophobic at a pH above its pKa; thus, hydrochloric acid (ca. 37 
wt%, Fisher Scientific) was used to protonate the monomer to make it hydrophilic.  An 
alternate route to improving the solubility of DEAEM was to precipitate solid DEAEM-
HCl from a 2 N HCl solution in ethyl ether.  The precipitate was recovered, washed with 
dry ethyl ether, excess solvent removed under reduced pressure, and then stored in 
vials at -20 °C until used. 
The redox initiator ammonium persulfate (APS) (Fisher Scientific) was used to 
initiate the polymerization, along with the accelerant sodium metabisulfite (NaMBS) 
(Fisher Scientific) to prevent the need of elevated temperatures.  The ratio of the two 
compounds was usually 4:1 by mole to prevent premature polymerization, and the 
chemicals were pre-mixed before polymerization in distilled deionized water (ddH2O) at 
a 1 wt% concentration of APS.  The initiator solution was used in an amount of 0.5% by 
moles of monomers. 
Several different polymers were synthesized with varying compositions.  The 
ratio of DEAEM to PEG grafts was either 10:1, 25:1, or no PEG grafts.  Crosslinking ratios 
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varied from 3 mol% up to 15 mol%.  Glucose oxidase concentrations were either 3.3 x 
10-4 mg/g polymer or 6.6 x 10-4 mg/g polymer.  Catalase concentrations were always five 
times the glucose oxidase concentration. 
Numerous steps were taken to provide the optimal polymerization conditions.  
The monomer solution was mixed in a glass test tube wrapped with aluminum foil to 
help decrease the chances of premature polymerization from light.  Acidifying the 
monomer was an exothermic reaction, so small quantities of acid were added to an ice 
cold monomer solution and then mixed.  This prevented premature thermally-induced 
polymerization of the uninhibited DEAEM.  Once all compounds had been well mixed in 
the test tube, it was transported to a glove box where it was purged with nitrogen for 20 
min to remove dissolved oxygen, a free-radical scavenger.  The initiator solution was 
then added, mixed via aspiration, and then pipette between two glass slides, separated 
by a 760 μm Teflon spacer.  The glass slide assembly was then placed in an acrylic air-
tight polymerization box, sealed, and transported to an incubator at 37°C for 24 h.  
Polymer films were synthesized in this way, and were washed in a jar of PBS for one 
week to remove unreacted monomers and small molecular weight polymers.  The 
polymers were then either stored in buffer or dried in a vacuum oven and stored in a 
dessicator until use.  The wash water was analyzed for residual, unreacted enzyme 
content. 
Polymer films had two fates: small discs (ca. 11 mm diameter), or crushed 
microparticles.  Polymer discs were formed by placing the hydrated polymer film on a 
Teflon slab and cutting it into discs with a cork-borer of inner diameter 11 mm.  
Microparticles were formed via a wet-sieving technique.  The hydrated polymer was 
placed in a sieve of a specific mesh size (typically 150 µm) and then forced through the 
sieve with a pestle.  If a smaller particle size was desired, the particles were placed in an 
even smaller mesh sieve and again forced through the screen.  Particle sizes as small as 
sub-30 µm were obtained using this method. 
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5.2.2 Incorporation of Enzymes into Polymer Structure 
Polymers were also synthesized with both glucose oxidase and catalase in order 
to render these polymeric systems glucose sensitive.  The enzymes were suspended in 
PBS and allowed to chill in an ice bath for 30 min.  Gentle stirring was used to allow 
mixing but to prevent flocculation.  After chilling, a small amount of acryloyl chloride 
(Alfa Aesar) was added to the solution.  The acid chloride moiety of acryloyl chloride has 
been shown to be preferentially attacked by the N-terminus of GOx and presumably CAT 
as well, as shown by the mechanism in Figure 5.3.  This step essentially converts the 
enzymes into very large monomers; the acrylate groups on the enzymes allow them to 
participate in the copolymerization, incorporating the enzymes covalently into the 
polymer backbone.  It has been reported that chemically immobilizing some enzymes 
has shown increased stability, and the loss of activity over time due to leeching of 
enzymes is no longer a concern. 
To synthesize these hydrogels, a solution of DEAEM, PEGnMMA and the 
crosslinking agent TEGDMA or PEG400DMA was made.  The DEAEM was passed through 
a column of basic alumina prior to use to remove inhibitor.  All other reagents were 
used as received.  Instead of neat PBS, the enzyme solution as prepared above was used 
as the solvent to prevent autoacceleration, in a ratio of about 1:1 by weight of the 
monomers.  Hydrochloric acid was used to increase solubility and was added slowly to 
reduce temperature spikes.  APS and NaMBS were used to initiate the polymerization in 
a ratio of 4:1 by mole, and the chemicals were pre-mixed before polymerization in 
ddH2O at a 1 wt% concentration of APS.  The initiator solution was used in an amount of 
0.5% by moles of monomers. 
Several different hydrogels were synthesized with varying compositions.  The 
ratio of DEAEM to PEG grafts was either 10:1, 25:1, or no PEG grafts.  Crosslinking ratios 
varied from 3 mol% up to 15 mol%.  Once all compounds had been well mixed in a test 
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tube, the solution was transported to a glove box where it was purged with nitrogen for 
20 min to remove dissolved oxygen, a free-radical scavenger.  The initiator solution was 
then added, mixed via aspiration, and then pipette between two glass slides, separated 
by a 760 μm Teflon spacer.  The glass slide assembly was then placed in an acrylic air-
tight polymerization box, sealed, and transported to a refrigerator at 4°C for 24 h to 
reduce any chance of enzyme denaturation.  This procedure resulted in polymer films 
which were either cut into small discs (ca. 11 mm diameter) or crushed into 
microparticles via a wet-sieving technique.  The discs were then washed in a jar of PBS 
for one week, refrigerated, to remove unreacted monomers and small molecular weight 
polymers.  The microparticles were suspended in fresh ddH2O, spun on a rotary mixer 
for 45 min, and then centrifuged at 3200 rcf for 20 min.  The pellets were resuspended 
and this process was repeated 5 times total.  The polymers were then either stored in 
buffer or dried in a vacuum oven (discs) or freeze dried (particles) and stored in a 
dessicator until use. 
5.2.3 Polymer Characterization via FT-IR 
Fourier transform infrared (FT-IR) spectra were obtained on a ThermoNicolet 
Nexus 470 spectrometer (Thermo Electron Corp., Waltham, MA) with a deuterated 
triglycine sulfate (DTGS) detector and potassium bromide (KBr) beam splitter.  Typically, 
128 scans were performed in the wavenumber range of 4000-400/cm, both forward and 
backward at 10 kHz, with a manual gain of one.  Pellets of ca. 10 mg polymer and 200 
mg KBr (spectroscopy grade, Acros Organics) were pressed at 15,000 psi using a Carver 
laboratory press.  Crushed microparticles were used for generating the spectra. 
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5.2.4 Polymer Characterization via NMR 
Nuclear magnetic resonance (NMR) spectra were obtained on a Varian Unity+ 
300 MHz spectrometer.  Deuterated water (D2O, Cambridge Isotope Laboratories, Inc., 
Andover, Ma.) was used to suspend nanoparticles for tether analysis.  Water 
suppression was used via the PRESAT macro with a saturation power of -2 and a 
saturation time of 5 s on any samples with significant water signals.  Small molecule 
analysis was obtained by using a suitable deuterated solvent, such as chloroform 
(CDCl3), dimethylsulfoxide (d6-DMSO), or d¬6-acetone, all obtained from Cambridge 
Isotope Laboratories.  Unless otherwise stated, for all 1H NMR spectra, the sample was 
spinning at 20 Hz, the number of transients was 8, and line broadening was 0.1. 
5.2.5 Polymer Characterization via DSC 
A PerkinElmer DSC 7 differential scanning calorimeter (PerkinElmer, Waltham, 
MA) using a heat/cool/heat method was used to characterize the polymers.  A rapid 
heating cycle was used to erase any thermal history from the samples, after which the 
samples were cooled back down to the starting temperature.  The final heating cycle 
had a ramp rate of 10⁰C/min, which was slow enough to detect a Tg in some samples.  
Since room temperature was above the Tg of most samples, a nitrogen cooling unit was 
used with an initial temperature of -55°C. 
5.2.6 Polymer Characterization via SEM 
A LEO Model 1530 SEM was used to determine the morphology of the 
synthesized particles.  Samples were prepared for imaging in one of two methods.  
Method one consisted of suspending the particles in a volatile non-solvent and then 
placing a drop on an aluminum stage.  Method two required the use of double-sided 
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conductive carbon tape to hold the lyophilized samples on the aluminum stage.  To 
prevent charging of the samples, they were sputter coated with gold using a Pelco 
Model 3 sputter coater.  Stages were stored in a dessicator until loading into the SEM. 
5.2.7 Polymer Swelling Characterization 
As stated above, nanoparticles were sized via DLS as a function of pH.  The 
swelling response of microparticles and disks was obtained gravimetrically.  The polymer 
samples were titrated to the desired pH with either 0.1N HCl or 0.1N NaOH, and the pH 
was measured with an ISFET probe as with the nanoparticles.  Swelling media was PBS 
with an ionic strength of 154 mM and initial pH of 7.4.  Microparticles were centrifuged 
at a relative centrifugal force of 3200g (Centra CL3R, Thermo IEC) and the supernatant 
was removed to obtain the mass of the particles. 
5.3 RESULTS AND DISCUSSION 
5.3.1 Poly(Diethylaminoethyl methacrylate) Polymer Film Synthesis 
Films, which were then either cut into discs or crushed into microparticles, were 
successfully synthesized.  Wet sieving yielded irregularly-shaped particles with sizes of 
sub-150 μm or sub-45 μm in the relaxed state, depending on which sized sieve was 
used.  It is necessary to note that all polymers in this work are referred to by their feed 
(pre-polymerization) compositions rather than polymer compositions due to the 
difficulty in quantitatively analyzing crosslinked copolymer compositions. 
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5.3.2 Incorporation of Enzymes into Polymer Structures 
The inclusion of the immobilized enzymes did not appear to alter the pKa of the 
hydrogels significantly, both films and microparticles.  Temperature, however, did affect 
the pKa.  At 20 °C, the pKa was very close to 7.4.  At a temperature of 37 °C, the pKa 
dropped to about 7.1.   
5.3.3 FT-IR Spectroscopy 
FTIR showed the functional groups present in each sample which indicated the 
successful removal of unreacted double bonds.  The C=C stretching absorbance near 
1650 cm-1 and the out-of-plane C-H bending of these same double bonds near 950 cm-1 
were nearly non-existent.  Also, the larger presence of etheric bonds in the samples 
containing PEG tethers, near a frequency of 1100 cm-1 (C-O stretching), indicates a 
higher content of PEG than those simply containing PEG crosslinker.  Thus, it is 
reasonable to assume that the PEG tethers were successfully incorporated into the 
hydrogel backbone. 
5.3.4 NMR Spectroscopy 
Water suppression was necessary for all samples analyzed in D2O; otherwise, the 
signal-to-noise ratios for the hydrogel peaks were too low for analysis.  1H NMR was 
attempted on crushed microparticles in several different solvents, including D2O and 
deuterated dimethyl sulphoxide (DMSO-D6).  Unfortunately, due to the limitations of 
solution NMR on crosslinked microparticles, very little useful information was able to be 
extracted from the spectra.  Solid NMR spectroscopy was a possible alternative, though 
it was decided not to pursue such a technique due to the lack of availability of the 
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equipment and the reduced amount of information the technique is able to provide 
(compared to solution NMR, as discussed in Chapter 6). 
5.3.5 Differential Scanning Calorimetry (DSC) 
Heat flow curves as a function of temperature were generated for several 
different polymeric systems and can be seen in Figure 5.5.  It is interesting to note that 
crushed microparticles did not have an observable Tm.  This result can be explained by 
the methods of polymerization and how they alter the polymer structure.  The crushed 
microparticles were synthesized as a film, where the PEG and DEAEM copolymerized 
without any partitioning and were randomly polymerized into the polymer chain.  The Tg 
of crosslinked hydrogels was unable to be determined, due to the highly restricted 
polymer chain motion from the of crosslinking.  Microparticles did not exhibit a 
detectable Tg.  However, the Tg of uncrosslinked PDEAEM was determined to be -20°C, 
which agrees with previous reports. 
5.3.6 Scanning Electron Microscopy (SEM) 
Scanning electron microscopy allowed the visual inspection of the crushed 
polymer microparticles.  Wet sieving of hydrogel films through sieves of 150 μm yielded 
the particles shown in Figure 5.6 and Figure 5.7.  These particles had irregularly shaped 
features due to the nature of the crushing.  These irregular features provided an 
increased surface area compared to a smooth sphere of a similar diameter, which could 
potentially affect the dynamics of swelling and insulin release.  The PEG surface grafts 
appeared to soften the surface features of the crushed particles compared to those 
without PEG grafts, as seen in Figure 5.6.  Particles with higher nominal crosslinking 
ratios had smaller collapsed particle sizes, as seen in Figure 5.7.   
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5.3.7 Polymer Swelling Characterization  
Swelling analyses of the systems showed a sigmoidal response to pH as expected 
(Figure 5.8), with the transition occurring rapidly near the pKa of the polymer.  The pKa 
of DEAEM polymers is a function of molecular weight, comonomer composition, and to 
some degree, temperature, with a range between pH 7.0-8.0.  At 25 °C the transition 
from fully collapsed to fully swollen occurs over a narrow pH range of less than 1 unit 
and occurred at about pH 7.2 (Figure 5.8).  This pKa range is important in several 
applications, most notably in biological systems which are typically buffered at a near 
neutral pH. 
Swelling results for microparticles are reported here as a weight swelling ratio 
(q),  
q = Ws / Wd, 
where Ws is the swollen weight of the particles and Wd is the dry weight of the 
particles.  Even when fully collapsed, particles retained about equal masses of polymer 
and solvent, resulting in a collapsed q of 2.  As crosslinker content increased, the overall 
mass swelling decreased due to restrictions in interchain movement.  Polymers with a 
15% crosslinking ratio swelled from a collapsed weight swelling ratio of 2 (q, weight 
swollen divided by weight dry) to a ratio of 6, samples that had 10% crosslinking ratio 
swelled to a ratio of 6.6, while samples that were only crosslinked at 3% swelled to a 
ratio of 11.  Solid lines represent a sigmoidal (hyperbolic tangent) fit to the data, and not 
just a guide to the eye.  These data agree with previous reports of similar systems [12-
14]. 
These swelling values were then used to estimate the mesh size of each sample.  
Since the mesh size of a hydrogel is essentially the molecular pore size, it can be used to 
help determine the ability of a given solute to diffuse through the polymer.  There are 
several methods of estimating the mesh size of a hydrogel; however, the Flory-Rehner 
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model was selected due to the difficulty of measuring such parameters as the relaxed 
volume (i.e., for the Peppas-Merrill or Brannon-Peppas equation).  Thus, these values 
are rough estimates of the actual values and should not be taken as the actual values 
themselves. 
To determine the polymer parameters, hydrogels were swollen to equilibrium 
and then mass swelling was determined.  The ratio of swollen mass to dry mass, q, was 
calculated for each data point, and the polymer volume fraction in the swollen state, 









=,2         (5.3) 
where m is the mass of dry particles, υ is the specific volume of the polymer 
(0.93 g/cm3), and wρ  is the density of water. 
 For the reasons mentioned above, estimation of the average molecular 
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The parameters are as follows: V1 is the molar volume of the welling agent (18 
cm3/mol for water), I is the ionic strength (1.7 for PBS, 0.002 for 2mM KCl), 1χ is the 
Flory polymer-solvent interaction parameter (0.2, as estimated by Hariharan [5]), and 
nM is the number average molecular weight of the polymer chains before crosslinking 
(estimated to be 15 kDa by GPC, though the actual value has negligible influence on 
estimates beyond a certain value).  Once cM was know, the mesh size (ξ ) was 
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where Cn is the Flory characteristic ratio (14.6 for vinyl polymers), Mr is the 
average molecular weight of the repeat units, and l is the length of the bond along the 
polymer backbone (1.54 Å for vinyl polymers).  
The results of this analysis are as follows and shown in Figure 5.9.  Polymers with 
a crosslinking ratio of 15% had, as expected, the smallest swollen mesh size at a value of 
34 Å.  As the crosslinking ration decreased, the hydrogels formed larger molecular pores 
with values of 40 Å for a 10% crosslinked sample and 78 Å for the 3% crosslinked 
sample.  All samples had a collapsed mesh size on the order of 1 Å.  Therefore, it should 
be feasible to entrap medium molecular weight compounds in the collapsed state, and 
allow controlled release of these compounds in the swollen state.  Small peptides, such 
as insulin with a monomeric radius of only 1.3 nm [15], were expected to have no 
trouble being imbibed into the polymer network and then become trapped upon 
collapse. 
5.4 CONCLUSIONS 
Hydrogels, in the forms of films and microparticles were successfully synthesized 
using a redox initiated free-radical polymerization.  These systems were characterized 
by several different techniques.  FT-IR confirmed functional group content.  DSC 
indicated the lack of a discernable Tg in these highly crosslinked systems. SEM 
micrographs provided a visual means of observing the crushed microparticle surface 
topology.  Surface features were also elucidated, indicating that PEG provides different 
surface properties in the dried state. 
These studies have demonstrated that all PDEAEM-based hydrogels synthesized 
exhibit a sigmoidal response to changes in pH.  With this increase in polymer volume, 
the mesh size increased, and an increase in the diffusion rate of solutes should be 
present.  Thus, these systems are ideal candidates for applications such as controlled 
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drug delivery of medium-sized molecules such as small peptides based on the estimated 
changes in mesh sizes that were calculated.  These hydrogel particles were further 
reduced to the nanometer size scale and these nanogels are discussed in Chapter 6.  The 
drug loading and release properties of these systems were characterized in Chapter 7 to 

































Figure 5.1. Chemical Reaction Catalyzed by Glucose Oxidase 
(a)  β-D-glucose is first oxidized to β-D-glucono-1,5-lactone while dissolved oxygen is 
reduced to hydrogen peroxide by the enzyme glucose oxidase (GOx).  β-D-glucono-1,5-
lactone is then hydrolyzed to gluconic acid in the presence of water. 
(b)  Hydrogen peroxide is oxidized back into water by catalase (CAT), evolving molecular 


































Figure 5.2. Monomers Used in the Synthesis of P(DEAEM-g-EGn) 
(a) DEAEM,  
(b) PEGDMA-n, n = 4 for TEGDMA, n ≈ 8 for PEGDMA400 



























Figure 5.3. Mechanisms of Enzyme Functionalization with Acryloyl Chloride 
Mechanisms of the functionalization of Glucose Oxidase (GOx) and Catalase (CAT) with 
acryloyl chloride.  The N-terminus is the most likely amine to attack the carbonyl group 




















Figure 5.4. Fourier Transform Infrared Spectra of PDEAEM Samples. 
FT-IR transmittance spectra of three DEAEM formulations.  The top spectrum is from a 
sample with 3% crosslinking (TEGDMA) and a 10:1 ratio of PEG400MMA grafts to 
DEAEM.  The middle spectrum is from a sample with 5% crosslinking (PEG400DMA) and 
a 10:1 ratio of PEG400MMA grafts to DEAEM.  The bottom spectrum is from a sample 
with 15% crosslinking (PEG400DMA) and a 10:1 ratio of PEG400MMA grafts to DEAEM.  
There is very little difference between these spectra, indicating that the amount of 
crosslinking does not affect the polymerization substantially.  PEG etheric peaks at 1100 























150 µm particles, 10:1 PEG100 Tethers
150 µm particles, No Tethers
microparticles, 25:1 PEG400 Tethers
 
Figure 5.5.  Differential Scanning Calorimetry Results for Select Polymer Formulations. 
Baselines were straightened and y-axis units are arbitrary heat flow.  Initial peaks (at -
55, -50, and -15) are artifacts of the initial measurement.  Note the lack of Tg for all 
samples and no other discernable features. 
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Figure 5.6. SEM Images of Crushed PDEAEM Microparticles, Tight View 
a) PDEAEM without PEG tethers, 3% crosslinking; b) PDEAEM without PEG tethers, 10% 
crosslinking; c) PDEAEM-g-EG1000 with a 10:1 ratio of DEAEM:PEG, 10% crosslinking.  
Scale bar = 10 μm. 
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Figure 5.7. SEM Images of Crushed PDEAEM Microparticles, Wide View  
a) PDEAEM without PEG tethers, 3% crosslinking; b) PDEAEM without PEG tethers, 10% 
crosslinking; c) PDEAEM-g-EG1000 with a 10:1 ratio of DEAEM:PEG, 10% crosslinking.  






































Figure 5.8.  Weight Swelling of Crushed Microparticles (150 μm) as a Function of pH 
An increase in the crosslinking ratio of the polymers reduced the overall swelling, 
reducing the amount of water uptake.  The transition pH for these particles was right 
near physiological pH of 7.4, and swelling bean to take place immediately below this pH.    
































Figure 5.9. Mesh Size Estimations of Crushed Microparticles (150 μm) as a Function of 
pH 
Initially, both systems remain collapsed at a mesh size of 1 nm, small enough to entrap 
small peptides and other such molecules.  At the transition pH, both particle systems 
swelled dramatically.  Samples with a crosslinking of only 10% swelled to a mesh size of 
4 nm whereas higher crosslinked samples only swelled to a mesh size of 3.5 nm. 
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CHAPTER 6 
Preparation and Characterization of Poly(Diethyaminoethyl methacrylate) 
Based Nanogels 
6.1 INTRODUCTION 
Nano-sized materials have attracted substantial interest over the last several 
years due to their unique characteristics and versatility.  Nanoparticles, or more 
specifically nanogels (nanometer-scale hydrogels), have garnered some of this attention 
due to their wide range of uses, from applications such as paints and thickening agents 
[1, 2], to drug delivery, diagnostics [3], and other biological applications.  However, 
improved methods of production of such hydrogels are required.  Here, a novel inverse 
emulsion polymerization is described for the synthesis of cationic nanogels that exhibit 
pH dependent swelling properties in aqueous environments. 
In order to accomplish the second specific aim of this dissertation, free-radical 
initiated cationic hydrogel systems were synthesized.  One of the most promising 
polymeric systems for closed-loop insulin delivery is based on the monomer 2-
(diethylamino)ethyl methacrylate (DEAEM) with entrapped glucose oxidase.  These 
polymers are cationic, with a pKa value very near physiological pH.  Thus, with an 
increase in glucose concentration, glucose oxidase catalyzes the formation of gluconic 
acid.  Therefore, the local pH drops, thus protonating the tertiary amines and swelling 
the system due to charge repulsion and polymer hydration.  Optimization was 
performed to determine the optimal concentrations of glucose oxidase and catalase, as 
well as the ratio of functional monomers to PEG grafts and crosslinks. 
DEAEM is a well studied methacrylate monomer that easily undergoes free-
radical polymerizations [4-6].  Several research groups have studied the macroscopic 
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properties of hydrogels based on DEAEM, either as a homopolymer or copolymerized 
with such monomers as methyl methacrylate (MMA) [7], 2-hydroxyethyl methacrylate 
(HEMA) [8], and others [9, 10].  These polymers have an increased hydrophilicity at pH 
values near and below the pKa of the polymer due to the protonation of the tertiary 
amine.  This process is reversible, and swellability is reduced with increased pH. 
Initial studies with DEAEM were performed by Shatkay and Michaeli [11], who 
identified the phase separation of PDEAEM at 7.48 and measured a pKa of 7.68 via 
titration.  Several factors can influence this pKa value such as polymer chain length, 
comonomer composition (and thus hydrophobicity), and crosslinking ratio, with other 
research groups reporting values in the range of 7.0 to 7.4.  These polymers also have a 
Tg below ambient temperature, with values ranging from 16-24°C [7, 12]. 
Previous reports have indicated that DEAEM polymer particle sizes can be 
reduced to the nanometer scale.  However, most of these methods relied on the 
hydrophobicity of DEAEM to form emulsions [13-15] or precipitates.  The incorporation 
of hydrophilic components in the interior of these nanogels was not considered, and in 
practice would be quite difficult with these methods due to the hydrophobicity of 
deprotonated DEAEM.  These reactions also either took over 24 h or relied on UV 
initiation, both of which could inhibit the scale-up of such materials. 
Currently, most attempts at closed-loop drug delivery devices with DEAEM 
involve the physical entrapment of both glucose oxidase and catalase in the polymeric 
device.  This procedure may allow the slow release of these enzymes into the 
surrounding medium, thus decreasing the effectiveness of the system as time 
progresses.  The nanoparticles described herein have chemically bound enzymes, which 
prevent the loss of enzyme over time.  It has also been shown that chemically bound 
enzymes may have increased specific activities when compared to physically entrapped 
enzymes [16].  The N-terminus of each enzyme was functionalized with acryloyl 
chloride, essentially turning each enzyme into a very large monomer.   
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The studies presented here examine the effects of a novel nanoparticle synthesis 
route of PDEAEM on several polymer properties, including surface charge and swelling 
response.  A new inverse emulsion (water-in-oil) polymerization method is described.  
The effects of crosslinking ratio and polyethylene glycol (PEG) tether length on physical 
properties are also examined.  The network morphology was also studied.  Finally, the 
potential for these systems to be used as drug delivery agents was evaluated. 
6.2 MATERIALS AND METHODS 
6.2.1 Poly(Diethylaminoethyl methacrylate) Polymer Nanoparticle Synthesis 
Nanoparticle hydrogels of P(DEAEM-g-EGn) were synthesized using a thermally 
initiated free radical inverse emulsion polymerization.  In an inverse emulsion 
polymerization, the monomer is in the aqueous phase and the continuous phase is the 
immiscible organic phase, whereas a typical emulsion polymerization has an aqueous 
continuous phase and an immiscible organic phase of monomer.  The initiator is also 
usually soluble only in the continuous phase; however, the thermal redox initiator 
ammonium persulfate (APS, Sigma-Aldrich, St. Louis. MO) is soluble in the aqueous 
monomer phase.  Thus, the accelerant used (which allowed the polymerization to 
progress at room temperature) was N,N,N’,N’-tetraethylmethylenediamine (TEMED, 
Fisher Scientific, Fair Lawn, NJ) which is more soluble in the organic phase than the 
aqueous phase.  To stabilize the emulsion, a mixture of surfactants was used; the 2:1 
molar ratio of nonionic surfactants Brij 30 (Sigma-Aldrich) and Triton X-100 (Sigma-
Aldrich) gave the best yield of particles with the most monodisperse size distribution. 
To form the prepolymer solution, a solution of DEAEM (Sigma-Aldrich), 
PEGnMMA (Polysciences, Warrington, PA) and the crosslinking agent tetraethylene 
glycol dimethacrylate (TEGDMA) or polyethylene glycol 400 dimethacrylate 
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(PEG400DMA) (Acros Organics, Morris Plains, NJ) was made.  The DEAEM was passed 
through a column of basic alumina (Fisher Scientific) prior to use to remove inhibitor.  
All other reagents were used as received.  Phosphate buffered saline (PBS) (Fisher 
Scientific) was used as the solvent to prevent autoacceleration and was reconstituted 
from a 10X concentrate with deionized water (Milli-Q Plus system, Millipore, Bedford, 
MA), in a ratio of about 1:1 by weight of the monomers.  Hydrochloric acid (ca. 37 wt%, 
Fisher Scientific) was used to increase solubility.  Ammonium persulfate (APS) (Fisher 
Scientific) was used to initiate the polymerization and was mixed into the prepolymer 
solution just prior to being added to the continuous phase.  Several different systems 
were synthesized with varying compositions.  The ratio of DEAEM to PEG grafts was 
either 10:1, 25:1, or no PEG grafts.  Crosslinking ratios varied from 3 mol% up to 15 
mol%. 
To form the emulsion, 85 mL of cyclohexane (Fisher Scientific) was added to a 
round bottom flask containing 4.7 g Brij 30 (Sigma-Aldrich) and 8.7 g Triton X-100 
(Sigma-Aldrich).  The aqueous monomer solution, prepared as stated above, was then 
added to the round bottom.  The mixture was homogenized (Ultra-Turrax T25, IKA, 
Wilmington, NC) at 24,000 rpm for 5 min.  The emulsion was then capped with a rubber 
septum and purged with N2 for 20 m to remove dissolved oxygen, after which 0.35 mL 
of TEMED were injected.  The reaction proceeded very rapidly, and appeared complete 
after roughly 30 min.  Immediately after injection, the reaction turned slightly cloudy, 
and then after about 5 min it turned opalescent.  Particles of about 220 nm (collapsed) 
were formed, depending on crosslinker ratio.  The cyclohexane was removed under 
reduced pressure on a rotary evaporator.  The particles were precipitated with ethyl 
ether (Fisher Scientific), which also dissolved most of the surfactant.  The solution was 
centrifuged, the organic layer was poured off, and the process was repeated twice 
more.  Sonication was necessary to resuspend the particles after the first wash, and 
resuspension became progressively more difficult as more surfactant was removed.  The 
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particles were then washed for one week in a dialysis membrane (SpectraPor, Spectrum 
Laboratories, Inc., Rancho Dominguez, CA) and the dialysate was changed twice a day.  
After the washing steps were completed, the particles were lyophilized on a Freezone 
freeze dryer (Model 77500, Labconco Corp., Kansas City, MO) and stored in a desiccator 
until use. 
6.2.2 Incorporation of Enzymes into Polymer Structure 
Polymers were also synthesized with both glucose oxidase and catalase in order 
to render these polymeric systems glucose sensitive.  The enzymes were suspended in 
PBS and allowed to chill in an ice bath for 30 min.  Gentle stirring was used to allow 
mixing but to prevent flocculation.  After chilling, a small amount of acryloyl chloride 
(Alfa Aesar) was added to the solution.  The acid chloride moiety of acryloyl chloride has 
been shown to be preferentially attacked by the N-terminus of GOx and presumably CAT 
as well.  This step essentially converts the enzymes into very large monomers; the 
acrylate groups on the enzymes allow them to participate in the copolymerization, 
incorporating the enzymes covalently into the polymer backbone.  It has been reported 
that chemically immobilizing some enzymes has shown increased stability, and the loss 
of activity over time due to leeching of enzymes is no longer a concern. 
To form the prepolymer solution, a solution of DEAEM, PEGnMMA and the 
crosslinking agent TEGDMA or PEG400DMA was made.  The DEAEM was passed through 
a column of basic alumina prior to use to remove inhibitor.  All other reagents were 
used as received.  Instead of neat PBS, the enzyme solution as prepared above was used 
as the solvent to prevent autoacceleration, in a ratio of about 1:1 by weight of the 
monomers.  Hydrochloric acid (ca. 37 wt%) was used to increase solubility.  APS was 
used to initiate the polymerization and was mixed into the prepolymer solution just 
prior to being added to the continuous phase.  Several different systems were 
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synthesized with varying compositions.  The ratio of DEAEM to PEG grafts was either 
10:1, 25:1, or no PEG grafts.  Crosslinking ratios varied from 3 mol% up to 15 mol%. 
To form the emulsion, 85 mL of cyclohexane was added to a round bottom flask 
containing 4.7 g Brij 30 and 8.7 g Triton X-100.  The aqueous monomer solution, 
prepared as stated above, was then added to the round bottom.  The mixture was 
homogenized at 24,000 rpm for 5 min.  The emulsion was then capped with a rubber 
septum and purged with N2 for 20 m to remove dissolved oxygen, after which 0.35 mL 
of TEMED were injected.  The reaction proceeded very rapidly, and appeared complete 
after roughly 30 min.  Immediately after injection, the reaction turned slightly cloudy, 
and then after about 5 min it turned opalescent.  Particles of about 220 nm (collapsed) 
were formed, depending on crosslinker ratio.  The cyclohexane was removed under 
reduced pressure on a rotary evaporator.  The particles were precipitated with ethyl 
ether, which also dissolved most of the surfactant.  The solution was centrifuged, the 
organic layer was poured off, and the process was repeated twice more.  Sonication was 
necessary to resuspend the particles after the first wash, and resuspension became 
progressively more difficult as more surfactant was removed.  The particles were then 
washed for one week in a dialysis membrane and the dialysate was changed twice a day.  
After the washing steps were completed, the particles were lyophilized on a Freezone 
freeze dryer and stored in a desiccator until use. 
6.2.3 Polymer Characterization via FT-IR 
Fourier transform infrared (FT-IR) spectra were obtained on a ThermoNicolet 
Nexus 470 spectrometer (Thermo Electron Corp., Waltham, MA) with a deuterated 
triglycine sulfate (DTGS) detector and potassium bromide (KBr) beam splitter.  Typically, 
128 scans were performed in the wavenumber range of 4000-400/cm, both forward and 
backward at 10 kHz, with a manual gain of one.  Pellets of ca. 10 mg polymer and 200 
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mg KBr (spectroscopy grade, Acros Organics) were pressed at 15,000 psi using a Carver 
laboratory press. 
6.2.4 Polymer Characterization via NMR 
Nuclear magnetic resonance (NMR) spectra were obtained on a Varian Unity+ 
300 MHz spectrometer.  Deuterated water (D2O, Cambridge Isotope Laboratories, Inc., 
Andover, Ma.) was used to suspend nanoparticles for tether analysis.  Water 
suppression was used via the PRESAT macro with a saturation power of -2 and a 
saturation time of 5 on any samples with significant water signals.  Small molecule 
analysis was obtained by using a suitable deuterated solvent, such as chloroform 
(CDCl3), dimethylsulfoxide (d6-DMSO), or d¬6-acetone, all obtained from Cambridge 
Isotope Laboratories.  Unless otherwise stated, for all 1H NMR spectra, the sample was 
spinning at 20 Hz, the number of transients was 8, and line broadening was 0.1. 
6.2.5 Polymer Characterization via DSC 
A PerkinElmer DSC 7 differential scanning calorimeter (PerkinElmer, Waltham, 
MA) using a heat/cool/heat method was used to characterize the polymers.  A rapid 
heating cycle was used to erase any thermal history from the samples, after which the 
samples were cooled back down to the starting temperature.  The final heating cycle 
had a ramp rate of 10⁰C/min, which was slow enough to detect a Tg in some samples.  
Since room temperature was above the Tg of most samples, a nitrogen cooling unit was 
used with an initial temperature of -55°C. 
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6.2.6 Polymer Characterization via DLS 
Nanoparticle hydrodynamic diameters were characterized using a ZetaPlus Zeta 
Potential Analyzer with a Multi Angle Particle Sizing Option installed (Brookhaven 
Instruments Corporation, Holtsville, NY) operating with a 25 mW laser at a wavelength 
of 635 nm.  Detection of scattered light was at 90° to the incident beam.  Each sample 
was subjected to 10 two-minute measurements.  Typically, solutions of up to 2 mg/mL 
were used for the characterizations, at a temperature of 25°C.  Freeze-dried particles 
were suspended in either PBS or 2 mM KCl.  The pH of the nanoparticle solution was 
altered with either 0.1N HCl or 0.1N NaOH (Fisher Scientific), and was measured with an 
ISFET probe using an IQ Scientific Instruments pH meter. 
A DLS measures the amount of a scattered laser beam passed through a 
suspension of particles.  An average intensity of scattered light is determined, usually at 
a 90º incident angle, which also includes fluctuations associated with the random 
motion of the particles due to Brownian motion.  The decay of these fluctuations can 
then be correlated to the diffusion coefficient of these particles.   Equation (6.1), the 






=          (6.1) 
In this equation, D is the diffusion coefficient of the particles, kB is Boltzmann’s constant, 
T is the temperature in Kelvin, η(T) is the temperature-dependent viscosity of the 
suspension, and d is the hydrodynamic diameter.  While there are limitations on the 
usage of DLS, it was ideal for quickly determining particle sizes in solution.  Thus, 
dynamic measurements were possible on submicron sized particles. 
ζ-Potential measurements were conducted using electrophoretic light scattering, 
also using the Brookhaven ZetaPlus.  Freeze-dried particles were suspended in a 10 mM 
KCl solution and diluted to 2 mM KCl with ddH2O.  Scattered light was detected at 15° 
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(175° to the incident beam) at a temperature of 25°C.  Each sample was subjected to 10 
measurements, with a 5 s delay between each measurement. 
6.2.7 Polymer Characterization via SEM 
A LEO Model 1530 SEM was used to determine the morphology of the 
synthesized particles.  Samples were prepared for imaging in one of two methods.  
Method one consisted of suspending the particles in a volatile non-solvent and then 
placing a drop on an aluminum stage.  Method two required the use of double-sided 
conductive carbon tape to hold the lyophilized samples on the aluminum stage.  To 
prevent charging of the samples, they were sputter coated with gold using a Pelco 
Model 3 sputter coater.  Stages were stored in a dessicator until loading into the SEM. 
6.3 RESULTS AND DISCUSSION 
6.3.1 Poly(diethylaminoethyl methacrylate) Nanoparticle Synthesis 
Sub-micron sized particles, or nanoparticles, were successfully synthesized via 
this novel inverse emulsion polymerization procedure.  The necessity for an inverse 
emulsion stems from the desire for these particles to contain hydrophilic components, 
such as PEG surface tethers and possibly either proteins or enzymes on the nanogel 
interior.  Previous synthetic approaches inhibited the incorporation of such hydrophilic 
components due to the hydrophobicity of deprotonated DEAEM.  Thus, monomeric 
DEAEM and hydrophilic comonomers (i.e., functionalized enzymes), did not properly 
copolymerize.  Using this novel polymerization method will allow the copolymerization 
of DEAEM with several hydrophilic monomers, including functionalized enzymes such as 
glucose oxidase for the detection of glucose in solution. 
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It was determined that a 2:1 molar ratio of nonionic surfactants Brij 30 (Sigma-
Aldrich) and Triton X-100 (Sigma-Aldrich) was able to form a stable inverse emulsion and 
provide fairly monodisperse nanogels.  This result is somewhat contrary to theory, since 
the hydrophile-lipophile balance (HLB) of each surfactant is 9 and 13.5, respectively (as 
provided by the manufacturer).  The HLB is a quantification of the ratio of hydrophilic to 
lipophilic functional groups in the surfactant, where surfactants with values < 10 
typically form inverse emulsions, and surfactants with values ≥ 10 form stable emulsions 
(oil-in-water).  Ionic surfactants were investigated, though several problems were 
encountered.  Select cationic surfactants (e.g. MyTAB) would not form inverse 
emulsions, and anionic surfactants (e.g. AOT) complexed with the partially protonated 
DEAEM monomers, which prevented proper polymerization. 
6.3.2 Incorporation of Enzymes into Polymer Structure 
After nanoparticles were synthesized neat, they were also synthesized with 
glucose oxidase and catalase as co-monomers.  These particles were examined and 
compared to the neat particles to determine if the glucose oxidase or catalase had any 
effects on the typical response of such systems to a pH stimulus.  As shown in Figure 6.5, 
DLS swelling studies (as explained later in section 6.3.6) indicated that hydrogels both 
with and without glucose oxidase and catalase swelled to very similar extents over the 
range of pH values tested.  Therefore, it can be concluded that the addition of these 
enzymes to not negatively affect the swelling characteristics of these nanoparticle 
systems in any observable way.  Nanogels with enzymes were also tested to ensure 
enzyme activity remained in tact.  After a polymerization was performed, a sample of 
the nanogels was taken and exposed to varying concentrations of glucose solutions.  If a 
batch did not swell in response to glucose levels, it was discarded. 
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6.3.3 FT-IR Spectroscopy 
FT-IR showed several important pieces of information.  First, as shown in Figure 
6.1, there was no substantial difference in spectra between nanogels with 5% and 15% 
crosslinking.  Thus, the crosslinking does not adversely affect the rest of the 
polymerization.  Second, the spectra indicated the functional groups present in each 
sample which indicated the successful removal of unreacted double bonds.  The C=C 
stretching absorbance near 1650 cm-1 and the out-of-plane C-H bending of these same 
double bonds near 950 cm-1 were nearly non-existent.  Also, the larger presence of 
etheric bonds in the samples containing PEG tethers, near a frequency of 1100 cm-1 (C-O 
stretching), indicates a higher content of PEG than those simply containing PEG 
crosslinker.  Thus, it is reasonable to assume that the PEG tethers were successfully 
incorporated into the hydrogel backbone.  This etheric peak also appears saturated in 
the highly crosslinked nanoparticles (X = 15%). 
6.3.4 NMR Spectroscopy 
Water suppression was necessary for all samples analyzed in D2O; otherwise, the 
signal-to-noise ratios for the hydrogel peaks were too low for analysis.  1H NMR was 
used to confirm the presence of PEG tethers on nanogels in D2O by identifying the PEG 
oxyethylene peak at about 3.6 ppm (Figure 6.2).  As the PEG tether length or PEG ratio 
was decreased, the area of the oxyethylene peak also decreased and was practically 
non-existent in the spectrum of nanogels synthesized without PEG tethers.  Lightly 
crosslinked nanogels were used in these analyses, which also allowed the observance of 
PDEAEM peaks as well (3.2 ppm, 3.5 ppm).  However, directly comparing the PEG 
oxyethylene peak to the methylamine peak on DEAEM did not provide an accurate 
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assessment of the ratio of DEAEM to PEG surface grafts due to limitations of NMR on 
crosslinked nanoparticles. 
6.3.5 Differential Scanning Calorimetry (DSC) 
Heat flow curves as a function of temperature were generated for several 
different polymeric systems and can be seen in Figure 6.3.  P(DEAEM-g-EG2000) 
nanogels exhibited a peak Tm at 47°C, which is consistent with the melting temperature 
of pure PEG at a molecular weight of 2000 Da.  These results are further evidence of the 
inclusion of PEG tethers on the nanogel surface, where tethers from several particles 
crystallized during the freeze-drying process.  Using the melting peak for PEG allowed 
the calculation of the initial PEG crystallization amount to be about 30% for PEG2000 
tethers, which could be recrystallized to 50% after melting; the enthalpy of melting 
values were obtained from Sanchez-Soto et al [17].  These values assume near 100% 
conversion of PEG monomer, which may not be accurate. 
It is interesting to note that crushed microparticles with the same composition as 
nanogels did not have an observable Tm.  This result can be explained by the methods of 
polymerization and how they alter the polymer structure.  The crushed microparticles 
were synthesized as a film, where the PEG and DEAEM copolymerized without any 
partitioning and were randomly polymerized into the polymer chain.  The nanogels, 
however, experienced PEG partitioning into the surfactant layer (the surfactants used 
were based on PEG derivatives).  Thus, PEG was more likely to polymerize near the 
surface of the polymer particles than on the inside.  This phenomenon resulted in more 
PEG protruding from the surface of the nanogels than from the microparticles.  These 
PEG tethers were then able to crystallize with each other during the freeze drying 
process, which resulted in an observable Tm. 
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The Tg of crosslinked hydrogels was unable to be determined, due to the highly 
restricted polymer chain motion from the of crosslinking.  Neither nanogels nor 
microparticles exhibited a detectable Tg.  However, the Tg of uncrosslinked PDEAEM was 
determined to be -20°C, which agrees with previous reports. 
6.3.6 DLS and ζ-Potential 
DLS provided the solvated hydrodynamic diameter of nanoparticles as a function 
of pH.  Similar to the crushed particles, the transition pH from collapsed to swollen 
occurred over a narrow range of about 7.4.  Due to the limitations of DLS, the swelling 
properties of some nanogels were not fully investigated.  The ability of DLS to measure 
particle size is dependent on the scattering of laser light off the polymer surface.  
However, as the nanogels swell with water, the polymer volume fraction can be as low 
as 1%.  Thus, the polymer gel is almost completely solvent (polymer volume fraction 
approaches zero), and it is difficult for the laser to scatter enough light to collect reliable 
data.  An increase in polymer concentration can help increase the signal to noise ratio, 
but this step also increases the viscosity of the solution drastically, which has also been 
shown to produce errant values for particle dimensions [18].  The nanogel suspension 
was first measured in a viscometer to reduce the possibility of this error. 
Several important observations were made via DLS.  As shown in Figure 6.4 the 
swelling response of DEAEM based nanogels was not significantly affected by the 
presence of PEG tethers.  When the crosslinking ratio was held constant, both systems 
had a transition from collapsed to swollen state at a pH of about 7.2, which agrees with 
previous reports on similar systems.  The particle size in the collapsed state for the non-
PEGylated systems was, however, larger than those with surface PEG tethers.  This 
phenomenon was most likely due to slight aggregation, since the deprotonated DEAEM 
was fairly hydrophobic without PEG tethers.  Nanogels viewed in their dried state 
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tended to have very similar “collapsed” diameters as shown by SEM below.  Finally, as 
mentioned above, as the polymers swelled at low pH, the standard deviation between 
measurements increased, mainly due to the difficulty in sizing via DLS at such 
conditions. 
The inclusion of the immobilized enzymes did not appear to alter the pKa of the 
systems significantly, as discussed earlier.  Temperature, however, did affect the pKa.  At 
20 °C, the pKa was very close to 7.4.  At a temperature of 37 °C, the pKa dropped to 
about 7.1.  It was also determined that slight temperature gradients existed in the 
samples during measurements due to the equipment’s ability to maintain sample cell 
temperature.  Thus, with a set point of 40 °C and 3 mL of sample, an average of 37 °C 
was attained throughout the sample and a temperature of 37 °C was attained at the 
level of the laser beam.  Because the particle sizing relied on Brownian motion, if 
convective currents were present, reported particle sizes may be lower than actual 
values. 
Systems were also characterized in glucose solutions.  Nanoparticles were 
equilibrated in a salt water solution (0.15 M NaCl) and then glucose was added, enough 
to raise the concentration to 200 mg/dL.  The response of a typical system can be seen 
in Figure 6.6.  The delay before the hydrogels became fully swollen was attributed to a 
mixture of diffusional limitations on glucose through the gel, which is significantly larger 
than a hydronium ion, and the reaction kinetics of the enzymes towards oxidizing 
glucose.  These data suggest that a device based on nanoparticles may be able to 
provide the desired response necessary for a closed-loop insulin delivery device. 
The ζ-potential of the nanoparticles was shown to be affected by PEG tether 
length (Figure 6.7).  The longer PEG chains were able to more effectively shield the 
surface charge of the polymers, thus reducing the measured ζ-potential at all pH values.  
The PEG tethers were also highly effective at preventing free hydroxide ions from 
adsorbing to the polymer surface at higher pH ranges.  The PEG tethers acted like a 
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molecular brush, preventing the adsorption of dissolved ions onto the polymer surface.  
Thus, there was a reduction in the overall surface charge, especially at higher pH values, 
which can be exploited for biological applications such as drug delivery. 
PEG also successfully shielded the positive charges on the protonated amines 
along the polymer background.  However, this shielding effect was less than that of the 
hydroxide ions at basic pH values.  This trend is most likely explained by the nature of 
PEG and ζ-potentials.  PEG is highly effective at preventing ions, proteins, and other 
molecules from adsorbing to a surface.  However, this effect is not fully able to shield 
the positively charged polymer due to the electric double layer present around such a 
material.  Even longer PEG chains should increase the gap between the polymer and this 
double layer, thus reducing the ζ-potential.  However, there is a practical limit to the 
PEG tether length due to the polymer synthesis method.  Finally, the total number of 
PEG tethers on the surface of a given particle does not change with swelling, yet the 
surface area increases by radius squared.  Thus, PEG tethers comprise more surface area 
of the nanogel when in the collapsed state versus the swollen state. 
Previous work has shown that the incorporation of PEG tethers can have 
substantial benefits, such as increased suspension stability and decreased surface 
adsorption [19].  Moghimi et al, showed that PEG grafts of at least 2000 Da were 
necessary to prevent protein adsorption, while weights over 5000 Da further decreasing 
overall effectiveness [20].  These observations are consistent with the data above, 
indicating that PEG tethers of molecular weight 2080 Da were ideal for preliminary 
studies.  Future studies could examine the effect of a tether longer than 2000 Da. 
6.3.7 Scanning Electron Microscopy (SEM) 
Several important observations can be made from the SEM micrographs shown 
in Figure 6.8.  The nanoparticle synthesis provided fairly monodisperse samples, with 
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only slight variations in size from particle to particle.  These micrographs confirm 
particle size determinations via DLS to be on the order of 200nm for collapsed particles.  
While these particles were freeze dried prior to imaging and do not directly provide 
collapsed particle sizes in solution, these data do agree well with data obtained from the 
light scattering method.   
There is a noticeable difference between nanoparticles synthesized with PEG 
tethers versus those without.  The surface characteristics of the nanoparticles with PEG 
tethers appear to be softer and more diffuse (Figure 6.8b & c), whereas particles 
without tethers appear to have more rigid boundaries.  This phenomenon could be 
explained by the hair-like protrusion of the PEG tethers from the surface of the particles, 
providing a more textured surface for the sputter coated gold layer to adhere to, which 
in turn could have caused decreased localized resolution.  It was reported that PEG 
tethers of 2000 Da could extend past the particle surface by as much as 7 nm based on 
the Flory radius of these tethers [21].  The low glass transition temperature of the PEG 
tethers also may play a role in this observation. 
The low glass transition temperatures of the PDEAEM polymers offered an extra 
challenge during imaging.  Deprotonated PDEAEM has a Tg below room temperature, 
whereas protonated PDEAEM has a somewhat higher Tg.  Thus, deprotonated PDEAEM 
is rubbery and likely to deform during sample preparation and coalesce into a film, 
making imaging of distinct particles difficult if not impossible.  Protonated PDEAEM, on 
the other hand, has a higher Tg making it glassy at room temperature.  This 
characteristic allows better imaging at the expense of the increased hygroscopic nature 
of the polymer.  These observations agree with previously reported results, which also 
indicate the difficulty in preventing latex films of PDEAEM during the sample 
preparation process [15].  Cornejo-Bravo and Siegel quantified the hygroscopic nature of 
dry, deprotonated PDEAEM by measuring the amount of water vapor absorbed from the 
air.  Polymer weight doubled, and the water acted as a plasticizing agent. 
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6.4 CONCLUSIONS 
Hydrogel nanoparticles, or nanogels, were successfully synthesized using a redox 
initiated free-radical polymerization.  A novel inverse-emulsion polymerization method 
was described, which allowed nanogels on the order of 200 nm to be synthesized.  
These systems were characterized by several different techniques.  FT-IR confirmed 
functional group content.  1H NMR indicated successful copolymerization of PEG which 
resulted in soluble tethers protruding from the surface of the nanogels.  DSC indicated 
the lack of a discernable Tg in these highly crosslinked systems but also confirmed PEG 
tether content.  DLS was used for nanoparticle sizing, though limitations of the 
equipment were observed which prevented the complete analysis of certain systems.  
SEM micrographs confirmed that particle sizing measurements provided by DLS were 
accurate.  Surface features were also elucidated, indicating that PEG provides different 
surface properties in the dried state. 
As mentioned in the ζ-potential results above, the PEG tether length directly 
affected the observed ζ-potential of the nanogels.  Longer chain lengths provided better 
shielding for the positive charges on the polymer backbone.  However, a PEG molecular 
weight of 2000 Da was the largest PEG tested.  The possibility of a longer PEG chain 
providing better shielding for the protonated amines may be worth investigating in 
future studies. 
These studies have demonstrated that all PDEAEM-based systems synthesized 
exhibit a sigmoidal response to changes in pH.  With this increase in polymer volume, 
the mesh size increased, and an increase in the diffusion rate of solutes should be 
present.  Thus, these systems are ideal candidates for applications such as controlled 
drug delivery of medium-sized molecules such as small peptides.  The loading and 
release properties of drugs with these systems were characterized in the following 
chapter to determine their feasibility in a drug delivery application.  Finally, since a novel 
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nanogel synthesis was created using inverse-emulsion polymerization, the option for 
including hydrophilic comonomers during polymerization is possible.  Thus, molecules 
such as functionalized enzymes (i.e. glucose oxidase) were successfully incorporated 
into these systems, allowing environmentally responsive systems capable of swelling 
























Figure 6.1. Fourier Transform Infrared Spectra of DEAEM Nanogels 
FT-IR transmittance spectra of three nanogel formulations.  The top spectrum is from a 
sample with 3% crosslinking (TEGDMA) and a 10:1 ratio of PEG400MMA grafts to 
DEAEM.  The middle spectrum is from a sample with 5% crosslinking (PEG400DMA) and 
a 10:1 ratio of PEG400MMA grafts to DEAEM.  The bottom spectrum is from a sample 
with 15% crosslinking (PEG400DMA) and a 10:1 ratio of PEG400MMA grafts to DEAEM.  
There is very little difference between these spectra, indicating that the amount of 
crosslinking does not affect the polymerization substantially.  PEG etheric peaks at 1100 








Figure 6.2. 1H Nuclear Magnetic Resonance Spectra of DEAEM Nanogels 
1H NMR spectra of different PDEAEM samples in D2O.  The bottom (black) spectrum is 
linear PDEAEM with no PEG, the top (green) spectrum is P(DEAEM-g-EG400) with 10:1 
PEG tethers, and the middle spectrum (red) is P(DEAEM-g-EG2000) with 10:1 PEG 


























150 µm particles, 10:1 PEG100 Tethers
Nanoparticles, 10:1 PEG2000 Tethers
150 µm particles, No Tethers
 
Figure 6.3.  Differential Scanning Calorimetry results for select polymer formulations. 
Baselines were straightened and y-axis units are arbitrary heat flow.  Initial peaks (at  
-55 °C, -50 °C, and -30 °C) are artifacts of the initial measurement.  Note the lack of Tg 
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Figure 6.4. Volume Swelling Ratios of DEAEM Nanogels 
Swelling response of two sets of particles, those with and those without PEG tethers, 
were identical.  Both samples were collapsed at elevated pH values and fully swollen by 


















Figure 6.5. Equilibrium Swelling of pH-Sensitive P(DEAEM-g-EG), Both With and 
Without Glucose Oxidase. 
Typical response of a 220 nm p(DEAEM-g-EG) nanoparticles at 20 °C either with or 
without entrapped glucose oxidase and catalase as a function of pH.  Crosslinking ratios 
were 3% with a PEG to DEAEM ratio of 1:10.  Blue dots correspond to particles without 
enzymes, red dots contained enzymes.  Black line is a sigmoidal regression of the data.  





































Figure 6.6. Dynamic Swelling of Glucose-Sensitive P(DEAEM-g-EG) Nanoparticles in 
Response to Step Change in Glucose Concentration. 
Typical response of 160 nm p(DEAEM-g-EG) nanoparticles with immobilized glucose 
oxidase and catalase to a step change in glucose from 0 mg/dL to 200 mg/dL.  Particles 
reached equilibrium in less than 20 minutes.  Fluctuations after 20 minutes are due to 







































Figure 6.7. ζ-Potential as a Function of pH for DEAEM Nanogels 
As PEG tether length increased, overall surface charge decreased, as indicated by the 
measured ζ-potential of the nanoparticles.  Nanogels without PEG adsorbed hydroxide 
ions at high pH values, while at low pH values the protonated amines were observed.  
Nanogels with PEG2000 tethers successfully prevented hydroxide ion adsorption in basic 




Figure 6.8. Scanning Electron Micrographs of DEAEM Nanogels 
a) PDEAEM without PEG tethers; b) PDEAEM-g-EG1000 with a 25:1 DEAEM:PEG ratio; 
c) PDEAEM-g-EG2000 with a 10:1 ratio of DEAEM:PEG.  Scale bars = 2 μm. 
 113 
6.6 REFERENCES 
1. Hellgren, A.-C., P. Weissenborn and K. Holmberg, Surfactants in water-borne 
paints. Prog Org Coat, 1999. 35(1-4): p. 79-87. 
2. Rodriguez, B.E., M.S. Wolfe and M. Fryd, Nonuniform Swelling of Alkali Swellable 
Microgels. Macromolecules, 2002. 27(22): p. 6642-6647. 
3. Bromberg, L. and L. Salvati, Bioactive Surfaces via Immobilization of Self-
Assembling Polymers onto Hydrophobic Materials. Bioconjugate Chem, 1999. 
10(4): p. 678-686. 
4. Kost, J. and R. Langer, Equilibrium swollen hydrogels in controlled release 
applications, in Hydrogels in medicine and pharmacy, N.A. Peppas, Editor. 1986, 
CRC Press: Boca Raton, Fla. p. 95-107. 
5. Siegel, R.A. and B.A. Firestone, pH-dependent equilibrium swelling properties of 
hydrophobic polyelectrolyte copolymer gels. Macromolecules, 1988. 21(11): p. 
3254-3259. 
6. Siegel, R.A., B.A. Firestone, I. Johannes and J. Cornejo, Weak Ionic Hydrogels - 
Effects of Ph, Ionic-Strength and Buffer Composition on Swelling Equilibria, 
Kinetics and Solute Release. Abstr Pap Am Chem S, 1990. 199: p. 119-POLY. 
7. Cornejo-Bravo, J.M. and R.A. Siegel, Water vapour sorption behaviour of 
copolymers of N,N-diethylaminoethyl methacrylate and methyl methacrylate. 
Biomaterials, 1996. 17(12): p. 1187-1193. 
 114 
8. Hariharan, D. and N.A. Peppas, Characterization, dynamic swelling behaviour and 
solute transport in cationic networks with applications to the development of 
swelling-controlled release systems. Polymer, 1996. 37(1): p. 149-161. 
9. Podual, K., F.J. Doyle and N.A. Peppas, Dynamic behavior of glucose oxidase-
containing microparticles of poly(ethylene glycol)-grafted cationic hydrogels in an 
environment of changing pH. Biomaterials, 2000. 21(14): p. 1439-1450. 
10. Schwarte, L.M. and N.A. Peppas, Novel poly(ethylene glycol)-grafted, cationic 
hydrogels: preparation, characterization and diffusive properties. Polymer, 1998. 
39(24): p. 6057-6066. 
11. Shatkay, A. and I. Michaeli, Potentiometric Titrations of Polyelectrolytes with 
Separation of Phases. The Journal of Physical Chemistry, 1966. 70(12): p. 3777-
3782. 
12. Tobolsky, A.V. and M.C. Shen, THE EFFECT OF HYDROGEN BONDS ON THE 
VISCOELASTIC PROPERTIES OF AMORPHOUS POLYMER NETWORKS. The Journal 
of Physical Chemistry, 2002. 67(9): p. 1886-1891. 
13. Hayashi, H., M. Iijima, K. Kataoka and Y. Nagasaki, pH-sensitive nanogel 
possessing reactive PEG tethered chains on the surface. Macromolecules, 2004. 
37(14): p. 5389-5396. 
14. Fisher, O.Z. and N.A. Peppas, Polybasic Nanomatrices Prepared by UV-Initiated 
Photopolymerization. Macromolecules, 2009. 42(9): p. 3391-3398. 
15. Amalvy, J.I., E.J. Wanless, Y. Li, V. Michailidou, S.P. Armes and Y. Duccini, 
Synthesis and characterization of novel pH-responsive microgels based on 
tertiary amine methacrylates. Langmuir, 2004. 20(21): p. 8992-8999. 
 115 
16. Jaworek, D., H. Botsch and J. Maier, Preparation and properties of enzymes 
immobilized by copolymerization. Methods Enzymol., 1976. 44: p. 195-20. 
17. Sanchez-Soto, P.J., J.M. Gines, M.J. Arias, C. Novak and A. Ruiz-Conde, Effect of 
molecular mass on the melting temperature, enthalpy and entropy of hydroxy-
terminated PEO. J Therm Anal Calorim, 2002. 67(1): p. 189-197. 
18. Malvern, The importance of sample viscosity in dynamic light scattering 
measurements, in Application note. Recognising the quality of data from photon 
correlation spectroscopy measurements. Technical note. 2005, Malvern 
Instruments. 
19. Owens, D.E. and N.A. Peppas, Opsonization, biodistribution, and 
pharmacokinetics of polymeric nanoparticles. Int J Pharm, 2006. 307(1): p. 93-
102. 
20. Moghimi, S.M., A.C. Hunter and J.C. Murray, Long-circulating and target-specific 
nanoparticles: Theory to practice. Pharmacol Rev, 2001. 53(2): p. 283-318. 
21. Wong, J.Y., T.L. Kuhl, J.N. Israelachvili, N. Mullah and S. Zalipsky, Direct 
Measurement of a Tethered Ligand-Receptor Interaction Potential. Science, 









Insulin Loading and Release from Poly(Diethylaminoethyl Methacrylate) 
Hydrogels 
7.1 INTRODUCTION 
It is essential for the loading and release properties of a controlled drug delivery 
device to be quantified.  The drug delivery device needs to provide the appropriate 
amount of drug loading and bioavailability, and the desired release profile.  A low 
loading efficiency would indicate difficulties associated with entrapping the drug of 
interest into the polymer matrix.  Low bioavailability would cause waste of the drug in 
the delivery device, since not all of the loaded drug would be released from the matrix 
and would not be available to the patient.  Finally, an incorrect drug release profile 
would not correctly treat the disease. 
Several previous studies have been performed on similar hydrogel systems to 
determine the loading and release behavior of different solutes.  Siegel and Firestone 
looked at the release of caffeine from dimethylaminoethyl methacrylate (DMAEMA) as a 
model drug [1, 2].  Oscillatory swelling and deswelling were achieved by varying the pH, 
and caffeine release was dependent on the pH of the media.  These gels exhibited a 
moving front mechanism of water sorption, which allowed the caffeine release from 
within these hydrogels.  
Ishihara, et al., investigated the release of imbibed insulin out of membranes 
made of 2-hydroxyethyl methacrylate (HEMA) and methyl methacrylate (MMA) [3, 4].  
This research showed that the release rate of insulin increased as the HEMA 
concentration increased, likely due to the increased hydrophilicity of the hydrogel at 
higher HEMA concentrations.  Zero order release out of these membranes was achieved 
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because of the relatively constant concentration of insulin inside the membrane device.  
However, diabetes patients require fluctuating insulin release depending on their body’s 
current condition; thus, zero order release is not ideal for an insulin delivery device. 
Schwarte and Peppas [5] also investigated several different systems for 
intelligent, controlled release.  They studied the permeation of proxyphylline, vitamin 
B12, and several different dextran molecules from P(DEAEM-g-EG) hydrogel discs.  All 
solutes of interest were neutral, thus having no attraction or repulsion to the cationic 
hydrogels.  The authors noted that the proxyphylline and vitamin B12 had much lower 
permeation values than expected, due to their molecular weights and the mesh sizes of 
the hydrogels investigated.  
Finally, Hariharan and Peppas [6] investigated several other solutes of interest.  
Several different hydrogel matrices were synthesized, including P(DEAEM-co-HEMA) and 
poly(diethylaminoethyl acrylate-co-HEMA).  Oxprenolol HCl, insulin, albumin, and 
myoglobin were loaded and released from these hydrogel discs.  It was determined that 
the release rate of certain drugs (i.e., oxprenolol) was due primarily to polymer chain 
relaxation whereas the others were Fickian controlled. 
A type I diabetic patient typically has to have a very specific insulin dosage 
regimen.  A general rule of thumb is that a diabetic patient needs to inject 
subcutaneously about 0.2 IU/kg/day of basal insulin, and between 0.05 and 0.1 IU/kg 
before consuming a meal.  One IU, or international unit, of insulin is precisely defined as 
1/22 mg (ca. 45.5 μg) of pure crystalline insulin.  Thus, for a patient with a body mass of 
75 kg (165 lb), these values correspond to a total daily insulin intake of about 30 mg.  
The basal insulin dose corresponds to roughly half of the daily dose, about 15 mg, 
whereas between 3.7 and 7.5 mg is necessary before the consumption of each meal [7, 
8]. 
Insulin is a peptide hormone of 51 amino acids with a monomeric molecular 
weight of ~5.8 kDa.  However, in the presence of zinc, it tends to form a hexameric 
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structure of approximately 35 kDa.  At physiological relevant conditions (pH 7.4), x-ray 
scattering has shown that the average radius of gyration of insulin is 1.98 nm, which 
corresponds to the hexameric structure.  The active form of insulin is the monomeric 
structure, and hexameric insulin will not bind to cellular receptors.  Thus, hexameric 
insulin remains in equilibrium with its monomeric form, and it slowly breaks down into 
monomeric insulin [9, 10]. 
The inactivity of hexameric insulin has been exploited in the treatment of 
diabetes.  Pharmaceutical companies synthesize several different analogs of insulin, 
each have differing abilities to form hexamers.  Thus, “long acting” insulin analogs such 
as Sanofi-Aventis’s Lantus (insulin glargine) are less soluble at physiological pH and take 
a longer time to dissolve into the monomeric insulin form.  These types of insulin are 
ideal for a long-term basal insulin delivery, such as a daily basal injection.  Lispro insulin, 
on the other hand, was modified to prevent the formation of dimers and hexamers.  
This analog is entirely in its monomeric form, which makes it a “fast-acting” insulin ideal 
for postprandial subcutaneous delivery [8].  Hexamers can also be prevented in vitro by 
using ethylenediaminetetraacetic acid (EDTA) to chelate the zinc ion. 
Chapter 5 discussed the physical properties of crushed microparticles of 
P(DEAEM-g-EG).  There, the mesh size was estimated for polymer samples with a 
crosslinking ratio of 3%, 10%, and 15%.  These estimates indicated that a collapsed mesh 
size of roughly 1 nm would potentially trap insulin, which has a monomeric 
hydrodynamic radius of 1.3 nm [11].  Thus, experiments were conducted to determine if 
these hydrogel particles could indeed entrap insulin and release insulin only under 
certain conditions, specifically acidic pH or increased solution glucose concentrations. 
Insulin loading and release studies were performed to determine the feasibility 
of using a polycationic based hydrogel system for treatment of type 1 diabetes.  
Physiologically relevant conditions in vitro were used to simulate how these polymers 
might respond in vivo.  Insulin was loaded into the hydrogels via both equilibrium 
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partitioning and ionic interactions.  The release on insulin from these cationic hydrogels 
was measured as a function of time.  Insulin release was triggered by either pH or 
glucose concentrations. 
7.2 MATERIALS AND METHODS 
7.2.1 Insulin Loading 
A stock solution of bovine insulin (Sigma-Aldrich, 30 USP U/mg) was prepared in 
phosphate buffered saline (PBS, Fisher Scientific) with ethylenediaminetetraacetic acid 
(EDTA, Sigma Aldrich) at a concentration of 1.0 mg/mL.  Insulin will only fully dissolve at 
acidic pH or after the addition of EDTA; thus, 0.04 mg EDTA per mg insulin was added to 
the PBS solution to facilitate insulin dissolution and loading.  EDTA chelates the zinc ion 
which lies at the center of a hexameric insulin unit; thus, this procedure forced insulin 
into its monomeric form.  After the insulin was dissolved, typically 7 mg/mL polymer 
sample (150 μm crushed microparticles) was added to the solution and the pH was 
lowered to about 5.6-5.8 using 1N HCl (Fisher Scientific). 
After allowing a suitable amount of time for loading, typically 4 hr, the gels were 
collapsed by raising the pH to 9 with 1 M NaOH.  This collapse physically trapped the 
insulin inside the microparticles.  Excess insulin was washed off the surface of the 
particles with dilute (10 µM) NaOH and finally ddH2O using a porcelain Büchner funnel 
atop a glass side-arm Erlynmeyer flask.  A plastic centrifuge tube was put in place below 
the funnel and inside the flask to catch the filtrate, allowing the measurement of insulin 
in the filtrate after each wash step.  The particles were then lyophilized and stored in a 
freezer until use. 
To perform the washings on nanoparticles, special centrifuge tubes with dialysis 
membranes of a molecular weight cut-off of 20 kDa were used (iCON Concentrators 
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#89886, Pierce, Rockford, IL).  These membranes allowed the surface insulin to be 
washed away, while retaining the collapsed nanoparticles inside the dialysis membrane. 
7.2.2 Insulin Release 
Insulin-loaded particles were suspended in appropriate media (i.e., PBS, saline) 
in SigmaCoted® glassware.  Typically, a particle concentration of 1 mg/mL was used.  To 
maintain physiological relevance, the temperature was kept at 37 °C using a 
recirculating water bath.  A dissolution apparatus (Distek Dissolution System 2100B, 
North Brunswick, NJ) was operated at 100 rpm using flat anchor impellers. 
At each desired time point, 100 μL of solution was extracted via pipette and 
ejected into a syringe attached to a 0.22 μm PVDF filter (Millipore Millex-GV filter unit, 
Bedford, MA).  This solution was filtered into a vial suitable for high performance liquid 
chromatography (HPLC, Waters Corp., Milford, MA).  All samples were analyzed via a 
Waters 2695 separations module (Waters Corp.) with a Waters 2487 Dual λ Absorbance 
detector and a Symmetry300™ C4 column (particle size 5 μm; dimensions 3.0 mm ID x 
150 mm length, Waters Corp.).  A mobile phase of 70% water (0.1% trifluoroacetic acid) 
and 30% acetonitrile (0.08% trifluoroacetic acid) was used. 
Insulin release was measured as a function of time.  Both pH and glucose 
concentration was used as the trigger for insulin release, and will be discussed 
separately below. 
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7.3 RESULTS AND DISCUSSION 
7.3.1 Insulin Loading 
7.3.1.1 Insulin Loading Efficiency 
The loading of insulin into PDEAEM microparticles was performed at a pH 
between 5.6 and 5.8.  This pH range allowed insulin to retain a net negative charge, 
while still swelling the hydrogels with a net positive charge (Figure 7.1).  Ionic 
interactions between the insulin and the polymer increased total loading of insulin into 
the hydrogels.  Previous experiments relied solely on equilibrium partitioning of insulin 
into the polymer; however, these techniques yielded lower overall insulin loading. 








EfficienyLoading i      (7.1) 
where m0 was the initial mass of insulin in solution and mi was the mass of insulin in 
solution at condition i.  Samples of the suspension medium were analyzed for insulin 
content using HPLC at the following conditions of interest: pre-collapse, post-collapse, 
and post-rinse.  Pre-collapse was the time immediately before the addition of NaOH (to 
raise the pH above the pKa), which was after particles had been suspended in the insulin 
solution and time was allowed for the particles to imbibe insulin.  Post-collapse refers to 
the time after the particles were collapsed to entrap insulin using NaOH, but prior to any 
surface rinsing.  Post-rinse was after rinsing surface-bound insulin from the particles 
using a filtration device, and consisted of the total mass of insulin recovered from the 
supernatant of the loading step plus all insulin collected after each wash step. 
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Figure 7.2 shows the relationship between the concentration of particles in the 
insulin loading solution to the loading efficiency of the particles.  The concentration of 
insulin remained constant at 1 mg/mL during these studies.  As the concentration of 150 
μm crushed microparticles was increased from 4.78 mg/mg insulin to 10.54 mg/mg 
insulin, the total amount of insulin imbibed into the particles increased from 72% to 
93%, after the rinsing step.  These results indicate that as the concentration of polymer 
particles was increased, more polymer was able to interact with the available insulin in 
solution, thus creating more ionic insulin-polymer interactions.  Therefore, more insulin 
was removed from solution and imbibed into the hydrogel particles as the 
concentration of particles increased. 
Even though these results indicated that increasing the particle concentration 
during insulin loading resulted in an increased amount of insulin being removed from 
solution, there was a practical limit to what polymer concentration was desired.  This 
optimization is discussed below in section 7.3.1.2. 
As shown in Figure 7.3, the loading efficiency for crushed microparticles was a 
function of crosslinking ratio.  Particles with a crosslinking ratio of 10% yielded the 
highest loading efficiency, at a value of almost 92% after rinsing, whereas particles with 
a crosslinking ratio of 3% provided only a 63% efficiency and particles with a crosslinking 
ratio of 15% only entrapped about 58% of the insulin in solution.  It is interesting that as 
the particles with a 3% crosslinking ratio were collapsed and rinsed, the loading 
efficiency dropped from nearly 87% down to 77% and 63%, respectively.  These results 
are due to the more loosely defined polymer network, which allowed the slight diffusion 
(and ultimately loss) of insulin out of the particles even in the collapsed state. 
The particles with higher nominal crosslinking ratios, 10% and 15%, also 
exhibited some interesting characteristics.  The amount of insulin entrapped in the 
polymer particles increased slightly between the pre-collapse and post-collapse steps.  
This result, which may be contrary to what was expected, could be explained by the 
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extent of ionic interactions.  As the particles were being collapsed, the negative charge 
density of the insulin increased.  Therefore, more insulin was imbibed into the hydrogel 
matrices due to increased ionic interactions.  Since the highly crosslinked hydrogels had 
smaller overall mesh sizes, the insulin was not squeezed out after collapse.  Finally, 
there was almost no difference between the post-collapse and the post-rinse steps, 
indicating that nearly all insulin that was entrapped in the particles occurred on the 
inside of these particles.  This result also indicates that the collapsed particles were 
bound tightly enough to prevent the premature diffusion of insulin out of the particles. 
7.3.1.2 Insulin Weight Fraction 
A second important means of characterizing the amount of insulin loaded into 











FractionWeightInsulin     (7.2) 
where mp was the mass of particles added to the insulin solution for loading.  This 
relationship indicates what mass percent of a given loaded particle is insulin.  In other 
words, if the insulin weight fraction is 10%, with a basis of 100 g of insulin-loaded 
particles, there would be 10 g of insulin and 90 g of polymer. 
Figure 7.4 identifies the relationship between the concentration of particles in 
the insulin loading solution to the insulin weight fraction of the particles.  The 
concentration of insulin remained constant at 1 mg/mL during these studies.  As the 
concentration of 150 μm crushed microparticles was increased from 4.78 mg/mg insulin 
to 10.54 mg/mg insulin, the relative amount of insulin per mass of particles imbibed into 
the particles decreased from 13% to 8%, after the rinsing step.  These results indicate 
that as the concentration of polymer particles was increased, less total insulin was 
available per hydrogel microparticle.  Therefore, even though more insulin was removed 
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from the solution at higher particle concentrations, the total amount of insulin in each 
particle decreased. 
These results indicated that a higher concentration of particles during the insulin 
loading was not necessary ideal.  For a drug formulation, the amount of drug loaded into 
each particle is an important parameter.  If the insulin weight fraction is very low for a 
given set of microparticles, then it would take more particles to deliver the same 
amount of insulin compared to a set of microparticles with a high insulin weight 
fraction.  For example, 5 g of particles with an insulin weight fraction of 8% has 400 mg 
of insulin.  However, 5 g of particles with an insulin weight fraction of 13% has 650 mg of 
insulin, more than 60% more insulin per mass of particles.  Thus, it would take 60% 
more particles of the lower insulin weight fraction to be able to deliver the same total 
amount of insulin as the particles with the higher insulin weight fraction. 
The ratio of 7 mg particles per 1 mg insulin was used for all further studies due to 
the high loading efficiency and relatively high insulin weight fraction of microparticles 
loaded at these conditions. 
As shown in Figure 7.5, the insulin weight fraction for crushed microparticles was 
also a function of crosslinking ratio.  Particles with a crosslinking ratio of 10% yielded the 
highest mass of insulin loaded per total mass, at a value of over 10% after rinsing, 
whereas particles with a crosslinking ratio of 3% provided only an 8% weight fraction 
and particles with a crosslinking ratio of 15% only contained about 6% of insulin per 
mass.  Similar to the loading efficiency, after the particles with a 3% crosslinking ratio 
were collapsed and rinsed, the insulin weight fraction dropped from nearly 11% down to 
10% and 8%, respectively.  Again, this phenomenon is most likely due to the more 
loosely defined polymer network which allowed some of the entrapped insulin to 
diffuse out during the hydrogel collapse. 
The particles with higher crosslinking ratios, 10% and 15%, exhibited some 
interesting characteristics in the insulin weight fraction as well.  The amount of insulin 
 125 
entrapped in the polymer particles increased slightly between the pre-collapse and 
post-collapse steps.  This result, which may be contrary to what was expected, could be 
explained by the extent of ionic interactions.  As the particles were being collapsed, the 
negative charge density of the insulin increased.  Therefore, more insulin was imbibed 
into the hydrogel matrices due to increased ionic interactions.  Since the highly 
crosslinked hydrogels had smaller overall mesh sizes, the insulin was not squeezed out 
after collapse.  Again, since there was almost no difference between the post-collapse 
and the post-rinse steps, nearly all insulin that was entrapped in the particles occurred 
on the inside of these particles and there was very little surface-bound insulin to be 
washed off.  This result also indicates that the collapsed particles were bound tightly 
enough to prevent the premature diffusion of insulin out of the particles. 
As determined by the mesh size estimates in Chapter 5, the crushed 
microparticles were indeed able to entrap insulin in basic media.  However, the ability to 
load insulin into the nanoparticles discussed in Chapter 6 was more problematic.  
Studies were inconclusive as to the effectiveness of trapping insulin inside these 
nanoparticles at elevated pH values.  In acidic media, negatively charged insulin was 
attracted to the positively charged nanogels.  However, upon addition of NaOH to 
collapse the nanogels and trap the imbibed insulin, most insulin appeared to simply 
diffuse out.  This result is due to the substantially increased surface-area-to-volume 
ratio of the nanogels compared with the microparticles, which substantially increased 
the diffusional surface per unit mass by orders of magnitude.  These results were further 
investigated with release studies performed with the nanogels, and discussed below. 
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7.3.2 Insulin Release 
7.3.2.1 pH-Sensitivity for Insulin Release 
Initial studies were first performed on crushed microparticles that were exposed 
to different pH media.  This proof-of-concept was used to ensure that insulin could be 
trapped in the hydrogel particles at elevated pH values (physiological pH of 7.4) and 
then be released at acidic conditions.  Crushed microparticles were used in the study 
represented by Figure 7.6, where the pH of the media was 7.4 until time 120 min, at 
which time an injection of HCl was used to reduce the pH to 4.0.  As desired, the insulin 
remained entrapped inside the hydrogel microparticles at the physiological pH.  After 
the addition of acid, the tertiary amines of DEAEM became protonated, and the insulin 
took on a net negative charge (pI = 5.3).  This charge repulsion caused particle swelling 
and the expulsion of imbibed insulin from the microparticles. 
Rapid insulin release occurred after the addition of hydrochloric acid, releasing 
most releasable insulin after 30 min and nearly 100% after about 50 min.  This 
experiment confirmed the ability to retain the insulin inside the hydrogel microparticles 
at elevated pH values and only release the insulin once the pH became acidic.  Attempts 
were made to release insulin in a controlled manner from nanoparticles (Figure 7.7).  
However, large errors were encountered in acidic media and the pH of the media did 
not affect the release in a desirable manner, even in basic media.  Thus, nanoparticle 
release was not exhaustively analyzed. 
7.3.2.2 Glucose-Sensitivity for Insulin Release 
The proof-of-concept results discussed above were promising, and indicated that 
further studies were necessary to determine the release profile for hydrogels exposed 
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to glucose solutions.  Since the mechanism of insulin delivery with the proposed system 
is during elevated glucose levels, it was necessary to determine the effect glucose had 
on the release of insulin. 
The first comparison was between two sets of crushed hydrogel microparticles 
which had differing crosslinking ratios.  Figure 7.8 shows the insulin release profile of 
microparticles with a crosslinking ratio of 3% and 10%.  Since the microparticles with 
only 3% crosslinking swelled substantially more than those with 10% crosslinking (see 
Chapter 5), more insulin was able to easily diffuse out during the insulin release study.  
Thus, 70% of the total amount of insulin that was releasable in the microparticles was 
released for the particles having 3% crosslinking.  This polymeric system would not be 
ideal for multiple, pulsed release due to over two-thirds of the total drug payload being 
released on the first pulse. 
The higher crosslinked particles exhibited more ideal characteristics for an 
insulin delivery device.  These microparticles released closer to one-third of the 
available insulin from within the matrix instead of 70%.  Thus, multiple dosages of 
insulin would be possible with such a hydrogel, potentially up to three for the particles 
investigated.  The actual amount of insulin released per mass of particles was 24 μg/mg 
for the 3% crosslinked microparticles and 6 μg/mg for the 10% crosslinked 
microparticles.  Therefore, for a typical patient of about 75 kg that would require a 
postprandial insulin dose of between 3.75-7.5 IU, roughly 30-60 mg of dry microparticles 
(10% crosslinking ratio) would be required per day. 
Figure 7.9 shows how the total amount of insulin able to be released from the 
particles was determined.  This value may differ from M∞ due to the method used.  
After the insulin release due to the glucose stimulus, hydrochloric acid was added to the 
solution to lower the pH to below the pI of insulin.  At a pH of 4, both the insulin and the 
hydrogel microparticles had net positive charges.  Thus, ionic repulsion helped force out 
any excess insulin still entrapped in the hydrogel after the glucose stimulus.  This 
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amount of insulin was quantified, and used as the total amount of insulin that was able 
to be released from the microparticles.  M∞, on the other hand, typically just refers to 
the amount of drug released at infinite time. 
Figure 7.10 indicated the effect a buffering system had on the release of insulin 
from the hydrogel microparticles.  The ionic strength of each solution was kept constant 
at 150 mM, and the only difference was whether there was a phosphate buffer (5 mM) 
present.  The buffered media reduced the total amount of insulin released due to the 
Donnan equilibrium effect, which has an effect on the overall swelling of the particles 
[12].  This effect indicates that a semi-permeable membrane, such as the hydrogel itself, 
may balance net charges by partitioning certain ions into either the membrane or the 
solvent phase [13].  Previous modeling studies indicated that the buffered medium 
substantially hindered the pH drop inside these particles [14].  It was also modeled that 
a pH profile along the radius of each particle, thus preventing total swelling.  With a 
decrease in the particle swelling, each insulin molecule was presented with a more 
tortuous diffusional path and was thus less likely to be able to leave the microparticle. 
7.4 CONCLUSIONS 
Several important conclusions were drawn from the above mentioned studies.  
First, the ideal insulin loading procedure for crushed microparticles was determined to 
be a particle concentration of 7 mg/mL, at an insulin concentration of 1 mg/mL.  These 
conditions yielded a high insulin loading efficiency (over 90%) and a relatively high 
insulin weight fraction in the particles.  It was also determined that particles with a 
crosslinking ratio of 10% provided the highest insulin loading efficiency compared to 
particles with 3% and 15% crosslinking.  Finally, particles with a crosslinking ratio of 10% 
only released about one-third of the total releasable insulin after a single glucose 
stimulus, compared to nearly 70% in the case of 3% crosslinked particles.  Thus, 
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microparticles with a crosslinking ratio of 10% were determined to have the optimal 
characteristics for insulin loading and release, both as a function of pH and as a function 
of glucose concentrations. 
The insulin release properties of these microparticles had several desirable 
characteristics.  The release of insulin was controlled by either pH or glucose 
concentration, and insulin release was minimal at physiological pH values.  The total 
amount of insulin released from the particles was a function of the crosslinking ratio, 
which would allow the tuning of the particles to provide a specific number of doses of 
insulin (each pulse of glucose causing the release of one of these insulin “doses”).  It was 
also possible to obtain physiologically relevant amounts of insulin release from these 
microparticle systems.  A patient of 75 kg would only need between 30-60 mg of 
microparticles per day for postprandial insulin delivery. 
However, some scientific concerns must also be noted.  Donnan equilibrium was 
determined to cause decreased release rates of insulin out of the swollen 
microparticles.  This phenomenon substantially decreased the amount of released 
insulin, as shown by the difference in release rates and amounts for hydrogel 
microparticles suspended in saline compared to buffer. 
Nanoparticles, which were expected to have the fastest response to a given 
stimulus (either pH or glucose), were very difficult to work with when it came to insulin 
loading and release.  Loading of nanoparticles after synthesis had challenges associated 
with washing and collection.  Due to the small size and the necessity to prevent 
premature diffusion of insulin out of the particles, rapid methods of collapse and 
collection were necessary.  Ultracentrifugation was not an option because it may have 
squeezed the loaded drug out of the matrix. 
Finally, the release of insulin from the nanoparticles was difficult.  These studies 
yielded unreliable data with large errors.  The large surface area to volume ratio of these 
nanoparticles substantially increased the diffusional driving force by increasing the area 
 130 
for mass transfer flux.  These results agree with modeling attempts of similar systems, 
which indicated that the submicron particle size would not properly work as an 









Figure 7.1. Theoretical Charges for Insulin Loading 
The theoretical charges on insulin (pI = 5.6) and PDEAEM (pKa = 7.4) indicate a window 
above pH 5.6 and below pH 9 where optimal ionic interactions will occur to increase 
insulin loading.  Since PDEAEM is not swollen above pH 7.4, this window is further 
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Figure 7.2. Insulin Loading Efficiency Insulin into Microparticles With 10% Crosslinking 
The loading efficiency of insulin into 150 μm crushed microparticles having a 
crosslinking ratio of 10%.  As the concentration of particles increased (with constant 
insulin concentration) from 4.78 mg/mg insulin to 10.54 mg/mg insulin, the loading 
efficiency also increased, from a low of 72% to a high of 93%.  These results were due to 









































Figure 7.3. Insulin Loading Efficiency Insulin into Microparticles With Varying 
Crosslinking Ratios 
Insulin loading efficiency of crushed microparticles, indicating the amount of insulin in 
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Figure 7.4. Insulin Weight Fraction of Loaded Microparticles With 10% Crosslinking 
The insulin weight fraction of loaded insulin into 150 μm crushed microparticles having a 
crosslinking ratio of 10%.  As the concentration of particles increased (with constant 
insulin concentration) from 4.78 mg/mg insulin to 10.54 mg/mg insulin, the insulin 
weight fraction of the particles decreased from a high of 13% to a low of 8%, after the 
rinsing step.  These results were because there was less insulin available for each 










































Figure 7.5. Insulin Weight Fraction of Loaded Microparticles With Varying Crosslinking 
Ratios 
Weight fraction of insulin in loaded crushed microparticles.  For example, a weight 












Figure 7.6. Insulin Release in Response to pH Change 
Insulin release from microparticles in response to a step change in pH.  At time 120 min, 
1N HCl was added to the solution to decrease the pH, and increase the amount of 
hydrogel swelling.  This swelling in turn increased the amount of insulin released 




































































Figure 7.7. Insulin Release from Nanogels at Physiological pH 
Release profile of insulin from loaded nanoparticles which were suspended in buffered 
media at pH 7.4.  While microparticles were able to retain the loaded insulin at this pH, 









































Figure 7.8. Insulin Release in Response to Glucose Stimulus 
The effect of crosslinking ratio on amount of insulin released in response to a glucose 
stimulus.  At time 0, a glucose bolus was delivered to the particle suspension and the 
amount of insulin released was observed.  Higher crosslinking ratios yielded in less 
fractional insulin release (amount released compared to amount loaded) thus allowing 












Figure 7.9. Insulin Release in Response to Glucose and pH Change 
To determine the total amount of insulin that is able to be released in Figure 7.8, 1 N HCl 
was added after the insulin release caused by a glucose bolus.  This change in pH caused 
the pH to drop below the pI of insulin, forming ionic repulsion between the positively 


































































Figure 7.10. Insulin Release in Response to Glucose, Solvent 
Release of insulin from 150 μm crushed microparticles.  At a time of 125 min, 300 mg/dL 
glucose was added to each sample.  Release of insulin in unbuffered saline (ionic 
strength I = 0.15 M) was much higher than in buffered PBS (I = 0.15 M) due to the 
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Preparation of Custom Monomers and Crosslinking Agents 
8.1 INTRODUCTION 
8.1.1 Alternate Cationic Monomers 
Since PDEAEM has a pKa very close to physiological pH, it may not be in its fully 
collapsed state when in a physiological environment.  Therefore, it may be beneficial to 
find polymers with even lower values of pKa and so other cationic monomers were also 
considered for intelligent insulin delivery devices.  Using small molecule analogs as a 
basis, one such monomer of interest was 2-(diethylamino)ethyl methacrylamide.           
2-(diethylamino)ethanol has a slightly higher pKa value than the corresponding amine,  
2-(diethylamino)ethylamine, and acrylates tend to have a slightly higher pKa value than 
methacrylates [1-3].  The methacrylamide moiety also has the potential for hydrogen 
bonding with the PEG grafts in a hydrogel, thus allowing an even more collapsed state 
(Figure 8.1) similar to copolymers of methacrylic acid and PEG.  This information was 
used to synthesize a new tertiary amine containing methacrylamide based monomer for 
possible use as an intelligent drug delivery hydrogel system. 
8.2.1 Biodegradable Crosslinking Agents 
To render these systems biodegradable, degradable crosslinking agents are 
necessary.  Often, methacrylate-based hydrogels are turned into degradable polymers 
by using biodegradable acrylated poly(lactide-co-glycolide) (PLGA) crosslinks.  However, 
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there are several problems with using PLGA based crosslinks in the described system.  
PLGA polymers exhibit acid-catalyzed degradation rates.  However, the PDEAEM system 
described in previous chapters uses glucose oxidase to detect glucose by producing 
gluconic acid.  This local drop in pH causes hydrogel swelling, which would also increase 
the rate of degradation of PLGA-based crosslinks.  The complexity of determining the 
appropriate amount of PLGA crosslinks for a desired degradation profile in such a 
system is quite large. 
  A second problem with PLGA-based crosslinks is that they degrade into lactic 
acid and glycolic acid.  While these byproducts have been shown to be safe and for the 
most part cytocompatible, their interaction with the proposed PDEAEM systems may be 
adverse.  These degradation products may cause swelling of the system even without 
the presence of a high glucose concentration, since PDEAEM responds to changes in pH.  
This problem would potentially lead to premature or sustained insulin release, which is 
not desired in a type I diabetes insulin delivery device.  Thus, a crosslinking agent that 
does not exhibit acid catalyzed degradation is ideal.   
One promising crosslinking agent is based on a labile carbonate bond.  These 
crosslinking agents show no increased degradation rates in acidic media compared to 
neutral media [4, 5].  Also, the degradation byproducts are carbon dioxide and a 
hydroxyl-terminated polymer.  The human body is already very capable in handling 
small shifts in the carbon dioxide equilibrium.  As shown in Figure 8.3b, the synthesis of 
the desired carbonate-containing crosslinking agent closely follows the synthetic steps 
of Bruining, et al. [5] (Figure 8.3a).  Bruining, et al., reported significant cytotoxicity in 
PDMAEM polymers that used these degradable crosslinks.  In this research, the 
triethylene glycol spacer was omitted, since small molecular weight PEGs have been 
known to be toxic [6, 7].  Degradation of the triethylene glycol containing hydrogels 
occurred rapidly, within about 4 days; adjusting the hydrophobicity of such a crosslink 
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was hypothesized to also alter the degradation rate since the mechanism of degradation 
is the hydrolysis of the carbonate bond. 
8.2 MATERIALS AND METHODS 
8.2.1 Synthesis of 2-(Diethylamino)ethyl acrylamide 
The synthetic route of 2-(diethylamino)ethyl acrylamide can be seen in Figure 
8.2.  All glassware was dried overnight in an oven at 120 °C, allowed to cool in a 
dessicator, and then subjected to three vacuum/nitrogen purge cycles before use.         
2-(diethylamino)ethylamine (16.54 g, DEAEA, Sigma-Aldrich) was dissolved in 75 mL dry 
DCM and chilled in an ice bath under nitrogen.  Acryloyl chloride (13.9 mL, Alfa Aesar) 
was added dropwise to prevent the reaction from progressing too quickly and the 
reaction mixture from becoming too hot.   
The reaction was allowed to proceed for a few hours, after which it was washed 
three times with 1 N NaOH, once with brine, and then dried over MgSO4.  The washed 
and dry crude product was filtered and then concentrated and stored in the refrigerator 
until use.  1H NMR was used to confirm the molecular structure.  Similar monomers 
could be synthesized in a similar fashion.  Analogs such as 2-(diethylamino)ethyl 
methacrylamide were considered for synthesis by replacing the acryloyl chloride with 
methacryloyl chloride.   
The pKa of monomers was measured by titration.  Briefly, 0.5 g monomer was 
dissolved in 10 mL ethanol and 100 mL ddH2O.  The pH was continuously monitored as 
increments of between 0.25 and 0.5 mL 0.1 N hydrochloric acid were added. 
Methacryloyl chloride was synthesized to be used in the synthesis of                    
2-(diethylamino)ethyl methacrylamide.  Methacrylic acid (Fisher Scientific) was 
dissolved in dry DCM and chilled in an ice bath under nitrogen.  An equimolar amount of 
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thionyl chloride (Sigma-Aldrich) was added dropwise to prevent the reaction from 
progressing too quickly and the reaction mixture from becoming too hot.  Triethyl amine 
(TEA, Sigma-Aldrich) was used in equal molar amounts to complex the liberated 
hydrochloric acid during the reaction, which then precipitated out as the TEA-HCl salt.  
The salt was filtered and the solvent was removed under reduced pressure to afford the 
acid chloride of methacrylic acid. 
8.2.2 Synthesis of Poly[2-(Diethylamino)ethyl acrylamide] 
Hydrogels of 2-(diethylamino)ethyl acrylamide and poly(ethylene glycol)-400 
monomethyl ether monomethacrylate, henceforth P(DEAEAAm-g-EG400) were 
synthesized using a free radical thermal polymerization in solution, where 400 refers to 
the average molecular weight of the ethylene glycol repeat units.  To synthesize these 
systems, a solution of DEAEAAm (synthesized above), PEG400MMA (Polysciences, 
Warrington, PA) and the crosslinking agent tetraethylene glycol dimethacrylate 
(TEGDMA) (Acros Organics, Morris Plains, NJ) was made.  All other reagents were used 
as received.  Phosphate buffered saline (PBS) (Fisher Scientific) was used as the solvent 
to prevent autoacceleration and was reconstituted from a 10X concentrate with 
deionized water (Milli-Q Plus system, Millipore, Bedford, MA), in a ratio of about 1:1 by 
weight of the monomers.  Ammonium persulfate (APS) (Fisher Scientific) and sodium 
metabisulfite (NaMBS) (Fisher Scientific) were used to initiate the polymerization in a 
ratio of 4:1 by mole, and the chemicals were pre-mixed before polymerization in 
distilled deionized water (ddH2O) at a 1 wt% concentration of APS.  The initiator solution 
was used in an amount of 0.5% by moles of monomers. 
Two different systems were synthesized with varying compositions.  The ratio of 
DEAEAAm to PEG grafts was either 25:1 or no PEG grafts.  Crosslinking ratios were 3 
mol% for both samples  Once all compounds had been well mixed in a test tube, the 
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solution was transported to a glove box where it was purged with nitrogen for 20 min to 
remove dissolved oxygen, a free-radical scavenger.  The initiator solution was then 
added, mixed via aspiration, and then pipette between two glass slides, separated by a 
760 μm Teflon spacer.  The glass slide assembly was then placed in an acrylic air-tight 
polymerization box, sealed, and transported to an incubator at 37°C for 24 h.  This 
procedure resulted in polymer films.  The films were then washed in a jar of PBS for one 
week to remove unreacted monomers and small molecular weight polymers. 
8.2.3 Synthesis of Biodegradable Crosslinking Agents 
Paraformaldehyde (9.384 g, Sigma-Aldrich) was dissolved in hydroxyethyl 
methacrylate (40.0 g. HEMA, Sigma-Aldrich) and cooled in an ice bath.  Thionyl chloride 
(15.2 mL, Sigma-Aldrich) was added dropwise to the solution, and the reaction was 
allowed to proceed for about 15 minutes.  The reaction mixture was then quenched 
with ice water and extracted twice with methylene chloride (DCM, Fisher Scientific).  
The organic layers were combined, dried over MgSO4 (Fisher Scientific), and filtered.  
The washed and dried reaction mixture was concentrated under reduced pressure.  The 
crude product, 2-chloromethoxy ethylmethacrylate, was purified by vacuum distillation 
to afford pure product, which was then characterized by 1H NMR.  
The second step of this synthesis proceeded as follows, and was varied to alter 
the spacer that was incorporated in the final structure.  Initial crosslinks did not contain 
PEG spacers. 
Silver carbonate (7.77 g, Alfa Aesar, Ward Hill, MA) was suspended in a solution 
of HEMA in 10 mL dry dimethylformamide (DMF, Alfa Aesar) and cooled to -15°C under 
nitrogen gas.  Crude 2-chloromethoxy ethylmethacrylate (7 mL, with unreacted HEMA) 
was added to the flask dropwise, with the exclusion of light, and allowed to react for an 
hour.  Cold acetone was added to quench the reaction, and the mixture was allowed to 
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warm to room temperature.  The crude product was filtered through a short packed 
silica column using ethyl acetate as the mobile phase.  After removing the solvent under 
reduced pressure, the crude product was dissolved in toluene and washed with brine.  
The organic layer was dried over MgSO4, filtered, and concentrated again under reduced 
pressure to afford degradable crosslinker 2 (DC2, Figure 8.3). 
To incorporate PEG spacers between the two HEMA analogs, the above 
procedure was slightly modified.  Silver carbonate (7.77 g) was suspended in a solution 
of 0.564 g PEG (i.e., PEG 200) in 10 mL dry DMF and cooled to -15°C under nitrogen gas.  
Pure (distilled) 2-chloromethoxy ethylmethacrylate (3.3 mL) was added to the flask 
dropwise, with the exclusion of light, and allowed to react for an hour.  Cold acetone 
was added to quench the reaction, and the mixture was allowed to warm to room 
temperature.  The crude product was filtered through a short packed silica column using 
ethyl acetate as the mobile phase.  After removing the solvent under reduced pressure, 
the crude product was dissolved in toluene and washed with brine.  The organic layer 
was dried over MgSO4, filtered, and concentrated again under reduced pressure to 
afford degradable crosslinker 1 (DC1, Figure 8.3). 
8.2.4 Molecular Characterization via NMR 
Nuclear magnetic resonance (NMR) spectra were obtained on a Varian Unity+ 
300 MHz spectrometer.  Both 1H and 13C spectra were obtained for most small 
molecular weight compounds.  Water suppression was used via the PRESAT macro with 
a saturation power of 2 and a saturation delay of 5 s on any samples with significant 
water signals.  Small molecule analysis was obtained by using a suitable deuterated 
solvent, such as chloroform (CDCl3), dimethylsulfoxide (d6-DMSO), or d¬6-acetone, all 
obtained from Cambridge Isotope Laboratories.  Unless otherwise stated, for all 1H NMR 
spectra, the sample was spinning at 20 Hz, the number of transients was 8, and line 
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broadening was 0.1.  Unless otherwise stated, for all 13C NMR spectra, the sample was 
spinning at 20 Hz and line broadening was 0.1.  The number of transients was typically 
greater than 128, but was ultimately dependent on the signal-to-noise ratio. 
8.3 RESULTS AND DISCUSSION 
8.3.1 Synthesis of 2-(Diethylamino)ethyl acrylamide 
Successful synthesis of the monomer 2-(diethylamino)ethyl acrylamide, was 
confirmed via 1H and 13C NMR spectroscopy.  Structural analyses by NMR can be seen in 
Figure 8.4.  1H NMR peaks in CDCl3 had the following assignment: δ 0.98 (6H, s, CH3), 
2.52 (6H, m, CH2), 3.36 (2H, q, CH2), 5.61 (1H, dd, NH), 6.10 (1H, m, vinyl H), 6.26 (2H, 
dd, vinyl H).  The pKa of the DEAEAAm monomer was estimated to be about 0.1 pH units 
higher than DEAEM monomer (8.4 versus 8.5), as measured by titration with sodium 
hydroxide.  Cationic polymers tend to have lower pKa values than their corresponding 
monomers, in part due to steric concerns and ionic repulsion [8, 9].  
8.3.2 Synthesis of Poly[2-(Diethylamino)ethyl acrylamide] 
Ultimately, the physical properties of poly[2-(diethylamino)ethyl acrylamide)] 
(PDEAEAAm) prevented it from further use as a potential intelligent insulin delivery 
device.  The theoretical hydrogen bonding in Figure 8.1 did not appear to occur as 
desired.  Instead, the acrylamide functional group increased the overall hydrophilicity of 
both the monomer and the polymer (compared to PDEAEM).  Thus, the polymer swelled 
in the presence of water despite the pH of the surrounding medium.  Controlled 
swelling and deswelling was difficult to achieve, even when the pH of the medium was 
substantially above the pKa of the monomer.  Structural integrity was also difficult to 
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maintain due to the extent of swelling.  Thus, PDEAEAAm was not used in insulin release 
experiments and it was not fully characterized. 
8.3.3 Synthesis of Biodegradable Crosslinking Agents 
Successful synthesis of the intermediate compound, 2-chloromethoxy 
ethylmethacrylate, was confirmed via 1H and 13C NMR spectroscopy.  Structural analyses 
by NMR can be seen in Figure 8.5 and Figure 8.6.  1H NMR peaks in CDCl3 had the 
following assignment: δ 1.95 (3H, singlet, CH3), 3.92 (2H, triplet, OCH2CH2OCH2Cl), 4.34 
(2H, triplet, OCH2CH2OCH2Cl), 5.48 (2H, singlet, OCH2CH2OCH2Cl), 5.60 (1H, multiplet, 
vinyl H), 6.15 (1H, multiplet, vinyl H).  13C NMR peaks in CDCl3 had the following 
assignment: δ 17.7, 62.2, 67.5, 82.1, 125.4, 135.4, 166.5. 
Vacuum distillation yielded a clear liquid product and occurred at either a 
temperature of 55 °C and pressure of 455 μbar, or a temperature of 34 °C and pressure 
of about 140 μbar.  The density was measured to be 1.15 g/mL.  Long-term stability of 
this compound was determined by comparing 1H NMR spectra of the same sample, 
taken several months apart.  Storage away from light at 4 °C provided at least 3 months 
of stability.  A yield of about 50% conversion was obtained, and for some syntheses 
(which used HEMA in the second step), the unreacted HEMA was left in the product 
since the second step required HEMA in excess.   
Successful synthesis of the degradable crosslinking agents DC1 was confirmed via 
1H and 13C NMR spectroscopy.  Structure analyses by NMR can be seen in Figure 8.7 and 
Figure 8.8.  1H NMR peaks in CDCl3 had the following assignment: δ 1.93 (6H, singlet, 
CH3), 3.65 (4H, singlet, CO3CH2CH2OCH2CH2OCH2CH2OCO2), 3.72 (4H, triplet, 
CO3CH2CH2O ), 3.92 (4H, triplet, OCH2CH2OCH2CO3), 4.29 (8H, multiplet, CO2CH2CH2-
OCH2CO3 and CO3CH2CH2O), 5.31  (4H, singlet, OCH2CH2OCH2O), 5.57 (1H, multiplet, 
vinyl H), 6.11 (1H, multiplet, vinyl H).  13C NMR peaks in CDCl3 had the following 
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assignment: δ 17.7, 62.8, 66.6, 67.8, 68.34, 70.1, 91.7, 125.4, 135.4, 154.0, 166.6. Long-
term stability of this compound was determined by comparing 13C NMR spectra of the 
same sample, taken one month apart (Figure 8.8 and Figure 8.9).  Storage away from 
light at 4 °C did not provide stability for one month, and this compound partially 
degraded into its precursory compounds. 
Successful synthesis of the degradable crosslinking agents DC2 was confirmed via 
1H NMR spectroscopy, as seen in Figure 8.10.  1H NMR peaks in CDCl3 had the following 
assignment: δ 1.21 (6H, multiplet, CH3), 1.90 (4H, singlet), 2.00 (4H, triplet), 3.77 (4H, 
multiplet), 4.08 (4H, quartet), 4.28 (2H, multiplet), 4.41 (2H, multiplet), 5.31  (2H, 
multiplet), 5.55 (2H, multiplet, vinyl H), 6.09 (2H, multiplet, vinyl H). 
8.4 CONCLUSIONS 
There are several conclusions that can be made from the research presented 
above.  The monomer 2-(diethylamino)ethyl acrylamide was successfully synthesized 
and purified.  Polymers were successfully synthesized using this monomer, and the 
polymers were partially characterized.  A novel family of degradable crosslinking agents 
was presented, and the synthetic steps necessary were elucidated.  The intermediate 
compound necessary for these syntheses was successfully isolated and characterized.  
Some of these crosslinking agents were successfully synthesized and purified as well. 
Unfortunately, the hydrophilicity of pure crosslinked P(DEAEAAm) was too great 
to form polymers which would collapse enough for the controlled drug delivery devices 
that this research focused on.  The extent of hydrogen bonding between PEG and 
DEAEAAm was not elucidated.  Further studies could be performed, however, on this 
monomer and these hydrogels, to determine if there are other potential uses.   
The degradable crosslinking agents synthesized showed promise as short-term 
degradable crosslinkers.  Due to the hydrolysis of the carbonate bond, each crosslinking 
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agent could potentially release up to two carbon dioxide molecules.  While in an 
aqueous environment such as bodily fluids, the carbon dioxide would dissolve as 
carbonate.  This carbonate anion could potentially affect the pH of the media, but at the 
low concentrations in a hydrogel, and the biological fluid’s natural buffering capacity, 
this pH variation was expected to be negligible.  Degradation of the pure crosslinking 
agents was apparent after less than a month of storage.  More studies would be 
necessary to fully characterize the degradation of these crosslinking agents for usage in 
hydrogel drug delivery systems, such as the kinetics of degradation and the analysis of 














Figure 8.1. Theoretical Hydrogen Bonding in P(DEAEAAm-g-EG) 
Theoretical hydrogen bonding between the amide hydrogen and either the tertiary 



























































Figure 8.2. 2-(Diethylamino)ethyl (Meth)acrylamide Synthetic Route 
Synthesis of  2-(diethylamino)ethyl (meth)acrylamide cationic monomer, where R=H for 
acrylamide and R=CH3 for methacrylamide. 




























































































Figure 8.3. Biodegradable Crosslinking Agent Synthetic Routes 
Synthesis of  (a) Degradable carbonate dimethacrylate crosslinking agent, with  
triethylene glycol spacer, degradable crosslinking agent #1 (DC1) [5]; 
(b) Degradable carbonate dimethacrylate crosslinking agent, without triethylene glycol 




















Figure 8.5. 1H NMR Spectrum of 2-(Chloromethoxy)ethyl Methacrylate 
1H NMR of 2-(chloromethoxy)ethyl methacrylate, the precursor to the degradable 









Figure 8.6. DEPT 13C NMR of 2-(Chloromethoxy)ethyl Methacrylate 
DEPT  13C NMR of 2-(chloromethoxy)ethyl methacrylate, the precursor to the 
degradable crosslinking agents, in CDCl3.  Each carbon peak is labeled.  The top spectrum 
only contains CH3 carbons, the second one only displays CH2 carbons, the third spectrum 
displays only CH carbons, and the final spectrum displays all carbons.  The peaks 












































Figure 8.10. 1H NMR Spectrum of Degradable Crosslinker 2 
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Conclusions and Recommendations 
9.1 INTELLIGENT INSULIN DELIVERY DEVICE DESIGN CONSIDERATIONS 
The goals of this research were to develop novel hydrogels for the intelligent 
delivery of insulin.  These hydrogels were then characterized in several ways, including 
determining the swelling as well as the insulin loading and release, as a function of both 
pH and glucose concentrations.  Finally, these hydrogel systems were evaluated as 
potential intelligent insulin delivery devices, and guidance is provided for potential 
designs. 
We were able to successfully synthesize pH responsive cationic hydrogels having 
various morphologies.  Polymer slabs, microparticles, and nanoparticles were 
synthesized and characterized in several ways.  These hydrogels were then made 
glucose responsive by the addition of glucose oxidase and catalase, which transduced a 
glucose signal into a pH signal.  We were able to load insulin into these hydrogel systems 
with a fairly high efficiency and then determine their efficacy as intelligent controlled 
drug delivery devices.  Thus, a glucose stimulus was successfully able to cause the 
release of an insulin bolus. 
Microparticles were successfully synthesized by first synthesizing a polymer film.  
This film was wet sieved through sieves of varying meshes (i.e., 150 μm, 35 μm) to 
produce relatively uniform particle size distributions.  Particles were successfully 
synthesized on the nanoscale using a novel inverse emulsion polymerization, with 
diameters as small as 120 nm in the collapsed state.  This process also allowed the 
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incorporation of hydrophilic components (i.e., enzymes) on the interior of the particles 
and PEG grafts on the surface of the particles for increased biocompatibility. 
The ideal insulin loading procedure for crushed microparticles was determined, 
which yielded a high insulin loading efficiency (over 90%) and a relatively high insulin 
weight fraction in the particles (over 10%).  It was also determined that particles with a 
crosslinking ratio of 10% provided the highest insulin loading efficiency compared to 
particles with 3% and 15% crosslinking.  Finally, particles with a crosslinking ratio of 10% 
only released about one-third of the total releasable insulin after a single glucose 
stimulus.  Thus, microparticles with a crosslinking ratio of 10% were determined to have 
the optimal characteristics for insulin loading and release for a cyclic intelligent insulin 
delivery device, both as a function of pH and as a function of glucose concentrations. 
The insulin release properties of these highly crosslinked microparticles had 
several desirable characteristics.  The release of insulin was controlled by either pH or 
glucose concentration, and insulin release was minimal at physiological pH values.  The 
total amount of insulin released from the particles was a function of the crosslinking 
ratio, which would allow the tuning of the particles to provide a specific number of 
doses of insulin (each pulse of glucose causing the release of one of these insulin 
“doses”).  It was also possible to obtain physiologically relevant amounts of insulin 
release from these microparticle systems.  A patient of 75 kg would only need between 
30-60 mg of microparticles per day for postprandial insulin delivery. 
Donnan equilibrium concerns with hydrogels as feedback controlled intelligent 
delivery devices were partially overcome by altering the hydrogel morphology.  Work 
performed has indicated that the swelling rate is significantly faster than the collapsing 
rate for macroscopic hydrogels.  Thus, collapsing the hydrogels rapidly to promptly cut 
off insulin release was difficult on macroscopically sized hydrogels.  To overcome this 
challenge, smaller gel sizes were used.  Microparticles and nanoparticles were 
synthesized, which offered superior swelling rates, equilibrating in minutes or less.  
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Thus, as delivery device sizes decrease, this deswelling rate complication was 
diminished. 
However, there were some challenges encountered while trying to design a 
feedback-controlled intelligent insulin delivery device based on hydrogels.  Loosely 
crosslinked hydrogels released up to 70% of the available insulin after the first stimulus.  
These hydrogels were able to respond more quickly due to their more loosely bound 
polymer chains, but were less able to be useful as repeated drug delivery devices.  
Nanoparticles, on the other hand, were almost impossible to control the release of 
insulin.  Insulin diffused out whether the particle was swollen or collapsed, and the 
release profile was not what was desired for a type I diabetes treatment. 
Donnan equilibrium also may play a part in preventing the gels from fully 
deswelling under cyclic conditions.  This behavior may also be in part due to the 
buffering nature of the hydrogel itself.  Therefore, when trying to collapse the 
hydrogels, significant amounts of H+ ions had to be released from the gels, mostly via 
conjugate bases.  This phenomenon substantially decreased the amount of released 
insulin, as shown by the difference in release rates and amounts for hydrogel 
microparticles suspended in saline compared to buffer.  With in vivo studies, however, 
there would be a significantly higher solvent-to-particle ratio, and thus this effect should 
be minimized. 
Finally, the release of insulin from the nanoparticles was problematic.  These 
studies yielded unreliable data with large errors.  The large surface area to volume ratio 
of these nanoparticles substantially increased the diffusional driving force by increasing 
the area for mass transfer flux.  These results agree with modeling attempts of similar 
systems, which indicated that the submicron particle size would not properly work as an 
injectable controlled drug delivery device.  Thus, it was determined that nanoparticles 
alone would not provide the desired insulin delivery characteristics. 
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9.2 FINAL RECOMMENDATIONS AND FUTURE WORK 
Ultimately, an intelligent insulin delivery device for type I diabetes treatment 
would need to have several specific features.  It would need to be able to replace the 
current insulin therapy methods employed today, which primarily consists of three 
insulin injections a day.  Thus, the delivery device would at least need to replace an 
entire day’s worth of insulin injections, but three to seven days worth would be 
preferable and insulin stability on such a time scale would not be a concern.  These 
delivery devices would also need to be able to degrade and be excreted on a similar 
time scale in order to prevent a large build up of hydrogels in the patient’s body. 
Initial aspirations and design considerations during this research were for an 
intravenous injectable hydrogel device which could respond to glucose levels and 
release insulin in the presence of elevated glucose levels.  Due to the small diameter of 
capillaries (5-9 µm), circulating particles could not possibly be larger than about 5 µm 
when swollen.  This limitation led the research towards the use of nanoparticles for 
insulin loading and release.  However, mathematical modeling determined that these 
particles would not be feasible due to the uncontrolled release of insulin, and 
experimental studies confirmed these conclusions.  Also, intravenous particles would be 
subjected to more immune response and current technologies have only been able to 
extend circulation to less than a day, even with PEG surface tethers. 
Thus, it is recommended that intravenous injectable hydrogels are not pursued 
for insulin delivery based on this body of work.  Crushed microparticles were shown to 
have acceptable glucose response and insulin release for type I diabetes treatment.  
Instead of injectable nanoparticles, microparticles could be implanted either in a 
synthetic matrix intraperitonealy or simply as free microparticles.  The proposed matrix 
would only need to entrap the microparticles until degradation, and not have an 
environmental response to the glucose; therefore, a hydrogel with an LCST is suggested, 
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which would allow the injection of a solution which would then gel upon warming to 
body temperature and entrap the microparticles. 
Degradable crosslinks are an obvious method of creating degradable hydrogel 
delivery devices.  Since the hydrogels investigated in this research respond to pH 
changes, lactic acid and similarly based degradable polymers would not be acceptable 
due to their elevated degradation in acidic media and the production of acidic 
byproducts.  Thus, this work described a whole family of possible degradable crosslinks 
based on labile carbonate bonds, whose hydrophilicity (and presumably degradation 
rate) was tunable by adjusting the PEG spacer length between carbonate bonds.  These 
crosslinking agents need to be fully characterized to determine their feasibility in an 
actual drug delivery device. 
Future work should include the characterization of these crosslinking agents and 
the investigation of microparticles implanted intraperitonealy either neat or contained 
in a secondary matrix.  This matrix would need to be investigated for its effects on 
glucose response and insulin release rates.  Finally, in vitro and in vivo biocompatibility 
studies would need to be conducted to determine the feasibility of such a drug delivery 
device.  Hydrogels exhibit several important features necessary for an intelligent drug 
delivery device, though many complications lie in the path to the development of a 
feedback controlled delivery device. 
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APPENDIX A 
The Biocompatibility of poly(ethylene glycol) Containing Biomaterials 
A.1 INTRODUCTION 
Biomaterials are natural or man-made materials used to replace, assist, or 
improve a component of a living system.  A biomaterial can range anywhere from an 
artificial skin graft [1, 2] to a dental implant [3, 4] to a drug delivery device [5, 6] to a 
synthetic heart [7].  They can range from nano-scale sizes up to macroscopic scale.  
These materials have intimate contact with biological surfaces, and thus a major 
problem in the development of new biomaterials has been the compatibility of the new 
material with its surrounding tissues.  This compatibility has been addressed in a 
number of ways, including using natural materials as a construct and decorating the 
material’s surface with more biocompatible materials [8]. 
It must be noted that there is a difference between toxicity and biocompatibility.  
Therefore, toxicity and biocompatibility tests must be performed on a new biomaterial 
to ensure limited or no complications will occur during usage.  Toxicity is generally 
caused by compounds leaching out of the biomaterial, such as unreacted monomer or 
degraded biomaterial byproducts.  Biocompatibility, on the other hand, is determined 
by the material itself and depends on the way the host immune system responds to the 
biomaterial's bulk and surface properties [9].  The bulk properties of the new 
biomaterial must be similar to the surrounding tissue to prevent damage to either the 
implant or the nearby tissue.  The interfacial properties of the implant and surrounding 
tissues must be tuned to reduce or eliminate an immune response, or else risk 
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degrading or losing the function of the device.  There are also numerous methods of 
testing for biocompatibility, both in vitro [10] and in vivo [11].   
Different materials inherently elicit different strengths of an immune response.  
Highly hydrophilic polymers, such as hydrogels, tend to mimic soft bodily tissue [12] and 
thus exhibit less immunogenicity [13, 14] than a much more rigid and hydrophobic 
polyethylene.  It has been shown that untreated titanium can even cause activation of 
platelets causing clotting [15].  In order to help make a material biocompatible, it is 
typically desirable to decrease protein adsorption, complement activation, and cell 
adhesion.  There are, however, certain instances where cell proliferation is desired on a 
biomaterial.  These devices, commonly referred to as scaffolds, are not covered in this 
review since they have entirely different properties from what one would want in a non-
cellular based biomaterial. 
A.2 IMMUNE RESPONSE 
The immune system is what springs to life when the host identifies some sort of 
injury or foreign material.  The foreign material can either be infectious, such as a 
bacterium or virus, or noninfectious, such as a biomaterial implant.  There are two parts 
to the immune system, the innate (rapid) and the adaptive immune systems, which 
distinguish “self” from “non-self” materials, cells, proteins, and molecules.  The goal of 
these systems is to destroy, remove, or segregate unwanted components from the rest 
of the host.  Without a defense mechanism as intricate as the human immune system, a 
simple laceration could potentially turn from a common annoyance to a very lethal 
problem [16]. 
The innate system produces a non-specific response to and is the first line of 
defense against foreign materials.  While it is able to quickly respond, within hours, to 
an infection, it can only recognize general motifs associated with “non-self” material.  It 
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is also not able to “remember” the last infection, and so the response is always the 
same.  The innate system is composed of cells (leukocytes) and circulating proteins, 
including cytokines and those composing the complement system.  It can also detect 
injuries to tissue, anticipating that the tissue damage was either caused by a foreign 
material or will allow a foreign material entry into the body [17-19].  This response is 
particularly important for biomaterial implants [16]. 
The innate system is strongly contrasted by the adaptive system, which is able to 
produce a much more specific response to each individual threat.  Humoral cells and 
proteins circulate through the host, and can either be activated directly by the foreign 
material or by the signals produced by the innate system.  Since they are able to adapt, 
they are able to respond to nearly an infinite array of “non-self” materials.  The adaptive 
system also “remembers” the invader from the last infection, and is able to respond 
more quickly to subsequent infections [8, 16]. 
These two pieces of the immune system work together to keep the host healthy 
and free of foreign substances.  After a biomaterial is introduced to the host, there is 
typically some sort of immune response.  It is very common during this process to coat 
the foreign object with numerous proteins to help aid in the detection of the intruder.  If 
the biomaterial is cell-based, the host will respond with its adaptive system; T-cell 
activation and B-cell antibody production will occur.  However, if the biomaterial is 
synthetic, it will most likely induce the innate system’s response.  A nonspecific reaction 
to the material will occur, by macrophages or the complement system, which can then 
lead to damage of the surrounding tissue.  It is therefore extremely important to 
prevent this cascade of events during the usage of a biomaterial [8, 16]. 
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A.3 COMPLEMENT SYSTEM 
The complement system was first described by Paul Ehrlich as the plasma 
proteins necessary for a host to recognize and dispose of bacteria via antibodies.  There 
are over 30 known plasma and surface proteins involved in the complement system 
which work together in a cascade to amplify the response to a foreign material [20, 21].  
The complement system has three known components: classical, lectin, and alternative 
pathway.  It plays an essential role in the immune system’s ability to identify “non-self” 
surfaces due to the ability of these proteins to adsorb to surfaces, and the ability of 
“self” cells to easily desorb or remove these proteins from their surfaces.  This process 
allows the complement system to coat a foreign surface and then recruit cells to either 
destroy or encapsulate it [16, 22]. 
All three components of the complement system are initiated differently but 
then converge with the activation of C3 [16, 20].  These earlier components, as well as 
C3 itself, are proenzymes which, upon cleavage, activate the next component.  This 
order of events allows an amplification of this cascade, since once activated, a 
component can then activate numerous more components.  Once activated, C3 is split 
into C3a and C3b [20]; C3a circulates through the blood to act as a signal, whereas C3b 
binds to the surface of the foreign material [23-25].  The classical pathway is activated 
by IgG or IgM [16] with C1 initiation on the surface of the foreign material, which then 
eventually activates C3.  The lectin pathway is initiated with mannan-binding lectin, 
which binds either mannose or fructose on the foreign surface [22].  The alternative 
pathway is directly initiated by activated C3, which circulates at very low concentrations, 
and then attaches to the foreign substance [26, 27].  Normal autonomous cells have 
specific proteins coating their surface to prevent buildup of activated C3, C3b, which 
prevents complement activation [16]. 
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It appears that this activation of C3 could be the most important aspect of the 
complement system [25, 28].  It has been shown that a conformational change in C3 
allows a hidden thioester group to become available on the surface of the protein [25], 
which is able to easily bind to free amino or hydroxyl groups on the biomaterial.  C3 can 
also changes its conformation and noncovalently bind to a polymer surface [29].  
Therefore, activation of C3 is an aid in determining foreign materials [24].  Prevention of 
this binding step is a potential target for increasing the biocompatibility of many 
biomaterial systems [25]. 
There are numerous methods of detecting complement activation, ranging from 
methods that measure levels of complement proteins adsorbed to the surface of the 
biomaterial, to the measurement of soluble factors in the medium surrounding the 
biomaterial.  With the way the complement system performs its cascade and 
amplification, for each proenzyme cleavage, there results in a smaller soluble factor 
which circulates and a larger enzymatic factor that tends to localize around or adsorb to 
the biomaterial itself.  The soluble factor can be detected with numerous analytical 
techniques, such as Enzyme-Linked ImmunoSorbent Assay (ELISA) [30, 31], precipitation 
tests using PEG [32], or 2-D electrophoresis [33].  Measurement of the bound C3b was 
performed by direct radioimmunoassay [34], the CH50 method [35, 36], and others. 
A.4 THROMBOGENICITY 
Thrombogenicity is the ability of a material to induce clotting upon contact with 
the blood.  This clot can form locally and remain local, form locally and detach (forming 
emboli), or form at some satellite location due to the presence of the biomaterial [8].  
This process is mediated by numerous proteins as well as cells and cell fragments.  As 
with many immunological responses, the clotting procedure follows a cascade of events 
which are amplified until a full-blown clot is formed [21, 37].  If a blood clot forms on a 
 177 
newly introduced biomaterial, there could be dire consequences for either the 
biomaterial itself or the patient. 
There are two distinct pathways towards a blood clot, which then converge upon 
the formation of thrombin and fibrin.  The intrinsic pathway begins with protein 
adsorption to negatively charged surfaces, which produces a cascade of factor 
activations ultimately activating factor X.  The extrinsic pathway, which is more specific 
to biomaterials [38], activates factor VII with the aid of tissue factors released from 
locally damaged cells.  Once thrombin is formed, it catalyzes the polymerization of 
fibrinogen into fibrin.  Unless streptokinase or urokinase degrades this fibrin clot, 
platelets will adhere forming a white clot.  The platelets adhere to the fibrin, becoming 
sticky and forming pseudopods.  The next step involves the entrapment of red blood 
cells, forming a red clot [8, 38].  By this time, the clot has reached a size of 30 µm or 
more and has become quite dangerous. 
As alluded to above, there are certain circulating proteins that specifically attract 
platelets, and adhesion of vitronectin, fibronectin [8], fibrinogen, or von Willebrand 
factor [39] onto a surface mediates platelet adhesion.  These proteins adhereing to the 
surface of the biomaterial propagate the clotting cascade.  Fibrinogen provides an 
irreversible means of attachment, which decreases as blood shear rate increases, 
whereas von Willebrand factor slowly provides more and more adhesion as shear rate 
increases [39].   
There are a number of methods that may potentially delay or inhibit clot 
formation [37].  If protein adsorption is prevented, then the clotting cascade cannot be 
initiated.  Antithrombin III and tissue factor pathway inhibitor (TFPI) are such proteins 
which can decrease clotting [8].  It has been shown that coating a surface with albumin 
can actually decrease the thrombogenicity of a material [40-43].  These data provide 
means of decreasing the clotting cascade that would otherwise retard or inhibit the 
usage of a biomaterial. 
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A.5 POLY(ETHYLENE GLYCOL) 
Poly(ethylene glycol) (PEG) is a biocompatible polymer of repeating ethylene 
glycol units.  In an aqueous environment, each ethylene glycol repeat unit binds multiple 
molecules of water.  This phenomenon allows the PEG chains to repel each other and 
form a “brush-like” conformation when the appropriate PEG density is achieved [44].  
PEG is soluble in both aqueous and organic environments while similar polyethers are 
not [45].  PEG in aqueous solutions also has a large excluded volume, which helps impart 
some of its interesting properties. 
PEG has long been known for its resistance to protein adsorption [46-48] which 
can be attributed to its steric repulsion, hydrophilicity, and chain mobility [49].  Two 
surfaces coated with PEG will develop repulsive forces when brought close enough, due 
to the steric stabilization of each PEG chain.  The interaction between infinitely sized 
[47] to small sized [46] proteins has been modeled, showing that van der Waals 
interactions between the PEG and protein are negligible.  Numerous groups have tried 
to model the ability of PEG to prevent protein adsorption [44, 46, 47], including using 
the single-chain mean-field analysis [50].  There are some studies that show an adhesive 
force between PEG and protein can be achieved [45], but high compressive forces were 
needed to obtain this adhesion and the PEG chains were possibly forced to envelope the 
protein.  While PEG itself is able to decrease protein adsorption, there are many other 
factors that influence whether an entire biomaterial will adsorb proteins. 
There are many groups working on PEG containing biomaterials [51-56].  Many  
times, a material with the correct physical characteristics to solve a biomedical problem 
just does not have the biocompatibility characteristics needed in a biomaterial.  
Therefore, a strong thrust towards increasing biocompatibility while retaining the 
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function of the biomaterial has been undertaken.  Following is a review of numerous 
attempts at using PEG in materials to make them more biocompatible; specifically, PEG 
has been used with biomaterials to decrease protein adsorption, decrease cell adhesion, 
increase blood compatibility, and decrease the activation of the complement system. 
A.5.1 PEG Coatings 
Many natural materials have been decorated with PEG in attempt to increase 
biocompatibility by decreasing protein adsorption, decreasing cell adhesion, and/or 
decreasing thrombogenicity [57-61].  Kishida, et al., took cellulose membranes and 
grafted PEG to the surface.  Both a mono-acid and di-acid form of PEG were used, which 
were covalently bound to the free hydroxyls of the cellulose.  The di-acid actually 
increased adsorption of bovine serum albumin as well as γ-globulin, whereas the mono-
acid did not change the protein adsorption from the neat cellulose.  Both did, however 
decrease complement activation.  It was suspected that the free carboxylic acid on the 
di-acid allowed ionic interactions between proteins and the surface, which increased 
adsorption [57]. 
Chitosan is another commonly used natural polymer for biomaterials [58-61].  
Five types of chitosan-PEG blends were studied to test their physical, chemical, and 
biological properties.  PEGs with molecular weights of 6000 and 8000 Da were used, in 
ratios of 2:1 and 4:1 by weight.  They showed that, for low levels of PEG, protein 
adsorption and cell adhesion and proliferation increased.  However, once the PEG 
surface coverage was high enough, protein adsorption decreased as did cell adhesion.  
While the study was for new cellular scaffolds, it was shown that an increase in the PEG 
content will also increase biocompatibility with the immune response [62]. 
There has been a significant amount of research in coating polymeric materials 
with PEG [63-68].  PEG has been adsorbed to the surface [65-68], covalently bound to 
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the surface, and formed interpenetrating networks [63] on the surface of numerous 
polymeric materials.  The advantages and disadvantages of each method have been 
studied.  Adsorbing to the surface can involve an easier synthetic route, such as ionic 
interactions or hydrophilic or hydrophobic interactions, but has the disadvantage of 
desorption over time.  If the device will be in vivo for prolonged periods of time, the 
biocompatibility of the device will decrease over time.  Covalently bound PEG, whether 
to the surface, copolymerized with the polymer, or polymerized as an interpenetrating 
network, appears to offer much longer compatibility. 
The effect of hydrophilic and hydrophobic components has also been studied on 
polymers composed of PEG and poly(tetramethylene oxide) (PTMO) or poly(dimethyl 
siloxane) (PDMS).  Both random and block copolymers were formed.  Measurements 
indicated that longer PEG lengths, as well as usage of PDMS instead of PTMO, increased 
hydrophilicity.  Significantly lower adsorption of human serum albumin, human 
fibrinogen, and IgG was measured on the PEG containing polymers.  With this decrease 
in protein adsorption, a decrease in platelet adhesion was also detected.  The most 
promising material was PDMS with a 3400 Da PEG graft [64]. 
A.5.2 PEG as a Copolymer 
Since hydrogels are similar to bodily tissue [12], it is only natural that they are 
used in biomaterial devices.  It is also only natural that an increase in biocompatibility 
would be desired.  Interpenetrating networks of acrylamide and ethylene glycol have 
been made {Bearinger, 1997 #44}, as have acrylonitrile membranes [69, 70] and other 
biomaterials.  Other forms of hydrogels containing PEG have also been synthesized [64, 
71-73].  These hydrogel systems have been tested for protein adsorption, cell adhesion, 
and complement activation in order to determine overall biocompatibility and 
resistance to blood clotting. 
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Instead of a traditional copolymerization procedure, interpenetrating networks 
of PEG have also been studied [63 , 74-76].  An interpenetrating network consists of two 
independent polymeric systems, both of which are crosslinked with themselves but not 
crosslinked with each other.  The chains of each network actually interpenetrate each 
other, thus producing a polymeric system of two entangled networks which cannot be 
separated without breaking chemical bonds [77, 78].  The advantage of this approach is 
that the PEG component of the device can be added after the fact; the original 
biomaterial can be prepared as usual, and provided that it has some sort of porosity, the 
PEG network can be formed around and through the existing material.  This procedure 
can make the synthetic route for the biomaterial significantly easier, since pre-made 
devices can easily be PEGylated. 
Interpenetrating networks of acrylamide and PEG were made on silicon wafers.  
The silicon was first coated with an acrylamide network by silanization and then 
photoinitiated polymerization of acrylamide with N,N-methylenebis(acrylamide) as a 
crosslinker.  PEG monomethylether monomethacrylate of molecular weight 1000 Da 
was then polymerized through the acrylamide network, also using N,N-methylenebis 
(acrylamide) as a crosslinker.  There was no statistically relevant adsorption of bovine 
serum albumin on either acrylamide or acrylamide-PEG interpenetrating networks; 
however, there was a statistical amount of adsorption on the untreated silicon.  Cell 
adhesion was also significantly decreased on the polymer-coated silicon surfaces.  
Therefore, it was shown that PEG does not have to be tethered to a surface to help 
impart resistance to protein adsorption [63]. 
Mixtures of hydrophobic polymers with PEG have been tested for their 
biocompatibilities.  Polymers of octadecylacrylate were synthesized, some of which 
were functionalized with either PEG or PEG-sulfate groups.  Free radical polymerization 
in toluene was performed.  Coagulation tests indicated that the PEG coated polymers 
had decreased protein adsorption and decreased thrombogenicity.  The PEG-sulfate 
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polymers had superior blood clotting characteristics, and improved complement 
activation over the normal PEG polymers.  Both C3 and C5 levels were decreased, 
markedly decreasing other factors indicating the improved complement system 
compatibility.  It was thought that the negative charge held on the sulfate group played 
a significant role in the decreased activation of the complement system [79].   
A.5.3 PEG and Polyurethane 
Polyurethane is one of the longest used biomaterial.  It was one of the original 
materials used in an artificial heart; however, it was plagued with problems of blood 
coagulation [8].  Polyurethane elastomers were synthesized, initiated from a PEG, PPO, 
or PTMO chain.  Human serum albumin adsorption was significantly reduced in the 
urethanes containing PEG.  However, there were no clear cut results as to whether 
bacterial adhesion was increased or decreased.  There were significant variations 
depending on species of bacterium used [80]. 
Other results were interesting.  Surface modified Pellethane 2363-80AE was 
made using multiple coatings.  Both surface adsorption, using ampiphilic block 
copolymers, and surface grafting were performed.  The ampiphilic polymers used were 
Pluronic PE9400 and a custom made segmented polyurethane using PEG of molecular 
weight 1500 Da.  The adsorption of fibrinogen and albumin was measured, and both 
were significantly decreased from the normal polyurethane sample.  The Pluronic results 
were very similar to the PEG grafting of molecular weight 20000 Da.  Blood clotting in 
vitro was also shown to have decreased with the surface coatings of PEG, indicating 
higher biocompatibility [81]. 
One last group indicated a much more promising outlook for PEGylated 
polyurethane [81, 82].  Segmented polyurethane, with dicumyl peroxide crosslinks, 
containing PEG, was synthesized.  The number of PEG repeat units varied from 0 to 98, 
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and both UV and temperature initiated polymerizations were used.  As little as 5% PEG 
was necessary to elicit changes in surface properties.  Platelet adhesion from fresh 
human blood, and therefore most likely protein adsorption, decreased with an increase 
in PEG content.  There was not much difference between UV and thermally initiated 
polymerizations.  These data follow more hydrophilic polymeric systems trends, 
indicating that PEG is able to shield the polyurethane core from the surrounding 
environment.  It was also noticed that the addition of PEG acts as a plasticizer of the 
polyurethane, decreasing the tensile strength and increasing the elongation at break 
[82].   
A.5.4 PEG on Membranes 
Membranes of acrylonitrile-co-maleic acid have been synthesized [69, 70, 83].  
Hydrophilicity of these membranes was increased significantly on the addition of PEG 
grafts.  PEG chains of molecular weight 200, 400, 600, and 1000 Da were used.  As PEG 
chain length increased or maleic acid content increased, bovine serum albumin 
adsorption decreased.  The same trends yielded improved filtration as well, which was 
attributed to the increased hydrophilicity.  Platelet and macrophage adhesion also 
decreased with increasing PEG content.  Therefore, these biomembranes have much 
lower fouling properties than the neat acrylonitrile-co-maleic acid membranes. 
A commonly used biomaterial is expanded poly(tetrafluoroethylene) (ePTFE) [84-
88].  It is highly inert, nontoxic, and microporous.  These properties combined were 
suspected to work well in a biological membrane device.  However, the extreme 
hydrophobicity can cause complications.  Atmospheric pressure glow discharge of PEG, 
with molecular weight of 600 Da, was used to coat ePTFE surfaces, which were then 
tested for biological use.  Albumin adsorption increased, while γ-globulin did not change 
and fibrinogen decreased.  More than 3% coverage with PEG seemed to induce platelet 
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adhesion, which could lead to clot formation.  However, with the decreased fibrinogen 
adsorption and the slight adhesion of platelets without conformational changes, the 
modified ePTFE appeared to be a fairly non-thrombogenic material [89].  The benefits of 
this improved membrane device could have implications in artificial kidneys, allowing 
improved dialysis with less membrane fouling, therefore reducing the maintenance 
costs of the devices. 
A.5.5 PEG on Non-Biological Surfaces 
Decorating material surfaces with PEG has been used with completely non-
biologically similar materials such as silicon [49, 90], glass [91], and gold [92].  Grafting 
linear PEG of molecular weights of 3400, 10000, and 20000 Da, as well as star PEG, to 
silicon wafers was achieved via aminosilane treatments of the silicon and tresyl 
treatments of the PEG.  The adsorption of cytochrome-c, albumin, and fibronectin were 
all studied, and grafting densities of 100 ng/cm2 yielded nearly zero adsorption for all 
proteins.  It was observed that, with the tested molecular weight PEGs, chain overlap 
was necessary for the protein adsorption resistance.  Therefore, as the molecular weight 
of the PEG chain decreased, the grafting density needed to increase.  However, star PEG 
chains were effective at preventing protein adsorption provided the gaps between 
chains were smaller than the proteins themselves [90]. 
Sharma, et al., were able to surface coat silicon squares with both a solution-
based and vapor-based approach.  The silicon may have micron or nano scale channels 
etched into the surface to provide functionality to the device, where the viscosity or 
surface tension of the PEG-silane solution could inhibit the formation of a confluent PEG 
layer.  Therefore, the vapor deposition of ethylene oxide appears to be a better method 
of obtaining an even PEG coating.  They demonstrated that both methods of PEGylation 
were able to significantly decrease fibrinogen and albumin adsorption over the neat 
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silicon, and there was no significant difference in adsorption between the two methods 
of PEGylation [49].  These data imply decreased cell adhesion and better 
biocompatibility over uncoated silicon devices. 
Glass can also be silanized with PEG to increase biocompatibility.  PEG of 
molecular weights 750 and 5000 Da were functionalized with silane and then allowed to 
self-assemble on the glass surface, thus the term “self-assembled monolayers” (SAMs) 
of PEG.  The lower molecular weight PEG formed brush-like structures, with the chains 
extending about 85% of their total lengths.  The higher molecular weight PEG tended to 
form a mushroom configuration, with significant entanglement away from the glass 
surface as shown by the approximately 25% extension of their total lengths.  Adsorption 
of bovine serum albumin on both PEGylated surfaces was significantly decreased, to 
about 6% of that adsorbed to uncoated glass.  There were, however, differences in 
diffusion and aggregation of bovine serum albumin on the different length PEGs, which 
was attribute to aqueous content and conformational differences [91]. 
SAMs can be used to coat gold slabs as well, by using PEG with thiol derivatives 
to form the self-assembled monolayer.  The reaction between gold and thiol groups has 
been well established [93-95].  The work done by Prime and Whitesides is interesting 
because they were able to find an empirical method of determining the molar coverage 
by PEGylation that is necessary for prevention of protein adsorption, specifically, n0.4 
where n is the number of ethylene glycol repeat units.  Alkanethiols with varying 
ethylene glycol repeat units were used to coat gold slabs, after which the adsorption of 
fibrinogen, lysozyme, pyruvate kindase and RNAse A were measured.  It was shown 
that, on average, there was no difference between hydroxy terminated and methoxy 
terminated PEGs, an increase in the number of PEG repeat units decreased the total 
surface coverage needed for the prevention of protein adsorption, and higher surface 
coverage prevented more adsorption [92].   
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One last similar approach is the coating of silica with PEG.  The silica layer was 
deposited by plasma-enhanced vapor deposition of SiH4 and O2, which was then 
activated with water plasma to coat the silica layers with hydroxyl groups.  PEG with a 
molecular weight of 400 Da was used to coat the silica, also via plasma deposition.  
Protein adsorption experiments were carried out to measure how much bovine serum 
albumin adsorbed to each surface.  While treating the silica with water plasma only 
slightly decreased the amount of adsorbed protein, treating with PEG significantly 
dropped to protein adsorption.  The interesting part of this research is the flexibility of 
the process [96].  Since the PEG is covalently bound to the silica, nearly any surface that 
can have silica plasma-deposited on it has the potential to be PEGylated via this method.  
This can decrease problems with finding reactive functional groups for a biomaterial or 
even issues with the shape and size of the biomaterial.  Therefore, it is possible to 
functionalize surfaces that would not normally be considered for use in biomaterials due 
to their inherent non-biocompatibility. 
A.5.6 PEG and the Complement System 
The majority of the previous work mainly focused on two aspects of 
biocompatibility, namely, adsorption of proteins and adhesion of cells to the surface of 
the biomaterial.  To test for complete nonimmunogenicity, the activation of the 
complement system must also be analyzed.  Without prevention of the activation of the 
complement system, biomaterial devices will rapidly be flagged by the body and either 
opsonized or isolated.  Decreased adsorption of serum proteins is not the only feature 
needed to decrease complement activation, as shown below. 
One common area of research for biomaterials is in the drug delivery field.  The 
general trend is to decrease the size of the devices, in hopes of decreasing the immune 
response to the device.  What started at macroscale oral tablets has shrunk to micro- 
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and nano-sized particles, allowing more rapid release and even allowing intravenous 
injections of long-circulating drug delivery devices.  The implications of improved drug 
delivery devices are to increase the patient compliance by increasing the bioavailability 
of the drug, as well as increasing the length of time between dosings.  This will 
ultimately result in improved control over the diseased state, as well as lower chances 
of falling out of the therapeutic window of the drug, either above (toxic) or below 
(ineffective).  These devices can be liposomic or polymeric in nature, and can be formed 
by a wide variety of methods [33, 35, 36, 97-100]. 
Liposomes are composed of amphiphilic lipid molecules that can self-assemble 
into spherical capsules.  The lipid molecules have hydrophilic heads and hydrophobic 
tails, and thermodynamics drives the molecules into spherical conformations.  
Monolayers, bilayers, and higher ordered systems can be formed; a monolayer would be 
preferred for a slightly water-soluble drug, whereas a bilayer would be preferred for a 
highly water-soluble drug.  Sizes can range from 10 nm to over 10 µm.  The inherent 
interest in liposomes lies in the fact that all known cells are composed of these lipid 
bilayers, and therefore even a synthetic liposome appears more natural than polymeric 
systems [36, 97, 98].  Unfortunately, non-functionalized liposomes are easily 
sequestered by the immune system and highly activate the complement system. 
The introduction of PEGylated liposomes was a significant breakthrough in the 
development of sustained release drug delivery devices [98].  These liposomes can be 
created in many different ways, but one common method is to link a methoxy 
terminated PEG to the phospholipids using a carbamate bond [98].  Other methods 
include terminal amino and epoxy group functionalizations [100].  It has been shown 
that, to yield the desired lack of protein adsorption, PEG of molecular weights between 
2000 and 5000 Da are necessary.  PEG chains larger than this size may cause instability 
of the liposome, whereas smaller chains may not provide the necessary coverage to 
prevent protein adsorption.  Sizes in the range of 70-200 nm seem to be ideal; 
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liposomes larger tend to be noticed and opsonized much more quickly, whereas 
liposomes smaller tend to get lost in the leaky vasculature of certain organs [98, 100].  
These modifications have increased circulation times, but not necessarily decreased 
complement activation [36].  Vonarbourg attributed this problem to too dense a PEG 
coating on small particles, which decreased the ability to shield the particles from 
protein adsorption and therefore phagocytosis. 
A second method of drug delivery is using polymeric micro and nano particles or 
capsules.  Common systems include poly(lactic acid) (PLA), poly(glycolic acid) (PGA), or 
mixtures of the two.  These systems are hydrolysable in aqueous media, and therefore 
are biodegradable in vivo. Numerous research groups are working on PLA/PGA based 
devices for delivering drugs, whether targeted or not.  One specifically tested adsorption 
versus covalent grafting of PEG to nanocapsules and nanospheres.  Data indicate that 
capsules tend to activate the complement system less than spheres, but could 
potentially be due to residual lecithin on the capsule surfaces.  As the PEG chain length 
increased, biocompatibility also increased [33].  
Other groups had much better success using PLA and PGA particles containing 
PEG.  Diblock copolymers of PLA-PEG were synthesized, using PEG of a molecular weight 
of 2000 Da.  Human serum was used in a CH50 test to determine complement 
activation.  PLA particles without PEG produced a strong and rapid complement 
activation, whereas PLA-PEG diblock copolymers having an average PEG surface density 
of greater than 0.2 molecules per square nanometer had significantly reduced 
complement activation.  Therefore, below the threshold PEG levels, the PEG is unable to 
produce its brush-like conformation, decreasing its ability to inhibit complement 
activation.  Once the PEG content was brought up above the threshold, complement 
activation was decreased drastically.  There still is the possibility of C3 activation by non-
covalent binding, but more tests needed to be performed to test that potential 
complement activation method [29]. 
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In contrast to covalently bonded microparticles, there are ionically stabilized 
microparticles.  One such device is a PEG-graft-poly(L-lysine) (PEG-g-PLL) copolymer, 
forced into microparticles by the ionic interaction with sodium alginate.  A noticeable 
decrease in protein adsorption, cell adhesion, and complement activation was observed 
for the PEG containing PLL polymers over the neat PLL polymers.  IT was also recorded 
that the microcapsules became leakier; that is, solutes diffused more rapidly out of the 
PEG-g-PLL/alginate systems than the PLL/alginate systems.  To compensate for this, 
multilayered devices were synthesized, using layers of alginate, then PLL, then alginate, 
then PEG-g-PLL, and then alginate once more.  This process yielded a more ideal device, 
as it retained its ability to prevent protein adsorption as well as decrease the activation 
of the complement system.  At the same time, it also decreased the diffusion of solutes 
out of the system, allowing a tunable delivery device.  These systems have also been 
determined to be stable for at least one month, providing the ability of mass-produced 
off-the-shelf delivery devices [34]. 
It must be noted that all articles reviewed thus far have been using an in vitro 
approach to measuring biocompatibility, and at most, have used blood plasma for the 
thrombogenicity studies.  Some work has been done to test the protein adsorption and 
blood clotting of PEGylated surfaces using whole blood.  Titanium is a common metal in 
medical applications due to its high strength-to-weight ratio.  Uncoated titanium, 
however, has been shown to elicit clotting of blood.  Ionically bonding a PEG layer, by 
treatment with poly(L-lysine)-g-PEG, was shown to increase clotting time threefold.  The 
treated titanium also showed no antibodies binding fibrinogen, kininogen, or C3.  These 
data indicate that a decreased clotting and decreased complement activation occurs 
when coating titanium with PEG [15].  Again, the evidence suggests that PEG can help 
decrease complement activation while decreasing protein adsorption and cell adhesion. 
 190 
A.5.7 PEG and Polystyrene 
Polystyrene has an interesting place in the review of PEG biomaterials.  
Untreated, polystyrene is highly non-biocompatible, and will induce protein adsorption 
quite rapidly.  However, attempts were made to PEGylate polystyrene in order to model 
cellular behavior.  PEG chains with mono and bi functionalities, including amino, 
methoxy, and hydroxyl, were used in this study.  Molecular weights of 1500, 3400, and 
5000 Da were used.  The control used was polystyrene coated with carboxylic acid 
functional groups.  Protein adsorption was measured by incubating samples in human 
plasma and then separating the particle out with centrifugation.  The proteins were then 
desorbed via sonication, and once again the particles were separated out.  Complement 
system activation was also measured with fresh human blood.  As PEG surface 
concentrations approached 40 pmol/cm2, the amount of protein adsorbed dropped to 
90% or less than the control.  The end group of the PEG did not appear to make any 
significant difference in protein adsorption.  Over 30% of the adsorbed proteins were 
albumin, or similar, and therefore are potentially beneficial.  As PEG concentrations 
increased above 55 pmol/cm2, substantial complement activation occurred.  Hydroxyl 
terminated PEG chains also induced much higher complement activation [101]. 
Another method of PEGylation involves using Pluronic™ materials.  Pluronics™ 
are made of poly(propylene oxide) (PPO) blocks with PEG blocks on each end.  This block 
copolymer was adsorbed to polystyrene surfaces.  The hydrophobicity of both the 
polystyrene and PPO provided a means of immobilizing the Pluronic™ chains.  Protein 
adsorption and complement activation were measured.  Factor H, a cofactor for 
inactivating C3 and a competing binding partner for B and Bb (parts of the C3 
complement activation cascade), was also bound to these polymeric devices.  The 
inertness of the PEG decreased protein adsorption, whereas the bound factor H helped 
decrease the complement activation.  However, a possible cause for slight complement 
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activation was the PPO block in the Pluronic™ [20].  It appears that there tends to be a 
tradeoff between decreased coagulation and decreased complement activation. 
Gorbet and Sefton concur with this tradeoff between complement activation and 
protein adsorption.  They also used polystyrene beads, TentaGel™, of 45 µm diameters 
to perform their experiments.  PEG chains of roughly 3000 Da were used.  Fresh whole 
blood from humans was used in the complement activation tests, of which serum was 
extracted.  Both the coated and uncoated polystyrene beads elicited C3b binding.  
Leukocyte adhesion was also fairly high.  Again, they attributed these issues to hydroxyl 
groups allowing the covalent attachment of C3 proteins to the ends of the PEG chains, 
thereby increasing complement activation [38]. 
A.5.8 Problems with PEG 
 While nearly all other reports indicate significant improvements in 
biocompatibility by the addition of PEG, some research indicates PEG may not be as 
bioinert as previously thought.  As noted earlier, liposomes are an interesting 
biomaterial for drug delivery.  Significant increases in circulating half-lives have been 
shown, simply by PEGylating the surface.  However, there may possibly be an 
“accelerated blood clearance phenomenon” which decreases the half-life of circulating 
liposomes instead.  Contrary to what would be expected, an increase in the initial dose 
of PEGylated liposomes actually decreases this phenomenon [102], while decreasing the 
time between injections increases this phenomenon [103].  There are certain serum 
factors circulating in the blood that help contribute to this phenomenon, notably IgM, 
which appear to bind to the PEG portion of the liposomes.  Even in “naïve” serum, slight 
complement activation was noted.  It is suggested that the IgM bound directly to the 
PEG, since it did not bind to non-PEGylated liposomes after the accelerated blood 
clearance phenomenon had been observed.  This may, however, be misleading since 
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PEG alone did not induce IgM binding until it had been coated on a liposome [104].  A 
similar phenomenon has been called the hypersensitivity reactions (HSRs) which have 
been common with liposomal drug delivery devices [105]. 
 A second report shows similar results, when a red blood cell was 
PEGylated to decrease the immune response to non-matching ABO antigens.  Typically, 
upon transfusion, if the ABO are not correctly matched, an immune response occurs, 
lysing the foreign red blood cell.  Upon PEGylation with cyanuric chloride activated PEG, 
molecular weight 5000 Da, the recognition of the red blood cell by antibodies.  
Unfortunately, it also increased the complement activation via the classical pathway.  
Again, an increase in IgM was noticed on the mismatched red blood cells, indicating that 
the possible cause of complement activation was the PEG itself.  It is interesting that 
PEGylation decreased the adaptive immune response while increasing the innate 
immune response [106]. 
A.6 SUMMARY AND CONCLUSIONS 
As shown above, the biocompatibility of a new biomaterial is one of the most 
important design criteria for the device.  There are numerous issues with trying to 
introduce new materials and devices into the body, whether the construct be of 
synthetic or natural materials.  The immune response to a material, whether it is 
complement activation, the formation of a fibrotic encapsulation, or blood coagulation, 
poses a serious threat to the deployment of mass-produced biomaterial devices.  All of 
these responses are due to cascades of events which amplify even a small 
immunological response to a scale that can cause significant problems to both the 
biomaterial device and the patient himself. 
One method of avoiding the immunological response has been to use 
poly(ethylene glycol) to prevent adsorption of proteins, adhesion of cells, and decrease 
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complement activation and blood coagulation.  The hydrophilicity, lack of ionic charge, 
and steric repulsion characteristics of PEG are what give it a place in biomaterial design.   
A plethora of articles have reported decreased protein adsorption and decreased cell 
adhesion with numerous variants of PEGylation and even more variations of devices and 
biomaterial systems.  With the range of problems that biomaterials can potentially fix, it 
is promising to see that an even larger range of materials are being tested for usage in 
biomaterials.  These data provide hope to the research and medical communities for 
finding a mechanism of creating truly “stealth” biomaterials to improve or repair the 
ailments of a patient. 
It is interesting that there are numerous ways to add PEG to a biomaterial 
surface.  Free hydroxyl groups are easy to react PEG on to, but many other functional 
groups such as amines, siloxanes, carbamates, and thiols can be used.  The biomaterial 
itself does not even have to be functionalized; silica or gold could be plasma deposited 
on the surface, and then the silica or gold surface can easily be functionalized.  This 
versatility increases the ability of researchers to be able to use PEG in the creation of 
new biomaterials and devices. 
There are, however, numerous problems with the usage of PEG.  If the PEG is not 
covalently bound to the device, then it will elute out of the system over time.  If it is not 
coated consistently enough or densely enough, then it will not provide the necessary 
protection from the immune system.  It has even been observed that PEG could possibly 
elicit a direct immune response, causing the formation of IgM that can actually bind PEG 
itself.  Several research groups observed that hydroxyl terminated PEG chains tend to 
elicit higher complement activation than methoxy terminated PEG chains.  Numerous 
groups have noted that PEG alone tends to have a tradeoff with improving 
biocompatibility properties.  As the protein adsorption, cell adhesion, and blood 
coagulation decrease with increasing PEG lengths and/or densities, the complement 
activation tends to increase.   
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It is therefore the view of the author that, while PEG offers significant 
advantages over neat biomaterial devices, it is still a long ways away from solving the 
total biocompatibility issue.  It also appears that PEG alone will not be able to provide 
the necessary protection of a new device from the immune response.  Coating the 
biomaterial with peptide fragments or proteins, in addition to the PEG, will most likely 
be necessary to produce truly “stealth” systems that can avoid the immune response.  
The human body is full of cells and biological molecules, and trying to trick the body 
with strictly synthetic methods will be a more frustrating and less fruitful endeavor than 
trying to use what nature has already provided. 
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